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1. Desmosomes 
 
Overview 
 
Desmosomes (DMs) are specialized and highly organized intercellular junctions that 
indirectly couple cytoskeletal intermediate filaments of adjacent cells. Strong cell-cell 
adhesion between adjacent cells is achieved through a complex network of protein-
protein interactions that distributes mechanical tension across all cells, maintaining the 
structural and functional integrity of tissues (Kowalczyk & Green 2013). DMs are 
present in all epithelial cells as well as in specific non-epithelial tissues such as the 
myocardium. Desmosome-mediated adhesion is particularly important in the skin and 
heart, which routinely undergo acute mechanical stress (Franke et al. 2006). They are 
especially predominant in these tissues, which are also the main targets in 
desmosome-related disorders. Desmosomal-diseases symptoms typically encompass 
epidermal fragility and blistering, palmoplantar keratoderma, and/or cardiomyopathy 
(Al-Jassar et al. 2013; Delmar & McKenna 2010; Ishida-Yamamoto & Igawa 2014).  
  
Structure  
 
Ultrastructurally, DMs appear as electron-dense discs symmetrically arranged in 
adjacent cells in a multi-layered manner. They are composed of three major protein 
families: desmosomal cadherins (desmogleins and desmocollins), armadillo proteins 
(plakoglobin and plakophilins) and plakins (desmoplakin) (Figure I1). Nonetheless, the 
precise molecular composition of DMs is variable, depending on tissue- and 
differentiation-specific expression of particular isoforms of the constituent proteins 
(Garrod & Chidgey 2008). The quite large number of desmosomal proteins isoforms, 
together with their complex expression patterns, suggests that specific isoforms make 
unique contributions to address the specific needs of different cell types or tissues.   
 
 
Figure I1. The desmosome. A) Schematic representation of the molecular composition of DMs and their 
organization. In brief, the desmosomal cadherins (desmocollins, green; desmogleins, blue) interact in the 
4 
extracellular space through their ectodomains. Intracellularly, desmosomal cadherins bind to armadillo-
proteins (plakoglobin, orange; plakophilins, yellow) which mediate the connexion to the intermediate 
filaments (IFs, brown) throughout desmoplakin (DP, purple). The interactions between plaque proteins and 
the cytoplasmic tails of the desmosomal cadherins take part in the outer dense plaque (ODP), whereas DP 
binds IFs at the inner dense plaque (IDP). B) Immunofluorescence image of E-cadherin (adherens 
junctions, green) and DSG-2 (DMs, red) in HaCaT cells growing in DMEM. Notice that DSG-2 is located in 
a punctuate pattern over the plasma membrane, presumably, where DMs are formed. E-cadherin also 
shows a peripheral and punctuate distribution but does no co-localize with DSG-2.  
Molecular composition 
 
Desmosomal cadherins belong to the cadherin superfamily of transmembrane 
glycoproteins that mediate calcium-dependent cell–cell adhesion (Saito et al. 2012). 
Two different cadherins subtypes participate in DMs: desmogleins (DSGs 1-4) and 
desmocollins (DSCs 1-3). DSGs and DSCs form intercellular contacts by establishing 
homo- and hetero-philic interactions between their ectodomains (Chitaev & 
Troyanovsky 1997). Intracellularly, the cytoplasmic tails of the desmosomal cadherins 
scaffold the desmosomal plaque proteins.  
 
Armadillo proteins (ARM-proteins) are characterized by the presence of a central 
domain containing repetitive units of ~42-amino acid that adopt an α-helical structure 
(ARM-repeats) (Choi & Weis 2005; Hatzfeld 1999). ARM-proteins do not necessarily 
show a high sequence identity but they share a similar structure where ARM-repeats 
are folded together in a superhelix that enables the interaction with many protein 
partners. Thus, ARM-proteins show very diverse cellular functions (Tewari et al. 2010). 
Within DMs, two different ARM-proteins tether desmoplakin (DP) and cluster the 
intracellular tails of DSGs and DSCs at the cytoplasmic plaque: plakoglobin (PKG) and 
plakophilins (PKPs).  
 
PKG is the best characterized ARM-protein of DMs. It is also found at adherens 
junctions (AJs) (Knudsen & Wheelock 1992) and harbours the 12 ARM-repeats that 
characterize this family. In addition to this structural role at the DM, PKG also mediates 
important roles in signal transduction pathways (reviewed in Aktary & Pasdar 2012; see 
examples in Aktary et al. 2010, 2013; Todorović et al. 2010).  
 
PKPs (in humans 1-3) belong to the p120-catenin subfamily, characterized by the 
presence of 9 ARM-repeats in the ARM-domain (Carnahan et al. 2010). They show 
complex tissue- and differentiation-specific expression patterns but at least one of the 
three PKPs is required for the formation of functional DMs. PKPs enhance the 
intercellular cohesion by recruiting desmosomal components to the cell junctions. 
Furthermore, they also play non-desmosomal roles in actin filament organization, 
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growth control, or protein synthesis (reviewed in Hatzfeld et al. 2014; see examples in 
Hatzfeld et al. 2000; Hofmann et al. 2006; Mertens et al. 2001).  
 
DP is an obligate desmosomal component. It belongs to the plakin family of cytolinkers 
that place cytoskeletal elements together and connect them to junctional complexes 
(reviewed in Bouameur et al. 2014). At the DMs, DP interacts with PKG and PKPs by 
means of its N-terminal plakin domain and with the intermediate filaments (IFs) through 
its C-terminal region.  
 
In addition, a variety of non-essential proteins are associated with DMs in specialized 
structures or differentiation-specific states. As an example, the armadillo protein p0071, 
also called PKP-4, has been identified in DMs of some cultured epithelial cells 
(Hatzfeld & Nachtsheim 1996). Despite of the name, p0071/PKP4 is more closely 
related to the AJs-protein p120-catenin than to PKPs. The dual localization of p0071 
has been related with a possible function of this protein in the cross-talk between DMs 
and AJs (Hatzfeld 2003). According to that, p0071 is able to interact with some AJ-
related cadherins as well as with DP (Calkins et al. 2003). Yet, its specific function has 
to be further investigated. Another example is Kazrin, which is up-regulated during 
keratinocyte terminal differentiation, and localizes to DMs where binds the epidermal 
cornified envelope protein periplakin (Groot et al. 2004; Sevilla et al. 2008).  
 
Protein-protein interactions  
 
The mechanical integration of adjacent cells provided by DMs is achieved through a 
complex network of protein-protein interactions. They have been described interactions 
between almost all desmosomal components but the main scaffold requires four types 
of associations: (i) outside cells, homo- and hetero-philic associations between DSGs 
and DSCs ectodomains form the extracellular interface; (ii) intracellularly, the 
cytoplasmic tails of the desmosomal cadherins bind the plaque proteins PKG and 
PKPs; (iii) PKG and the PKPs in turn associate with the N-terminal region of DP; and 
lastly, (iv) DP bridges all the previous associate proteins to the cytoskeleton through 
interactions of its C-terminus with the IFs. 
  
Figure I2 shows the interactions between desmosomal proteins reported so far 
(Harmon & Green 2013). References for each interaction are specified in table I1. Most 
of the interactions have been proved through co-immunoprecipitation (co-IP), in vitro 
binding experiments, or yeast two hybrid assays. 
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Figure I2. Protein-protein interactions within the DM. Schematic representation of the DM architecture 
showing the main interactions between desmosomal proteins reported so far. Interactions have been 
proved by using in vitro binding experiments, co-IP, and yeast two hybrid assays. Notice that binding-sites 
are not represented in the diagram, which just indicates which protein interacts with which other. For 
simplicity, isoforms and variants are omitted. Table I1 lists the references for each interaction. PM, plasma 
membrane; ODP, outer dense plaque; IDP, inner dense plaque. 
 
Although the Figure I2 illustrates all of the reported interactions so far, some 
considerations must be taken. For instance, PKG-IFs and PKPs-IFs interactions have 
been widely reported in vitro; however, considering the accepted ultrastructural 
architecture of DMs where PKG and PKPs are in the outer dense plaque (ODP), 
whereas the IF-linkage occurs at the inner dense plaque (IDP), it seems that a spatial 
constraint would limit such interactions (North et al. 1999). In addition, there is also in 
vitro evidence of directly interaction between desmosomal cadherins and DP. However, 
it is though that adaptor proteins, such as PKG and PKPs, are required to link DP to 
desmosomal cadherins in vivo. Furthermore, the diagram does not consider the tissue- 
and differentiation-specific expression of different isoforms that may prevent some 
combinations.  
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Table I1. Reported desmosomal protein-protein interactions 
Code Interaction type Reference 
1 Interaction between DSGs cytoplasmic tails  (Chen et al. 2012) 
2 DSGs – DSCs cytoplasmic tails associations (Kami et al. 2009) 
3 Homo-association between DSCs extracellular tails  (Syed et al. 2002) 
4 Homophilic interactions between DSGs  (Waschke et al. 2007; Nie et al. 2011) 
5 Heterophilic associations between DSGs and DSCs (Chitaev & Troyanovsky 1997; Aoyama et al. 2009) 
6 Homophilic interactions between DSCs  (Nie et al. 2011) 
7 PKG – PKPs interactions (Chen et al. 2002; Bonné et al. 2003) 
8 PKPs – DSGs interactions 
(Smith & Fuchs 1998; Hatzfeld et al. 2000; Chen et al. 2002; 
Bonné et al. 2003; Kami et al. 2009) 
9 PKPs – DSCs interactions (Smith & Fuchs 1998; Chen et al. 2002; Bonné et al. 2003) 
10 PKG – DSCs interactions 
(Smith & Fuchs 1998; Choi et al. 2009; Kowalczyk et al. 1996; 
Troyanovsky, et al. 1994; Witcher et al. 1996)  
11 DP – DSGs interactions (Bornslaeger et al. 2001; Kami et al. 2009) 
12 PKPs – DP interactions 
(Smith & Fuchs 1998; Hatzfeld et al. 2000; Hofmann, Mertens, et 
al. 2000; Chen et al. 2002; Bonné et al. 2003; Kowalczyk et al. 
1999) 
13 PKG – DP interactions 
(Kowalczyk et al. 1997; Smith & Fuchs 1998; Bornslaeger et al. 
2001) 
14 DP – DSCs interactions (Smith & Fuchs 1998) 
15 PKG – DSGs interactions 
(Mathur et al. 1994; Roh & Stanley 1995; Choi et al. 2009; 
Bornslaeger et al. 2001; Smith & Fuchs 1998; Kowalczyk et al. 
1999; Kowalczyk et al. 1996; Stappenbeck & Green 1992; 
Witcher et al. 1996; Andl & Stanley 2001; Palka & Green 1997; 
Troyanovsky et al. 1994) 
16 PKG – IFs interactions (Smith & Fuchs 1998) 
17 DP – IFs interactions 
(Green, Stappenbeck, et al. 1992; Stappenbeck & Green 1992; 
Kouklis et al. 1994; Bornslaeger et al. 1996; Meng et al. 1997; 
Kowalczyk et al. 1997) 
18 PKP – IFs interactions 
(Kapprell 1988; Smith & Fuchs 1998; Hatzfeld et al. 2000; 
Hofmann, Mertens, et al. 2000; Bonné et al. 2003; Hatzfeld et al. 
1994) 
 
Desmosome functions and dynamics 
 
During years, DMs have been considered simple spot-welds with the mere structural 
function of providing mechanical stability to a wide range of tissues. Today, in addition 
to maintenance cellular adhesion it is known to function in multiple processes through 
interactions with signalling pathways molecules important for cell polarity, cell shape or 
motility. In addition, they participate in the balance of proliferation versus differentiation. 
This multitasking role needs a strictly regulation of the DM dynamics, which depends 
on the proper synthesis, assembly, and turnover of the desmosomal components. DM 
remodelling is also essential in wound healing, development, and morphogenesis.  
 
8 
In cultured keratinocytes, DMs are assembled in response to cell–cell contact and 
raised levels of extracellular calcium (eCa) (Bikle et al. 2013; Kimura et al. 2007). DMs 
establishment upon increase of eCa in cell culture mimics the differentiation pattern of 
keratinocytes within the epidermis due to an ascending gradient of intracellular calcium 
(iCa) from the basal layer to the stratum granulosum (Kimutai et al. 2002), and has 
served as a tool to control DM formation in vitro. The importance of iCa homeostasis 
for desmosomal adhesion it is also revealed by diseases such as Darier’s and Hailey–
Hailey’s diseases, which arise from mutations in calcium ATPases (Leinonen et al. 
2009).   
 
In brief, when calcium levels are low, newly synthesized desmosomal proteins are 
unstable. Only after DM assembly, desmosomal proteins are stabilized at the plasma 
membrane, probably due to the association with the IF-cytoskeleton. Desmosomal 
cadherins are thought to localize to the plasma membrane in association with PKG, 
whereas DP moves to cell-cell contacts in complexes with PKP2 (for detailed reviews 
see Kowalczyk & Green 2013; Nekrasova & Green 2013).  
 
Interestingly, DMs have been reported to undergo a transition from a calcium-
dependent state to an independent where they are hyper-adhesive. This conversion is 
appreciable in confluent culture sheets and intact epithelia in vivo and does not involve 
significant qualitative or quantitative changes in DMs composition (Kimura et al. 2007). 
Hyper-adhesion is considered the property that distinguishes DMs from the other cell 
junctions, providing the strong adhesion that contributes to tissue integrity (for a review 
see Garrod & Kimura 2008). In vivo the majority of the DMs are Ca+2-independent and 
only revert to weaker adhesion after wounding. The regulation of the hyper-
adhesiveness is mediated by PKCα phosphorylation (Garrod et al. 2005). Interestingly, 
it is thought to require structural changes in cadherins packaging (Garrod et al. 2005). 
Garrod and colleagues have suggested that changes in the interactions between 
cadherins ectodomains may accomplish a highly organized midline that has the ability 
to mediate stronger adhesion and to resist Ca2+ chelation because it is trapped by cis-
interactions between cadherins tails.  
 
2. Plakophilins 
 
Overview 
 
PKPs are vertebrate-specific proteins that, based on their primary sequence, have 
been classified as p120-catenin subfamily members. The p120-catenin subfamily 
comprises seven members, including δ-catenin/NPRAP (Neural Plakophilin-Related 
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Armadillo Protein), ARVCF (Armadillo Repeat Protein Deleted in Velo-Cardio-Facial 
Syndrome), p0071/PKP-4, and the more distantly related PKPs 1-3 (Carnahan et al. 
2010). Like the others ARM-proteins, p120-catenin subfamily members mediate cell-
cell adhesion. Based on their localization to the DMs instead of AJs and on the low 
degree of sequence similarity with the other p120-catenin subfamily members, PKPs 
are considered to form a separate group (Hatzfeld 2005).  
 
Structure 
 
The ARM-domain of PKPs is characterized by the presence of 9 ARM-repeats. The 
fifth and sixth domains are linked by a spacer sequence that results in a characteristic 
kink in the structure as shown by X-ray crystallography of the ARM-domain of PKP1 
(PDB: 1XM9, Choi & Weis 2005). This domain is flanked by quite long N- and very 
short C-terminal domains. The head domain (N-terminal region) of the three PKPs is 
mostly devoid of any known secondary structure and is considered largely disordered. 
They do not exhibit homology to themselves or other proteins, only a small region near 
the amino-terminus, the so-called homology region 2 (HR2) (Bonné et al. 1999), shows 
some similarity between them (Figure I3). Interestingly, all the PKPs-binding partners 
reported so far interact with the head domain, although the ARM-domain contains the 
characteristic LxNL motifs along the groove that have been shown to bind a variety of 
proteins in the case of β-catenin (Huber et al. 1997; Choi & Weis 2005). 
 
 
 
Figure I3. Multi-domain structure of plakophilin 1a. A) Schematic representation of the domain 
organization of PKP1a. B) Cartoon representation of the X-ray structure of the ARM-domain of PKP1 
(PDB: 1XM9). ARM-repeats are shown in rainbow colours, starting in red in the N-terminus and ending in 
blue at the C-terminal region.  
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PKPs expression patterns  
 
PKPs show complex but overlapping expression patterns in mammalian tissues. PKP2 
shows the most widespread distribution, occurring in all proliferative epithelial cells and 
in non-epithelial tissues such as myocardium and arachnoid tissue (Rickelt 2012). 
PKP3 also presents a broad occurrence with the exception of hepatocytes and 
cardiomyocytes (Bonné et al. 2003). Conversely, PKP1 is localized in DMs of complex, 
stratified, and transitional epithelia but it is absent in simple epithelia (Moll et al. 1997). 
The three PKPs exist in two isoforms, a shorter “a” and a larger “b”, resulting from 
alternative splicing of the primary genes (Schmidt et al. 1997; Mertens et al. 1996; 
Mühmer et al. 2014). The “a” and “b” isoforms also show distinct subcellular 
localization. The different but overlapping expression patterns of the three PKPs 
suggests tissue- and/or differentiation-specific functions, but at the same time allow for 
some redundancy, smoothing PKPs-related diseases where more than one are present 
(McGrath & Mellerio 2010; Sklyarova et al. 2008), compared with scenarios where 
there is only one, such as heart (Grossmann et al. 2004).   
 
PKPs functions 
 
PKPs enhance intercellular cohesion by recruiting desmosomal components to cell 
junctions. Moreover, based on their interaction with many desmosomal proteins PKPs 
appear to act as scaffolds by linking desmosomal cadherins and PKG to DP and IFs 
(Chen et al. 2002; Bonné et al. 2003; Bornslaeger et al. 2001).  
 
Although the three PKPs localise to DMs, only PKP1 enhances the number and/or size 
of junctions when overexpressed in cultured cells (Kowalczyk et al. 1999; Hatzfeld et 
al. 2000; South et al. 2003; South 2004; Tucker et al. 2014). This is in agreement with 
the in vivo situation where PKP1 is highly expressed in the suprabasal layer of the 
epidermis which contains numerous and large DMs. In addition, loss-of-function 
mutations in PKP1 produce epidermal-phenotypes with small and few DMs (McGrath et 
al. 1997).  
 
PKPs also play non-desmosomal roles in actin filament organization, growth control, 
cell migration, and protein synthesis (reviewed in Hatzfeld et al. 2014; see examples in 
Godsel et al. 2010; Hatzfeld et al. 2000; Hofmann et al. 2006; Koetsier et al. 2014; 
Mertens et al. 2001; Wolf et al. 2010). Based on the phenotype of PKP3-deficient mice, 
it has also been suggested a contribution of PKP3 in limiting the inflammatory response 
via its interaction with the RNA binding protein FXR1 (Sklyarova et al. 2008). 
Interestingly, it has also been reported a main function of PKP1 in the transition of 
keratinocytes from a calcium-dependent to a calcium-independent, hyper-adhesive 
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state. In the latter conformation DMs are protected from Pemphigus vulgaris 
autoantibodies-induced loss of cell adhesion (Tucker et al. 2014).  
 
PKPs in the nucleus 
 
It has been demonstrated that both, endogenous and overexpressed PKPs prominently 
localise to the nucleus in DM-bearing and non-bearing cell lines (Schmidt et al. 1997; 
Mertens et al. 1996; Bonné et al. 1999). Although the nuclear localization has been 
reported for all PKPs (PKP1-3) the prevalence appears highly variable, being PKP1 the 
most nuclear-prominent. Likely, distinct mechanisms regulate nuclear localization of 
PKPs. One possible mechanism regulating PKP2 nuclear localization involves c-TAK1 
mediated phosphorylation of the head domain of PKP2 to create binding sites for 14-3-
3 proteins (Müller et al. 2003). This mechanism may be extended in the future to the 
whole family since: (i) PKP3 was recently shown to co-purify with the 14-3-3 family 
member stratifin (Roberts et al. 2013), and (ii) two of the PKP1-motifs phosphorylated 
by Akt2 are putative 14-3-3 binding sites (Wolf et al. 2013).  
 
So far, it has been reported an interaction between PKP2 and the RNA polymerase III, 
PKP3 and the ETV1/ER81 transcription factor, as well as PKP1 binding to single-
stranded DNA (ssDNA) (Mertens et al. 2001; Sobolik-Delmaire et al. 2010; Munoz et al. 
2014). PKP1-head also binds ssDNA in vitro and is redistributed after induction of DNA 
damage, suggesting a putative function of PKP1 in DNA damage response. However, 
PKP1 nuclear binding partners have not been identified and there are no mechanistic 
insights about the PKP1 nuclear function. Thus, the identification of nuclear partners 
and functions of PKPs remain one future challenge.  
 
3. Desmoplakin  
 
Overview 
 
DP belongs to the plakin family of cytolinkers. Plakins are huge proteins characterized 
by a multi-modular structure that provides an optimal architecture to interconnect 
elements of the cytoskeleton and tether them to membrane-associated junctions. 
Plakins cross-linking contributes to cell shape and polarity. They also participate in 
dynamic processes such as cell migration and differentiation, acting as scaffolds or 
adaptors for signalling proteins that modulate cytoskeletal dynamics (Bouameur et al. 
2014; Sonnenberg & Liem 2007).  
 
Mammalian plakins comprise 7 members: DP, plectin, bullous pemphigoid antigen 1 
(BPAG1), microtubule actin cross-linking factor 1 (MACF1), periplakin, envoplakin, and 
epiplakin. Some plakins exist as tissue- and differentiation-specific variants (see 
12 
examples in Angst et al. 1990; Leung et al. 2001). Among plakins, only DP localizes to 
DMs, where it is an obligate plaque protein. DP also participates in specialised DM-like 
structures, such as the area composita of cardiomyocytes (Franke et al. 2006).  
 
Structure 
DP shares the typical tripartite domain organization of the plakins: (i) The N-terminus of 
DP is composed of a plakin domain (PD) characterized by a high α-helical content, (ii) 
the PD is followed by a central coiled-coil rod domain responsible for the formation of 
parallel dimers (O´Keefe et al. 1989), and (iii) a C-terminal region consisting of three 
homologous plakin repeat domains (PRDs), named A, B, and C, followed by regulatory 
regions that cooperate to facilitate the association with IFs (Sonnenberg & Liem 2007; 
Kouklis et al. 1994). Each domain is ~1000 residues long (Figure I4). 
 
 
Figure I4. Structure of desmoplakin. A) Schematic representation of the domain organization of DP. 
Similarly to other plakins, DP has a tripartite organization: the N-terminal region contains the plakin 
domain; the middle region is occupied by a rod domain with coiled-coil structure involved in the 
dimerization of the molecule; lastly, the C-terminal region is composed of three plakin repeats domains 
(PRDs). The plakin domain is formed by an array of spectrin repeats. The presence of a SR2 domain 
upstream the SR3 is analysed in this work. B) Ribbon representation of the crystal structure of the SR3-
SR6 region of DP (PDB entry 3R6N). Each SR consists of three α-helices (A, B, and C). C) Ribbon 
representation of the crystal structure of one PRD of DP (PDB entry 1LM5). Each PRD consists of 4.5 
copies of a 38-amino acid plakin repeat (PR1 to PR5). Each PR is differentially coloured in the structure. 
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The plakin domain of DP  
 
The plakin domain of DP (DP-PD) is formed by an array of seven spectrin repeats 
(SRs) termed SR3 to SR9 because of their correspondence to the SRs of plectin 
(Sonnenberg et al. 2007; Al-Jassar et al. 2011) (Figure I4-A). Each SR consists of 
three α-helices (A, B, and C) forming a helical bundle. As observed in the rest of the 
family, the DP-PD also contains a SH3 domain inserted between helices B and C of the 
SR5 (Jefferson et al. 2007; Ortega et al. 2011). The crystal structure of the SR3-SR6 
segment of DP revealed a rod like structure in which, similarly to other SR tandem 
arrays, the helix C of a SR is fused to the helix A of the adjacent domain (Choi & Weis 
2011) (Figure I4-B). This 3D structure is very similar to that observed for the SR3-SR5 
segment of plectin (Ortega et al. 2011). In contrast with the roles of other SH3 domains 
involved in protein-protein interactions that regulate signal transduction pathways and 
trafficking (Li 2005), the SH3 domain of DP and plectin does not contain the canonical 
protein binding pocket. In these plakins, this area is occluded by hydrophobic 
interactions with the SR4, suggesting that the SH3 might have a main structural 
function in plakins, likely contributing to the stability of the PD (Ortega et al. 2011). It 
has been suggested that the region upstream of the SR3 was intrinsically disordered 
(Al-Jassar et al. 2011; Choi & Weis 2011). However, experiments performed in this 
thesis have suggested the presence of a SR2-like domain in this region.  
 
The PD of DP is important for targeting DP to the desmosomal plaque through 
interactions with the armadillo proteins PKG and PKPs (Bornslaeger et al. 2001; 
Kowalczyk et al. 1997; Kowalczyk et al. 1999). Interestingly, phosphorylation events 
are thought to be involved in the regulation of these associations. For instance, the 
S299R mutation abolishes the PKG-DP interaction resulting in arrhythmogenic right 
ventricular cardiomyopathy (ARVC) (Rampazzo et al. 2002).  
 
DP isoforms 
 
In humans, DP exists in two splice variants, DPI (322 kDa) and DPII (259 kDa), 
resulting of alternative splicing of the same gene in the region of the rod domain. DPII 
lacks almost two thirds of the dimerization domain (O´Keefe et al. 1989). In addition, it 
has recently been reported a new minor isoform (DPIa) of intermediate size (Cabral et 
al. 2010). DPIa is expressed at lower levels but shows the same tissue distribution of 
DPI/II, usually expressed together. Based on the severe ARVC caused by complete 
ablation of DPI without affectation of DPII (Uzumcu et al. 2006), it is thought that DPI 
and DPII do not share all the functions.  
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DP functions 
 
Mutations in the DP gene have been linked to devastating inherit diseases affecting 
skin, hair, nails, and teeth, as well as the heart (reviewed in Lai Cheong, Wessagowit, 
and McGrath 2005). DP-null mice (Gallicano et al. 2009) and epidermis-specific DP 
knockout mice (Vasioukhin et al. 2001) die early after bird. Ultrastructurally, DMs seem 
to be normal, indicating that DM-structure is not disrupted after DP ablation. However, 
a more detailed study of the DMs show a completely lack of IF attachments, resulting in 
the fatal outcome. Thus, although DP is not required for DM assembly, DP-null DMs 
are not functional, underlying the importance of DP in the intracellular scaffolding of 
desmosomal proteins and IF-tethering for maintaining tissue integrity.   
 
One of the main roles proposed for DP in the DMs is promoting lateral associations 
through interactions with both PKG and PKPs. These lateral interactions drive 
clustering of desmosomal cadherins in the plasma membrane (reviewed in Hatsell & 
Cowin 2001). This idea is supported by biochemical (Kowalczyk et al. 1999) and 
cryoelectron microscopy tomography data (Al-Amoudi et al. 2011).  
 
Beyond the DMs, DP has been reported to be important for microtubule organization, 
shape and size control of microvilli in the intestinal epithelium, and integrity of 
capillaries through its involvement in the formation and stabilization of microvasculature 
(Lechler & Fuchs 2007; Sumigray & Lechler 2012; Zhou et al. 2004; Gallicano et al. 
2001).  
 
4. Summary  
 
There is a conventional understanding of the structure, functions, and protein 
interactions within the DM. However, the precise molecular mechanisms behind 
protein-protein interactions that orchestrate fully functional DMs are still not completely 
understood. Knowing how desmosomal proteins associate provides useful information 
about protein functions, interacting networks, and regulation (see an example in Garrod 
et al. 2005). In the case of desmosomal proteins, these insights are fundamental to 
understand how cells maintain their shape and polarity or regulate movement, 
adhesive potential, and strength.  
 
The work presented here provides the first detailed examination of the molecular 
domains that mediate the formation of the DP-PKP1a complex. The precise mapping of 
the protein-protein interactions led us to determine the key interacting-regions in both 
molecules. In addition, the combined structural study of the PD of DP shed light on the 
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possible arrangement of this interaction. This work should assist in providing an 
understanding of how desmosomal proteins interplay their specific roles at DMs.  
 
Non-desmosomal functions of ARM-proteins are becoming increasingly remarkable 
each day; however, the nuclear role of PKP1a is still largely unknown. Here, we 
presented the first comprehensive analysis of the major determinants of the PKP1a 
head domain, including the DP-binding region and the nuclear-targeting sequences. 
This study provides evidence of how PKP1a is able to combine DP-associated 
functions, with its prominent nuclear localization.  
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The overall scope of this work is to better understand the organization of the 
desmosome by characterizing two of its components, DP and PKP1a, as well as their 
interaction. To achieve this goal, the following specific objectives have been 
addressed: 
 
i) To map in detail the interacting domains in the DP-PKP1a complex. 
ii) To identify the regions implicated in the subcellular localization of DP and PKP1a 
iii) To elucidate the structure of the plakin domain of DP. 
 
By using a multi-methodological approach, we have narrowed the molecular definition 
of the DP-PKP1a recognition sites in both molecules. Moreover, we have identified the 
main regions implicated in the desmosome- versus nuclear-localization of PKP1a and 
we have obtained the big picture of the structural organization of the PD of DP.  
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1. cDNA 
The cDNAs of human PKP1a, PKP2a, and PKG were obtained as I.M.A.G.E. clones 
from Imagenes GmbH (currently Source Bioscience) (Table M1). 
Table M1. cDNA IMAGE clones used to create DNA constructs  
Protein UniProt Code cDNA IMAGE clone Vector Description 
Plakophilin 1a Q13835-2 IRCMp5012B0632D PCR-BluntII-TOPO PKP1a cDNA full length  
Plakophilin 2a Q99959-2 IRATp970H11100D pBluescriptR PKP2a cDNA full length  
Plakoglobin P14923 IRAUp 969F061D pOTB7 PKG cDNA full length  
 
The cDNA coding for the PD of human DP (Uniprot entry P15924) was amplified by 
RT-PCR of mRNA extracted from Hek293T cells, kindly provided by Dr Carmen 
Guerrero (University of Salamanca, Spain). Total RNA was purified using the RNeasy 
Mini Kit (Qiagen) and mRNA was then isolated using the Poly(A)Purist MAG Kit 
(Ambion, Life Technologies). The cDNA coding for the DP-PD region (residues 1-1056) 
was amplified by two consecutive and nested PCRs using the primers shown in Table 
M2. The PCR product was cloned in the pETEV15b vector (see below) using NdeI and 
BamHI sites.  
Table M2. Primers used to obtain DP-PD  
A) Primers used to perform the first PCR reaction using as template DP cDNA obtained from mRNA 
 
DP-NEST-U001 5´ TTG CCC GCC GAC ATG AGC TGC 3´  
 
                                         M        S        C 
                                         1 
DP-NEST-L1061 5´ G GTT CTG ATC CAG GAA TTT GTT CTT ATT ACA G 3´  
 
          N      Q      D      L       F     K      N     K      N      C 
       1061                                  1056 
        
B) Primers used to perform the second PCR reaction using as template DP DNA obtained in (A)  
 
DP-U001 5´ TGA GAA TTC CAT ATG AGC TGC AAC GGA GGC TCC C 3´ 
 
                   EcoR I             Nde I         S        C        N         G       G        S 
                                                             2 
DP-L1056 5´ GAA TTC GGA TCC CTA CTA TTT GTT CTT ATT ACA GTT TTC CGA GTT G 3´  
 
      EcoR I      BamH I    stop stop   K      N     K      N     C      N     E       S      N 
                                                     1056 
 
 
PKP1 and PKP2 exist as two isoforms, a shorter “a” and a longer “b”, due to alternative 
splicing of the primary genes products (Rickelt 2012). All of the work described here 
has been done with the shorter isoforms of both proteins, PKP1a and PKP2a. 
Nonetheless, most of the constructs names have been simplified and did not show the 
isoform specification “a”. 
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2. Modification of the PKP2a cDNA 
 
The PKP2a sequence was modified to enable the use of specific restriction enzymes 
required for some cloning strategies (see below). Specifically, we eliminated from the 
PKP2a sequence one BamHI and two NotI restrictions sites. These sites were 
destroyed introducing silent mutations by site directed mutagenesis using the 
QuikChange method (Agilent Technologies). Briefly, the method consists of amplifying 
by PCR the whole vector containing the sequence of interest using two primers that 
hold the desired substitution. Then, the PCR product is digested with the endonuclease 
DpnI (Thermo Fisher Scientific) to eliminate the parental DNA. We used as template 
the cDNA of full length PKP2a (residues 1-838) cloned in the pBluescript SK- vector. 
The amplification was made by using the high fidelity polymerase Pfu Turbo (Agilent 
Technologies) and the primers reported in table M3. 
Table M3. Mutagenesis primers for PKP2a 
Primers for eliminating the BamHI site 
PKP2-BamX-F                                   5' CAAGAGCCTGCGGATCCAGGAGCAGGTG 3' 
PKP2-BamX-R                                    5' GCTGCACCTGCTCCTGAATCCGCAGGC 3' 
Primers for eliminating the NotI sites 
PKP2-Not325X-F                               5' GTCGGCCAGGCGGCGGCAGGGGGAAG 3' 
PKP2-Not325X-R                              5'  CTTCCCCCTGCCGCCGCCTGGCCGAC   3' 
PKP2-Not45X-F                                5'  GGGGAGCAGCGGGCGCGGCGGCCAG   3' 
PKP2-Not45X-R                                5'  CTGGCCGCCGCGCCCGCTGCTCCCC     3'               
1 
Notice that the amino acid exchanges maintain the residues in the protein sequence 
 
3. DNA constructs overview 
 
DNA constructs were made by PCR amplification of the specific cDNA regions that 
were cloned in the appropriate vector according to their specific purpose using 
standard molecular biology techniques. All constructs were sequence verified before 
use. Tables M4, M5, and M6 summarize PKP1a, DP, and PKP2a constructs, 
respectively. They include given name, amino acid boundaries, restriction enzymes 
used to clone, vector cloned into and the main purpose of the constructs. These wide 
collections of PKP1a, PKP2a, and DP-PD fragments were generated based on 
different pieces of evidence such as, sequence analysis, structure predictions, and 
previously defined subdomains limits in the literature to ensure the structural integrity of 
all of them. Fragments design has been a continual and iterative process where the 
results contributed by the earliest directed the design of the upcoming ones.  
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Table M4. PKP1a constructs summary 
Construct name Boundaries Vector name Tag
Ŧ
 Restriction sites Host Purpose 
PKP1-FLAG 1-726 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP / FIM 
PKP1-head-FLAG 1-243 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP 
PKP1-1-120 1-120 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP 
PKP1-1-51 1-51 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP 
PKP1-52-243 52-243 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP 
PKP1-121-243 121-243 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP 
PKP1-ARM-FLAG 244-726 pCEFLAG FLAG EcoRI-NotI Mammalian co-IP / FIM 
PKP1-HA 1-726 pCEFLHA HA EcoRI-NotI Mammalian FIM 
PKP1-ARM-HA 244-726 pCEFLHA HA EcoRI-NotI Mammalian FIM 
PKP1-pcHA 1-726 pcDNA3-HA HA EcoRI-NotI Mammalian FIM 
PKP1-ARM-pcHA 244-726 pcDNA3-HA HA EcoRI-NotI Mammalian FIM 
PKP1 1-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-head 1-243 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-1-115 1-115 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-1-132 1-132 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-116-132 116-132 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-52 52-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-75 75-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-98 98-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-104 104-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-110 110-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-116 116-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-121 121-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-127 127-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-133 133-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-151 151-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-181 181-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-ARM 244-726 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-Δ116-132 1-726(Δ116-132) pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-Δ110-150 1-726(Δ110-150) pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-head-Δ116-132 1-243(Δ116-132) pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP1-head-Δ110-150 1-243(Δ110-150) pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
co-IP, co-immunoprecipitation; FIM, Fluorescence Imaging Microscopy 
Ŧ All the tags are located at the N-terminus of PKP1a 
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Table M5. DP constructs summary 
Construct name Boundaries Vector name Tag
Ŧ
 Restriction sites Host Purpose 
DP-PD-HA 1-1056 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP/ FIM 
DP-NT-HA 1-545 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-SR2-SR5-HA 64-545 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-SR3-SR5-HA 180-545 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-SR2-HA 1-170 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-1-SR4-HA 1-376 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-1-SR6 1-630 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-SR3-SR6 180-630 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-CT-HA 544-1056 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-CT1025-HA 544-1025 pCEFLHA N-HA EcoRI-NotI Mammalian co-IP 
DP-CT-FLAG 1-1056 pCEFLAG N-FLAG EcoRI-NotI Mammalian Dimerization 
DP-PD 1-1056 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-SR2-SR9 64-1056 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-SR3-SR9 180-1056 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-SR4-SR9 272-1056 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-SR5-SR9 377-1056 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-NT 1-545 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-SR3-SR5 180-545 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-SR2 1-170 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-1-SR4 1-376 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-CT 544-1056 pcDNA3-V-N3 N-Venus EcoRI-NotI Mammalian FIM 
DP-PD-N3 1-1056 pcDNA3-V-N3 C-Venus KpnI-BamHI Mammalian FIM 
DP-NT-N3 1-545 pcDNA3-V-N3 C-Venus KpnI-BamHI Mammalian FIM 
DP-CT-N3 544-1056 pcDNA3-V-N3 C-Venus KpnI-BamHI Mammalian FIM 
DP-SR2-L-pET 64-164 pETEV15b N-octa-His NdeI-BamHI E. coli Biophysics 
DP-SR2-S-pET 64-155 pETEV15b N-octa-His NdeI-BamHI E. coli Biophysics 
DP-1-SR6-pET 1-630 pETEV15b N-octa-His NdeI-BamHI E. coli Biophysics 
DP-CT-pET 660-1056 pETEV15b N-octa-His NdeI-BamHI E. coli Biophysics 
DP-CT-GCN4-22b 660-1060-GCN4 pET22b --- NdeI-BamHI E. coli Biophysics 
pcDNA3-V-C4/N3, pCDNA3-Venus-C4/N3; co-IP, co-immunoprecipitation;  FIM, Fluorescence Imaging Microscopy 
Ŧ N-, refers to tags located in the N-terminus; C-, refers to tags located in the C-terminus 
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Table M6. PKP2a constructs summary 
Construct name Boundaries Vector name Tag
Ŧ
 Restriction sites Host Purpose 
PKP2-pBSK 1-838 pBluescript SK (-) --- EcoRI E. coli Mutagenesis 
PKP2 1-838 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP2-65 65-838 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP2-151 151-838 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP2-220 220-838 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
PKP2-ARM 349-838 pcDNA3-CFP-C4 CFP EcoRI-NotI Mammalian FIM 
FIM, Fluorescence Imaging Microscopy
 
Ŧ All the tags are located in the N-terminus of PKP2a 
 
In addition, PKG full length (residues 1-745) was cloned in pcDNA3-CFP-C4 using 
EcoRI and NotI restriction sites. CFP-tagged PKG was used to analyse the subcellular 
distribution of desmosomal proteins in cell cultures of COS-7 cells and keratinocytes by 
confocal microscopy.  
 
3. Primers 
 
Primers used to generate PKP1a, PKP2a, PKG, and DP constructs were between 29 
and 46 bases in length with a melting temperature (Tm) around 60ºC. They included at 
the 5’ end sequences recognized by specific restriction enzymes. In addition, if 
necessary, reverse primers included a stop codon (TAG). Examples of primers used to 
clone PKP1a cDNA in different vectors are shown in table M7, similar primers were 
used to amplify and clone the other cDNAs. 
Table M7. Examples of primers used to amplify the cDNA of PKP1a 
Primer name Sequence (5´ to 3´)
Ŧ 
Tm (ºC)
ǂ
 Vectors 
PKP1-U001 TGA GAATTC CAT ATGAACCACTCGCCGCTCAAGACC 
           EcoR I  Nde I  M    N     H     S      P      L     K     T    
                                   1 
 60.8 pETEV15b, 
pBSK (-), 
pET22b 
PKP1-L726 TGA GAATTC GGATCCCTACTAAGAATCGGGAGGTGAAGTTCCTG   
           EcoR I     BamH I Stop Stop   F     R     S      T      F     N     R                             
                                                      726 
 
58.8 pETEV15b, 
pBSK (-), 
pET22b 
PKP1-U001-EcoRI TGA GAATTC ATGAACCACTCGCCGCTCAAGACC 
          EcoR I     M     N     H     S     P      L     K     T    
                          1        
60.8 pCEFLAG/HA, 
pcDNA3-C4/HA 
PKP1a-L726-NotI TGA GCGGCCGC CTA GAATCGGGAGGTGAAGTTCCTGAG 
               Not I        Stop     F     R     S      T      F     N     R    L 
                                        726 
 
59.1 pCEFLAG/HA, 
pcDNA3-C4/HA 
pBSK (-), pBluescript SK (-), pcDNA3-C4, pcDNA3-CFP-C4 and pcDNA3-Venus-C4
 
Ŧ
 Restriction sites and the encoded amino acids are shown under the DNA sequences 
ǂ
 The Tm was calculated for the region matching the PKP1a cDNA 
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4. Vectors and cloning 
 
Cloning in pBluescript SK (-) 
 
pBluescript SK (-) (Agilent technologies) is a phagemid for bacterial expression used to 
general cloning. pBluescript harbours a versatile multi cloning site (MCS). PKP2a was 
subcloned in pBluescript SK (-) by using EcoRI as restriction enzyme to perform the 
mutagenesis reactions.  
 
Cloning in pCEFL vectors 
 
pCEFLAG and pCEFLHA vectors (Chiariello et al. 2000) encode for a Kozak 
consensus sequence (Kozak 1986) followed by the FLAG (Hopp et al. 1988) or the HA 
(Wilson et al. 1984) tags (Figure M1). Both vectors harbour equivalent MCS. 
Expression of the cDNA fragments is under the control of the elongation factor 1 
promoter (EF1). PKP1a-constructs were subcloned in pCEFLAG and DP-constructs in 
pCEFLHA, unless otherwise indicated. In all cases, cDNAs were cloned using EcoRI 
and NotI restriction sites. 
 
 
 
 
Figure M1. MCS of pCEFL vectors. DNA sequence of the coding strand of the MCS of the pCEFL 
vectors. Main characteristics such as Kozak sequence (KZ), tag (FLAG or HA) and restriction sites used to 
clone (EcoRI and NotI) are highlighted in bold.  
 
Cloning in pcDNA3-CFP/Venus vectors 
 
 
The pcDNA3 vector for mammalian expression (Invitrogen) was modified to create 
fusion proteins tagged with the cyan fluorescent protein (CFP) (Heim & Tsien 1996) or 
with Venus, which is an improved version of the yellow fluorescent protein (YFP) 
(Nagai et al. 2002). The cDNA of CFP and Venus was amplified using as templates the 
pCFP-N1 and pVenus-N1 vectors, kindly provided by Prof A. Sonnenberg (Netherlands 
Cancer Institute, Amsterdam; The Netherlands). We engineered two kinds of vectors, 
those coding for fusion proteins with CFP or Venus at the N-terminus (pcDNA3-CFP-C 
and pcDNA3-Venus-C) and those that code for C-terminal fluorescent proteins 
(pcDNA3-CFP-N and pcDNA3-Venus-N). 
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pcDNA3-CFP-C and pcDNA3-Venus-C vectors 
 
Table M8 summarizes the pcDNA3-CFP-C and pcDNA3-Venus-C vectors that we 
engineered. 
 
Table M8. pcDNA3-CFP-C and pcDNA3-Venus-C vectors   
Vector name Tag
 Ŧ
 Sites for CFP/Venus Modification 
pcDNA3-CFP-C1 N-CFP HindIII/BamHI 
---- 
pcDNA3-CFP-C2 N-CFP HindIII/BamHI EcoRI in frame with BamHI 
pcDNA3-CFP-C3 N-CFP HindIII/BamHI A206K, monomeric CFP 
pcDNA3-CFP-C4 N-CFP HindIII/BamHI Intermediate flexible linker  
pcDNA3-Venus-C1 N-Venus HindIII/BamHI ---- 
pcDNA3-Venus-C2 N-Venus HindIII/BamHI EcoRI in frame with BamHI 
pcDNA3-Venus-C3 N-Venus HindIII/BamHI A206K, monomeric CFP 
pcDNA3-Venus-C4 N-Venus HindIII/BamHI Intermediate flexible linker  
Ŧ N-, refers to tags located in the N-terminus 
 
All the experiments reported here were performed with pcDNA3-CFP-C4 or pcDNA-
Venus-C4 vectors. They were created as follows: first, the cDNA of CFP and Venus 
were amplified by PCR using forward primers that add a HindIII site and a Kozak 
sequence, and reverse primers that add a BamHI site (Table M9). PCR products were 
cloned in pcDNA3 using HindIII and BamHI sites. We named the resulting vectors 
pcDNA3-CFP-C1 and pcDNA3-Venus-C1. 
 
Table M9. pcDNA3-C1 primers 
CFP/Venus-Hind-For  
 
 
5’  TGA GAATTC AAGCTT GCC GCC  ACC ATG GTG AGC AAG GGC  3’  
                EcoRI        HindIII                    K Z    M       V       S      K      G 
 
CFP/Venus-BamH-Rev   
 
5’ GCC GAATTC GGATCC CTT GTA CAG CTC GTC CAT GC 3’ 
               EcoRI     BamHI      K      Y       L      E      D      M  
 
KZ, Kozak consensus sequence  
 
We intended to use the EcoRI site for cloning our cDNA of interest, yet the EcoRI site 
in the C1 vectors was not in the correct frame with the CFP and Venus sequences. 
Therefore, we deleted one base pair between the BamHI and EcoRI sites by site 
directed mutagenesis using the QuikChange method (Agilent Technologies) as 
explained before. Table M10 shows the parental sequence, the primers, and the 
resulting sequence of the vectors named pcDNA3-CFP-C2 and pcDNA3-Venus-C2. 
30 
Table M10. pcDNA3-C2 modifications 
pcDNA3-C1 original MCS 
TAGGGAGACCCAAGCTTGGTACCGAGCTCGGATCC  ACT AGT AAC GGC CGC CAG TGT GCT G
Ŧ
GA ATT CTG 
                                 HindIII                                  BamHI                                                                                 EcoRI 
Mutagenesis primers 
pcDNA3-EcoRI-F 5' GC CGC CAG TGT GCT   GAA TTC TGC AGA TAT CC 3' 
pcDNA3-EcoRI-R 5' ATA TCT GCA GAA TTC    AGC ACA CTG GCG GCC G 3' 
pcDNA3-C2 resulting MCS 
 
TAGGGAGACCCAAGCTTGGTACCGAGCTCGGATCC  ACT AGT AAC GGC CGC CAG TGT GCT GAA TTC TG 
                                   HindIII                                  BamHI                                                                             EcoRI 
 
Ŧ 
Note the guanine eliminated to keep BamHI and EcoRI restriction sites in frame  
 
In a third step, we introduced the A206K substitution in CFP and Venus by site directed 
mutagenesis (Table M11). The mutation A206K disrupts the dimerization interface 
resulting in monomeric forms of CFP and Venus (von Stetten et al. 2012), and prevents 
false positives in protein-protein interaction studies. Vectors carrying the A206K 
substitution were named pcDNA3-CFP-C3 and pcDNA3-Venus-C3.  
 
Table M11. pcDNA3-C3 modification primers 
CFP-A206K-F 5’ CCTGAGCACCCAGTCCAAGCTGAGCAAAGACCCCAAC 3’ 
CFP-A206K-R 5’ GTTGGGGTCTTTGCTCAGCTTGGACTGGGTGCTCAGG 3’ 
Venus-A206K-F 5’ CCTGAGCTACCAGTCCAAGCTGAGCAAAGACCCCAAC 3’ 
Venus-A206K-R 5’ GTTGGGGTCTTTGCTCAGCTTGGACTGGTAGCTCAGG 3’ 
 
 
Finally, we introduced a small linker comprising five repetitions of Gly-Ser between the 
fluorescent tag and the gene cloned after the EcoRI site. The combination of small 
(Gly) and polar (Ser) residues provides flexibility to the fusion protein (Argos 1990). 
The cDNA coding for the linker was created by annealing two complementary 
oligonucleotides that left single stranded tails that were complementary for the BamHI 
and EcoRI overhangs in the digested vector (Table M12). For annealing, a mixture 1 
μM of each primer in annealing buffer (10 mM Tris, pH 7.5–8.0, 50 mM NaCl, 1 mM 
EDTA) was heated for 5 min at 95 °C and was slowly cooled down to 15 °C over a 
period of 90 min using a thermal cycler. The resulting cDNA was cloned using the 
BamHI and EcoRI sites to create the final pcDNA3-CFP-C4 and pcDNA3-Venus-C4 
vectors. 
 MATERIALS & METHODS   31 
 Table M12. pcDNA3-C4 modification primers 
                            G    S    G     S       G      S      G      S      G      S   
                        5’  gatccGGTAGCGGCTCGGGCAGTGGAAGTg      3’ 
                           3’      GCCATCGCCGAGCCCGTCACCTTCACTTAA  5’ 
Link-BamEco-GS8-F 5’ gatccGGTAGCGGCTCGGGCAGTGGAAGTg  3’ 
Link-BamEco-GS8-R 5’ AATTCACTTCCACTGCCCGAGCCGCTACCG 3’ 
 
The cDNAs of PKP1a and DP were amplified using forward primers that add and 
EcoRI site, and reverse primers that add a stop codon and a NotI site. They were 
cloned in the pcDNA3-CFP-C4 and pcDNA3-Venus-C4 using EcoRI and NotI sites. 
 
pcDNA3-CFP-N and pcDNA3-Venus-N vectors 
 
pcDNA3-CFP-N and pcDNA3-Venus-N vectors produce fusion proteins with CFP or 
Venus in the C-terminus. Table M13 summarizes the variants of these vectors that we 
created.   
 
Table M13. pcDNA3-CFP-N and pcDNA3-Venus-N vectors   
Vector name Tag Sites for CFP/Venus Modification 
pcDNA3-CFP-N1 C-CFP EcoRI/XhoI ---- 
pcDNA3-CFP-N2 C-CFP EcoRI/XhoI A206K, monomeric CFP 
pcDNA3-CFP-N3 C-CFP EcoRI/XhoI Intermediate flexible linker 
pcDNA3-Venus-N1 C-Venus EcoRI/XhoI ---- 
pcDNA3-Venus-N2 C-Venus EcoRI/XhoI A206K, monomeric Venus 
pcDNA3-Venus-N3 C-Venus EcoRI/XhoI Intermediate flexible linker 
Ŧ C-, refers to tags located in the C-terminus 
 
The cDNAs of CFP and Venus were amplified by PCR using forward primers that add 
an EcoRI site and reverse primers that included a termination codon and an XhoI site 
(Table M14). PCR products were digested with EcoRI and XhoI and were cloned in 
pcDNA3 using these sites. We named the resulting constructs pcDNA3-CFP-N1 and 
pcDNA3-Venus-N1.  
 
Table M14. pcDNA3-CFP-N1 and pcDNA3-Venus-N1 primers 
CFP/Venus-Eco-For   
5’ GCC GAA TTC GCG GCC GC T
Ŧ
 ATG GTG AGC AAG GGC GAG GAG  3’  
                EcoRI        Not I                   M      V       S      K       G      E       E  
 
CFP/Venus-Eco-Rev   
5’ GCC GAT ATC CTC GAG TTA CTT GTA CAG CTC GTC CAT GCC 3’ 
               EcoRV       XhoI      stop   K      Y      L       E      D      M     G  
Ŧ 
Note the extra-base added to keep CFP/Venus in frame  
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Next, we introduced by site directed mutagenesis as described above the A206K 
substitution to create pcDNA3-CFP-N2 and pcDNA3-Venus-N2. Finally, a cDNA 
encoding a Gly-Ser linker was introduced between the BamHI and EcoRI sites (see 
above) to create the pcDNA3-CFP-N3 and pcDNA3-Venus-N3. 
 
DP cDNAs were subcloned in pcDNA3-Venus-N3. PCR amplification was made using 
forward primers that add a Kozak sequence and a KpnI site, and reverse primers that 
add a BamHI site and do not contain stop codons. The PCR products were digested 
with KpnI and BamHI and were cloned using the same sites in pcDNA3-Venus-N3.  
 
Cloning in pETEV15b 
 
pETEV15b is a derivative of the pET15b vector (Novagen) for expression of His-tagged 
fusion proteins in bacteria. pETEV15b had been engineered in our laboratory to code 
for an amino-terminal octa-Histidine tag followed by a sequence recognized by the 
tobacco etch virus (TEV) protease (Alonso-García et al. 2009) (Figure M2). The small 
MCS contains NdeI and BamHI sites that were used for cloning in this vector.  
 
 
 
Figure M2. pETEV15b MCS. DNA sequence of the coding strand of the pETEV15b vector. The main 
characteristics of the vector have been highlighted. The TEV protease recognizes the ENLYFQ site 
(underlined) and digests right after it. cDNAs were cloned using the NdeI and BamHI sites (highlighted in 
red).  
 
To clone in pETEV15b, fragments of cDNA of DP were amplified using forward primers 
that add an NdeI site and reverse primers that add a stop codon followed by a BamHI 
site (see Table M7 for examples of similar primers). PCR products were digested with 
NdeI and BamHI and cloned into pETEV15b using these sites. 
 
Cloning in pET22b  
 
The pET22b vector (Novagen) was used to express in bacteria the recombinant protein 
DP-CT-GCN4 without any additional sequence or tag (DP-CT-GCN4-22b). The 
expression region of pET22b codes for a pelB leader secretion sequence flanked by 
NdeI and NcoI sites, followed by a MCS that includes a BamHI site. The chimera DP-
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SR7-SR9-GCN4 was made as follows. In a first round of PCR two cDNA fragments 
were produced. On one side the cDNA coding for the residues 660-1060 of DP was 
amplified using the forward primer DP-U660 (that adds an NdeI site) and the reverse 
primer DP-L1060-GCN4 (that adds 19 nucleotides of the GCN4 cDNA) (Table M15). In 
parallel, the GCN4 cDNA was amplified using the primers GCN4-U01 and GCN4-Bgl-L. 
A mix of the PCR products of the two previous reactions was used as template for a 
second PCR in which the DP-GCN4 chimera was amplified using the primers DP-U660 
and GCN4-Bgl-L. The resulting DNA was digested with NdeI and BglII and was ligated 
to pET22b previously digested with NdeI and BamHI (the single strand produced by 
BglII matches that produced by BamHI resulting in the destruction of both sites after 
ligation). The coding cDNA included a stop codon upstream of the BglII-BamHI site; 
hence, the expressed protein did not contain any additional sequence. 
 
Table M15. Primers used to create the DP-GCN4 chimeric constructs 
Primer                                                              Sequence (5’ to 3’) 
DP-U660 TGA GAA TTC CAT ATG GAA AAT GAC AAG CAA GAA ACA TGG ATG CTG 
                         Nde I       E     N      D     K      Q     E      T     W     M     L   
                                      660 
DP-L1060-GCN4 C TTC CAG CTG TTT CAT GCG CTG ATC CAG GAA TTT GTT CTT ATT ACA GTT TTC CGA GTT G 
      E     L      Q    K     M     R     Q     D      L      F     K     N     K    N     C     N     E      S     N      
                      GCN4                 1060                                      DP 
GCN4-U01 CGC ATG AAA CAG CTG GAA GAC 
   R     M     K     Q     L       E      D 
GCN4-Bgl-L  TGA GAA TTC AGA TCT CTA CTA GCG TTC ACC AAC CAG TTT TTT CAG 3’ 
                            BglII  Stop Stop   R    E      G     V      L     K    K     L 
 
5. Recombinant DNA maintenance and production 
 
Recombinant DNA was maintained in the E. coli strain DH5α. Bacteria were grown 
either in solid media using LB agar plates or in the liquid media LB or 2xYT. In all 
cases, antibiotic selection was maintained by adding ampicillin (100 mg/l) to the 
medium. Recombinant DNA was isolated from bacterial cultures using the GeneJETTM 
Plasmid Miniprep or Maxiprep Kits (Thermo Fisher Scientific) according to the 
manufacturer's specifications. 
 
6. Cell lines and culture conditions 
 
Cell lines used through this work are specified in table M16. This table also 
summarizes the main cellular characteristics and culture conditions as well as the 
people who provide us with the different cell lines.  
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Table M16. Cell lines and culture conditions 
Cell line Organism Tissue Medium Freeze medium Provider Selected references 
COS-1 C. aethiops kidney DMEM DMEM + 5-10% DMSO 
C. Guerrero 
 (CIC, Salamanca) 
(Gluzman 1981) 
COS-7 C. aethiops kidney DMEM DMEM + 5-10% DMSO 
A. Sonnenberg  
(NKI, Amsterdam) 
(Gluzman 1981) 
Hek293T H. sapiens kidney DMEM DMEM + 5-10% DMSO 
A. Sonnenberg 
(NKI, Amsterdam) 
(DuBridge et al. 1987) 
NHK H. sapiens foreskin SFM 
50% SFM + 40% FBS + 
10% DMSO 
A. Sonnenberg 
(NKI, Amsterdam) 
(Niessen et al. 1996) 
HaCaT H. sapiens skin DMEM 
50% DMEM + 40% FBS 
+ 10% DMSO 
A. Sonnenberg 
(NKI, Amsterdam) 
(Boukamp et al. 1988) 
PA-JEB/β4 H. sapiens skin SFM 
50% SFM + 40% FBS + 
10% DMSO 
A. Sonnenberg 
(NKI, Amsterdam) 
(Niessen et al. 1996) 
PKP1-null H. sapiens skin SFM 
50% SFM + 40% FBS + 
10% DMSO 
AP. South 
(MRI, Dundee) 
(South et al. 2003) 
NHK, Normal Human Keratinocytes;  PKP1-null, PKP1-null keratinocytes; C. aethiops, Cercopithecus aethiops;  H. 
sapiens, Homo sapiens; SFM, Keratinocyte Serum-Free Medium 
 
Dulbecco´s modified Eagle´s medium (DMEM; Sigma-Aldrich or Life Technologies) 
was supplemented with 10 % fetal bovine serum (FBS; Life Technologies) and 1% 
penicillin/streptomycin (Life Technologies). Keratinocyte serum-free medium (SFM, Life 
Technologies) was supplemented with 50 μg/mL bovine pituitary extract (BPE), 5 
ng/mL epidermal growth factor (rEGF), 100 U/mL penicillin, and 100 U/mL streptomycin 
(Life Technologies) providing a complete medium to grow keratinocytes at a low Ca2+ 
concentration (0.09 mM). Where necessary, cells were grown between 8-24 hours in 
DMEM, containing 1.2 mM Ca2+ concentration, to stimulate keratinocyte differentiation. 
All keratinocyte cell lines, with the exception of HaCaT cells, were seeded on collagen-
coated (Advanced BioMatrix or Corning) dishes. Cell number was determined using 
either a Neubauer chamber or a cell counter (Beckman Coulter).  
 
7. Transient transfections 
 
The main purposes and conditions of the transient transfections of fusion proteins are 
summarized in table M17. Cells were processed 24-48 hours after transfection.  
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Table M17. Transient transfection conditions 
Construct type Cell line  Purpose Reagent Medium Ratioǂ   DNA (µg) Dish type  
FLAG/HA-tagged COS-1 co-IP JetPei (Polyplus transfection) NaCl 1:2 5/10 60/100 mm 
FLAG/HA-tagged COS cells FIM 
X-tremeGENE 9 (Roche) /  
PEI (Polysciences inc.) 
DMEM free
Ŧ
 1:3 1/5 12-well plate 
CFP/Venus-tagged COS-7 FIM PEI (Polysciences inc.) DMEM free
Ŧ
 1:2 1 6/12-well plate 
CFP/Venus-tagged Keratinocytes FIM X-tremeGENE HP (Roche) Optimem 1:4 1 12-well plate 
FIM, Fluorescence imaging microscopy (includes Immunofluorescence experiments, confocal microscopy, and FLIM) 
Ŧ
DMEM free, DMEM without any supplementation 
ǂ
 Ratio, DNA / Transfection reagent ratio 
 
 
8. Cell lysis, co-immunoprecipitation (co-IP) and Western blotting 
 
Total protein extracts were obtained from cells seeded at high density. Typically, cells 
were washed twice with ice-cold phosphate buffered saline (PBS) and subsequently 
lysed on ice in Triton X-100-based buffer consisting of 20 mM Tris-HCl (pH 7.5), 150 
mM NaCl, 0.5 % Triton X-100, 1 mM Na3VO4, 25 mM NaF, 1 mM PMSF, 1x protease 
inhibitor cocktail (Roche). Cell lysates were cleared by centrifugation at 16000 xg (4ºC) 
and protein concentrations were determined with a Bradford assay using bovine serum 
albumin (BSA) as a standard. Equal amounts of total protein (30-40 µg) were loaded in 
SDS-polyacrylamide gels (9-20 %) after being heated at 95ºC in Laemmli buffer (2x: 
125 mM Tris-HCl (pH 6.8), 4 % SDS, 55 % glycerol, 2 % β-mercaptoethanol, 0.02 % 
bromophenol blue; 4x: 250 mM Tris-HCl (pH 6.8), 8 % SDS, 40 % glycerol, 4 % β-
mercaptoethanol, 0.04 % bromophenol blue), and separated by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE). Proteins were electrophoretically transferred to 
Immobilon-P membranes (Millipore) and analysed by Western blotting according to 
standard procedures. Inmmunoreactivity was detected using ECL reagents (Bio-rad, 
Thermo, or GE Healthcare) or the Odyssey Infrared Imaging System (LI-COR, Inc.).  
Primary and secondary antibodies used in Western blotting are summarized in tables 
M18 and M19, respectively.  
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Table M18. Primary antibodies used in Western blotting 
Antibody Species Epitope Supplier Dilution 
HA.11 Clone 16B12 Mouse HA: influenza hemagglutinin epitope (YPYDVPDYA) 
Covance 
(MMS-101R) 
1:1000 
HA-probe (Y-11) Rabbit Internal region of the influenza hemagglutinin (HA) 
Santa Cruz 
(sc-805) 
1:1000 
Anti-FLAG M2 Mouse FLAG tag (DYKDDDDK) 
Sigma-Aldrich 
(F3165) 
1 µg/mL 
Anti-β-Actin Clone AC-15 Mouse N-terminal end of the β-isoform of actin 
Sigma-Aldrich 
(A5441) 
1:10000 
 
 
Table M19. Secondary antibodies used in Western blotting 
Antibody Type Detection Species Target Supplier 
ECL Mouse IgG, HRP-linked HRP-conjugated  ECL Sheep Mouse IgG 
GE Healthcare 
(NA931) 
Goat anti-rabbit IgG-HRP HRP-conjugated  ECL Goat Rabbit IgG 
Santa Cruz 
(sc-2004) 
Goat anti-Mouse IgG, DyLight 680 Dye-conjugated Odyssey  Goat Mouse IgG 
Thermo 
(35518)  
Goat anti-Rabbit IgG, DyLight 680 Dye-conjugated Odyssey  Goat Rabbit IgG 
Thermo 
(35568) 
HRP, horseradish peroxidase, ECL, Chemiluminescent detection, Odyssey, Odyssey Infrared Imaging System.  
Ŧ 
Subject to same case-by-case exceptions, secondary antibodies where applied using a dilution 1:5000 
 
Co-immunoprecipitation assays (co-IP) were performed after transient transfection of 
FLAG- and HA-tagged proteins. FLAG-fusion proteins were purified by using the anti-
FLAG M2 affinity gel (Sigma-Aldrich), which consists of a purified murine IgG 
monoclonal antibody covalently attached to agarose. The resin was used in the batch 
format following the indications of the manufacturer. Briefly, cleared lysates where 
fractionated in order to preserve ~20 % of the lysates for verification purposes of total 
lysates by Western blotting. The remaining lysates were incubated with the pre-
equilibrated beads for 1 hour at 4ºC with rotation. During this time, FLAG-tag proteins 
bind to the resin and interacting partners become attached to FLAG-tag proteins. After 
washing 4 times, proteins were eluted by adding SDS-PAGE sample buffer. Co-IP 
were followed by Western blotting proved with a polyclonal α-HA antibody to identify 
the HA-tagged fragments that have interacted with the FLAG-fusion protein during the 
incubation step.  
 
9. Immunostaining and fluorescent imaging acquisition 
 
Generally, cells growing in glass coverslips were rinsed with PBS, fixed in 2-4 % 
paraformaldehyde (PFA), washed twice with PBS, permeabilized by treatment with 0.2 
% Triton X-100, and washed again with PBS. Coverslips were subsequently blocked 
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with 2 % BSA in PBS for 1 hour, incubated with primary antibodies for 1 hour, washed 
three times with PBS, and incubated with secondary antibodies for 45 minutes; all 
these steps were run at room temperature (RT). After washing with PBS (3 times), 
coverslips were mounted in Mowiol supplemented with DABCO (Calbiochem). Cells 
transiently transfected with fluorescent tags were just fixed in 2-4 % PFA and mounted 
before fluorescent imaging acquisition.  
 
Previous reports have shown different immunolocalization results of PKPs when using 
different experimental protocols (see Rickelt, 2012; Schmidt et al., 1997; South et al., 
2003). In our hands, with the standard indirect immunofluorescence protocol (described 
above) we only saw PKP1a and PKP2a over the plasma membrane. Thus, for the 
experiments where we wanted to observe the possible nuclear localization of these 
proteins, cells were treated with 0.2 % Triton X-100 in PBS for five minutes before 
fixation. The following steps were the same than in the standard protocol.  
 
Nuclear counterstaining was made by using different dyes depending on the needs. In 
standard indirect immunofluorescences we used DAPI (Invitrogen) as blue nuclear 
counterstain, whereas when we worked with CFP-transfected cells UV-excited dyes 
are not useful because of the bleed-through between channels. In these cases, we 
chose a red (propidium iodide (PI), Life Technologies) or far-red (TO-PRO-3, Life 
Technologies) counterstain. Fixed cells were label with 1 μg/mL DAPI or 1 μM TO-
PRO-3 in PBS for 5-15 minutes just before mounting. PI also binds to RNA, requiring 
treatment of specimens fixed in PFA with RNase in order to eliminate such staining. 
Thus, fixed and permeabilized cells were incubated with 100 μg/mL RNase A (5 
PRIME) in PBS for 30-60 minutes before adding 1 μg/mL PI for 5 minutes before 
fixation.  
 
Images were obtained in a Leica TCS SP5 confocal microscope. Pictures were 
processed using LAS-AF software (Leica Microsystems). Antibodies used in indirect 
immunofluorescences are summarized in tables M20 and M21.  
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Table M20. Primary antibodies used in immunofluorescence 
Antibody Target Species Supplier Dilution 
Desmoplakin I/II C-20 C-terminus of human DP I/II Goat Santa Cruz 
(sc-18086) 
1:50 
Desmoglein I + II (clone DG3.10) “Band 3” polypeptide of bovine DMs Mouse 
 
Acris Antibodies 
(BM370) 
1:50 
E-Cadherin  Clone  36  Recombinant C-terminal human E-
Cadherin 
Mouse BD Biosciences 1:50 
 
Anti-FLAG M2 FLAG tag (DYKDDDDK) Mouse Sigma-Aldrich 
(F3165) 
3 µg/mL 
HA.11 Clone 16B12 HA epitope (YPYDVPDYA) Mouse Covance 
(MMS-101R) 
1:100 
γ-catenin C-20  C-terminus of human γ-catenin  Rabbit  Santa Cruz 
(sc-1497) 
1:50 
Plakophilin-1 (3G250) N-terminal region of human PKP1 Mouse Thermo 
(MA1-25786) 
10 µg/mL 
Plakophilin-2 (28)  residues 19-183 of human PKP2 Mouse Santa Cruz 
(sc-136039) 
1:50 
 
Table M21. Secondary antibodies used in immunofluorescence 
Antibody Target Species Supplier Dilution 
Texas Red goat IgG (H+L) mouse Goat Life Technologies 
(T-862) 
1:200 
Alexa Fluor 488 IgG (H+L) goat Donkey Life Technologies 
(A-11055) 
1:200 
Cy3  IgG (H+L) rabbit goat Abcam 1:200 
Cy5-conjugated AffiniPure IgG (H+L) mouse Donkey Jackson Immunoresearch 1:200 
 
10. Fluorescence lifetime imaging microscopy  
 
Fluorescence lifetime imaging microscopy (FLIM) is a quantitative tool to measure the 
lifetime (Ʈ) of molecular fluorescence. Fluorescence lifetime is the average time that a 
fluorophore remains in an excited state before returning to the ground state. This time 
is dependent of the environment of the fluorescent molecule providing an useful tool to 
investigate, among other purposes, the interaction between proteins in living cells (see 
examples in Danquah et al. 2012; Thomas et al. 2006; von Arnim et al. 2004).  
 
FLIM was the method of choice for studying DP-PKP1a interactions because, unlike 
fluorescence intensity —the property measured in the most of the Förster resonance 
energy transfer (FRET)-based methods—, lifetime is independent of fluorophore 
concentration. This is a key point in the study of inter-molecular interactions, being 
FLIM the preferred method when donor-acceptor stoichiometry is variable. Among the 
different FLIM approaches, we have used frequency domain FLIM (FD-FLIM) which 
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uses periodically modulated light for the excitation and the generated fluorescent light 
is demodulated by using a micro-channel plate image intensifier (technical details can 
be reviewed in Zhao, Young, & de Jong, 2011).  
 
Simplifying, a routine FLIM experiment requires co-transfection of cells with the 
proteins of interest tagged with an appropriate FRET-pair of fluorophores. In our case, 
we used CFP to tag PKP1a-fragments and the YFP variant Venus to tag DP-
fragments. Twenty-four hours post-transfection, cells growing in 24 mm coverslips were 
mounted in slide holders and positioned in a wide-field microscope equipped with a 
fluorescence lifetime measuring system and a climate control chamber to keep sample 
temperature as stable as possible (37ºC degrees in our case). After calibration of the 
system with a fluorophore of known lifetime (e.g. rhodamine or fluorescein), the donor 
fluorophore (CFP) is excited; once in its electronic excited state (S2), if the acceptor 
fluorophore (Venus) is close enough (<10 nm), CFP may transfer energy to it through 
non-radiative processes. This transfer will reduce CFP lifetime (Figure M3). Measuring 
the donor lifetime allows us to know whether CFP and Venus are coupled by dipole-
dipole interactions and, therefore, whether the proteins of interest are interacting.  
 
FLIM experiments were performed by using a LIFA (Lambert Instruments Fluorescence 
lifetime Attachment) system (Lambert Instruments BV) which includes a LI2CAM 
Intensified CCD camera (Lambert Instruments BV) as reference camera and a Leica 
DM IRE2 (Leica Microsystems) as inverted microscope. FD-FLIM system was 
controlled via the LI-FLIM software developed by Lambert Instruments. The fluorescent 
filter cube was comprised by a 472-nm single-band excitation filter, a 495-nm long pass 
dichroic mirror, and a 520-nm single-band emission filter (Semrock Inc.). We used a 
Zeiss oil objective with a magnification of 40x and a numerical aperture of 1.3 for the 
lifetime measurements. The calibration of the system was carry out using a 10 μM 
fluorescein solution (Sigma-Aldrich) in deionized water (Ʈ=3.83 ns). During 
measurements cells were maintained in HBS buffer (10 mM HEPES, 140 mM NaCl, 5 
mM KCl, 1mM MgCl2, 10 mM glucose, pH 7.20) (for further technical details see Qiaole 
Zhao et al., 2012).  
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Figure M3. Simplified Jablonski diagrams illustrating the lifetime depletion due to non-radiative 
energy transfer between the CFP/Venus FRET-pair.  A) Schematic drawing of the structure of the 
proteins of interest tagged with the fluorophores. On the left side, a situation of no interaction (distance > 
10 nm) and, therefore, no FRET is represented. On the right side, proteins are interacting (distance < 10 
nm) which allows the non-radiative energy transfer by means of dipole-dipole interactions between CFP 
and Venus. B) Simplified Jablonski diagrams illustrating the situations represented in A. On the left side, 
upon excitation of CFP by modulated light (h), CFP goes into an excited state (S2) (green arrow) for a 
certain characteristic time (CFP lifetime, ƮCFP) and then relaxes to the ground state (S0) (red arrow) by 
emission of a less energetic photon (CFP fluorescence). On the right side, the closeness between CFP 
and Venus due to interaction between the fusion proteins, leads to resonance energy transfer from the 
donor to the acceptor, quenching the donor fluorescence. Note that CFP lifetime (ƮFRET) is reduced (red 
arrow) when an interaction exists in comparison of a situation with no interaction between tested proteins 
(ƮCFP, red dashed arrow). 
 
Statistical analysis of FLIM data 
 
Data analysis of FLIM experiments was performed by using GraphPad Prism 6.04 
(GraphPad Software, Inc.). Statistical differences between the samples and the control 
group were evaluated using a 2-tailed t-test with the Welch´s correction in order to 
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avoid the necessity for equal variances in the samples (Ruxton 2006). A p-value ≤ 0.05 
was used as indicative of statistical significance.  
 
When mapping the PKP1a-interaction site in DP, the control group was the co-
transfection of a PKP1a-fragment tagged with CFP with the fluorophore Venus cloned 
in the empty vector pcDNA3-Venus (coding for free-Venus). When mapping the DP-
interaction site in PKP1a the control group was the co-transfection of both empty 
vectors pcDNA3-CFP and pcDNA3-Venus (coding for free-CFP and free-Venus). 
Average CFP lifetimes higher than the average CFP lifetime of the control group were 
considered not significant because only decreases in the CFP lifetime have biological 
relevance in FLIM experiments, being representative of protein-protein interaction. 
These higher values of CFP lifetime are often observed in samples where there is no 
interaction but the expression levels of the proteins are quite lower than the expression 
of the free fluorophores of the negative control.  
 
11. Bacterial protein expression and purification 
 
Bacterial protein expression was carried out using the E. coli strain BL21(DE3)T1 
(Studier & Moffatt 1986) growing in 3 L of Terrific Broth (Tartof & Hobbs 1987) 
supplemented with 100 mg/L ampicillin. Protein expression was induced in log phase 
(A600= 0.6-0.8) by addition of 0.2 mM IPTG. Bacteria were allowed to grow for 3-4 
hours at 37 ºC or O/N at 15 ºC. Pelleted bacteria were resuspended in binding buffer 
containing 20 mM Tris-HCl (pH 7.9), 500 mM NaCl, 5 mM imidazole and 0.1 % (v/v) 
Triton X-100. Bacteria lysis was completed by one freezing-thawing cycle, followed by 
sonication. The soluble fraction was separated from the cell debris by centrifugation at 
16,000 xg (30 min, 4ºC).  
 
Fusion proteins were purified from bacteria supernatants by immobilized metal ion 
affinity chromatography (IMAC) using a 5 mL Ni2+ Hi-Trap chelating column (GE 
Healthcare) coupled to an ÄKTA Prime system (GE Healthcare). Protein elution was 
achieved by an imidazole gradient from 5 to 500 mM in 20 mM Tris-HCl (pH 7.9), 500 
mM NaCl buffer. Fractions were analysed by SDS-PAGE followed by Coomassie 
Brilliant blue staining and those containing the protein were collected and dialyzed 
against 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA in dialysis 
tubes (Spectra/por membranes, Spectrum Laboratories). During the dialysis the octa-
His tag was exscinded by digestion with the recombinant TEV protease. A second 
purification step was performed to eliminate non-digested protein, the octa-His tail, and 
the recombinant protease, which contains a His-Tag. Collected fractions were 
extensively dialyzed against the buffer of choice depending on the purpose. A 
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concentration step was carried out by ultra-filtration in Amicon stirred cells (Millipore) 
using YM3 or YM10 membranes (Millipore). Once the desire volume and concentration 
were reached, possible aggregates were removed by high-speed centrifugation at 
149,000 xg using a TLA 100.3 fixed-angle rotor (Beckman Coulter).  
 
Under specific circumstances, the purification protocol was modified to add an 
additional purification step needed in some forthcoming procedures such as SAXS. In 
these cases, we used a Sephacryl S-300 HR 26/60 (GE Healthcare) gel filtration 
column for preparative separation of midsize proteins instead of the second standard 
IMAC. Subject to some case-by-case exception, the size exclusion chromatography 
was run in 20 mM NaPi (pH 7.5), 150 mM NaCl, 5 % Glycerol, 1-3 mM DTT. 
 
Alternatively, the construct named DP-CT-GCN4-22b (DP residues 660-1060 fused 
with the C-terminus of the GCN4 coiled coil, in pET22b), which does not contain any 
additional tags, was purified by precipitation with ammonium sulphate (AS). Once the 
soluble fraction of the bacterial cultures was obtained as stated before, AS was added 
(119.5 g per 100 mL of protein solution) to get 21 % saturation. After 30 min at 4ºC, the 
protein solution was centrifuged at 43000 xg during 45 min at 4 C. The pellet, that 
contains the DP protein, was resuspended in 5 mL of 20mM NaPi (pH 7.5), 150 mM 
NaCl, 5 % Glycerol, 1 mM DTT and the protein was purified by size exclusion 
chromatography using a Sephacryl S-300 HR 26/60 column equilibrated in the same 
buffer (GE Healthcare). Finally the protein was concentrated by ultra-filtration as 
described above. 
 
12. Protein quantification 
 
Protein concentration was determined by measuring the absorbance of the aromatic 
amino acids at 280 nm (A280) in an U-2001 UV-Visible double beam spectrophotometer 
(Hitachi) using quartz absorption cuvettes with a 10 mm pathlength (Hellma GmbH). 
Molar (ε280) and mass (E280) extinction coefficients were calculated based on the amino 
acid sequence (Pace et al. 1995) using the Protparam tool implemented in ExPASy 
(http://web.expasy.org/protparam/) (Wilkins et al. 1999). Table M22 summarizes the 
molar and mass absorption coefficients used to calculate protein concentrations.  
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Table M22. Molecular weight (MW) and extinction coefficients of recombinant DP fragments 
Construct name aa boundaries
a
 ε
280
(M
-1
 cm
-1
) 
b
 E
280
( (mg mL
-1
) 
-1
 cm
-1
 ) 
b
 MW (Da) 
DP-SR2-L-pET 64-164 4470 0.363 12307.1 
DP-SR2-S-pET 64-155 4470 0.376 11271.8 
DP-1-SR6-pET 1-630 102220 1.388 73640.1 
DP-CT-pET 660-1056 44350 0.948 46772.4 
DP-CT-GCN4-22b 660-1060-GCN4 45840 0.899 50973.3 
a  
pET proteins contain an additional tetra-peptide GSHM in their N-terminus.  
 
b
ε
280 
and E
280 
are estimated in water, assuming all Cys residues are reduced.  
 
13. Crystallization assays 
 
Initial crystallization assays were performed by vapor diffusion methods in sitting-drop 
format using different commercial collections of crystallization solutions: Crystal Screen 
and SALT Rx (Hampton Research), Wizard I & II and Cryo I & II (Emerald Biosystems), 
and PACT (Newman et al. 2005) including a total of 432 crystallization conditions. All 
the conditions were assayed both at RT and a 4 ºC in 96-well plates (Swissci AG) and, 
if possible, two different protein concentrations were used. Additionally, DP-SR2-L 
(region 64-170) crystallization was also assayed in: Structure Screen 1 & 2, MIDAS, 
ProPlex, JCSG, Morpheus, and PGA-LM (all from Molecular Dimensions). Briefly, 1 µL 
of protein solution in 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM DTT (standard 
conditions) was mixed with an equal volume of mother liquor and equilibrated against 
80 µL of mother liquor present in the reservoir.  
 
Secondary fine screenings around conditions that yielded crystals in the initial screen 
were done using 24-well Cryschem sitting drop plates (Hampton Research). 
Parameters such as pH, precipitant or salt concentration, and volume of the drop were 
changed to attempt to improve the crystallization process. 
 
14. Protein sequence analysis 
 
Protein sequence analysis studies were performed by using different bioinformatics 
tools: 
 
i) Protein sequences were obtained from the repository Uniprot 
(http://www.uniprot.org/). In several cases, domain limits were defined by sequence 
homology with other members of the protein families. In these cases, we searched for 
protein sequence homology by aligning and comparing the protein sequences with the 
BLAST (Basic Local Alignment Search Tool) algorithm implemented in the web page.  
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ii) Multiple sequence alignments were made with Clustal Omega (Sievers & Higgins 
2014) that uses seeded guide trees and HMM profile comparisons to generate multiple 
alignments. Clustal Omega was run online at the web server of the European 
Bioinformatics Institute (EMBL-EBI) (http://www.ebi.ac.uk/Tools/msa/clustalo/).  
 
iii) HMM profiles were built using the hmmbuild tool of the HHMER software 
(http://hmmer.janelia.org/) (Finn et al. 2011). Once we got the HMM profiles, they were 
used to search for homology against the human proteome database 
(ftp://ftp.uniprot.org/pub/databases/uniprot/), Pfam (Finn et al. 2014) or within 
sequences of specific proteins by using the hmmsearch tool of the same software.  
 
iv) Secondary structure predictions were performed by using the online servers Jpred3 
(http://www.compbio.dundee.ac.uk/jpred) (Cole et al. 2008) and PredictProtein 
(https://www.predictprotein.org/) (Yachdav et al. 2014).  
 
15. Circular dichroism  
 
Circular dichroism (CD) is a well-established low-resolution structural technique to 
determine the secondary structure content of chiral biomolecules based on the 
interaction of these molecules with polarized light (reviewed in Kelly, Jess, & Price, 
2005 and Ranjbar & Gill, 2009). Optically active molecules exhibit circular dichroism 
because the absorption of light circularly polarized in one direction (right-handed) is 
different from that absorption in the opposite direction (left-handed). CD spectra are 
obtained when the dichroism is measured as a function of wavelength. The shape of 
the CD spectrum of proteins provides information about the structure. Protein 
secondary structure composition (content of helix, sheet, turns, etc.) can be 
quantitative estimated by CD spectroscopy in the far-UV spectral region (absorption in 
the range ~185 to 250 nm). At these wavelengths the chromophore of interest is the 
peptide bond; hence the CD signal is sensitive to the conformation of the polypeptide 
backbone. Furthermore, changes in the CD signals induced by denaturing agents 
(such as chemical denaturants or temperature) can be used to provide quantitative 
estimates of the conformational stability of a folded protein (Fasman 1996).  
 
CD spectra were acquired with a Jasco J-720 dichrograph employing 1 mm and 0.1 
mm optical path cells (Hellma GmbH) at 20 ºC. Four consecutive scans between 187 
and 260 nm (bandwidth of 1 nm) were averaged from samples of purified protein in 20 
mM NaPi (pH 7.5), 150 mM NaCl, 0.3 mM TCEP. Denaturation profiles were conducted 
by using as denaturant agent a temperature ramp from 20 to 90 ºC with a heating rate 
of 40 ºC/hour. A fixed wavelength of 222 nm was employed during thermal 
denaturation.  
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The secondary structure content of a protein can be estimated from its far-UV CD 
spectra using bioinformatic tools. Specifically, we used the methods SELCON 
(Sreerama et al. 1999), CONTIN (van Stokkum et al. 1990), and CDSSTR (Sreerama & 
Woody 2000) implemented in the online server DICHROWEB (Whitmore & Wallace 
2004), and the K2D3 method (Louis-Jeune et al. 2012). When needed, the reference 
database number 6 was used for the analysis since it is optimized for a data range 
from 185 to 240 nm, and includes the broadest CD spectra in this range of data (Janes 
2009).  
 
CD denaturation profiles analysis 
 
Changes induced by the temperature in the CD signal at 222 nm of the SR2-like 
fragments of DP were analysed using a two-state transition model that assumes an 
equilibrium between the folded and the unfolded state (Greenfield 2007). The following 
equation of a two-state transition was used for determining the midpoint temperature of 
the transition (melting temperature, Tm) (Koepf et al. 1999): 
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Where: Y is the measured ellipticity at each temperature. ΔHm is the enthalpy at the 
unfolding transition. Tm is the melting temperature (in Kelvin). T is the temperature (in 
Kelvin). R is the universal gas constant (1.987 cal K−1 mol−1). mn is the slope of the 
pre-transition (native) state. yn is the intercept of the pre-transition (native) baseline. md 
is the slope of the post-transition (unfolded) state. yd is the intercept of the post-
transition (unfolded) baseline. 
 
The equation assumes that the ellipticity of the pre-transition (native) and post-
transition (unfolded) states changes linearly with the temperature. This model was fitted 
to the thermal denaturation CD curve using a nonlinear least-square fit running in 
Sigmaplot (Systat Software Inc). 
 
16. Thermal shift assays using ThermoFluor 
 
Thermal shift assays are fluorescence-based experiments useful to assess the thermal 
stability of proteins. Briefly, the method makes use of fluorescent probes that 
experience a large increase in the fluorescent intensity when they bound to 
hydrophobic regions of proteins. In native states proteins typically do not show large 
hydrophobic surfaces. However, hydrophobic patches are exposed upon unfolding. 
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Therefore, thermal induced unfolding transitions can be monitored as an increase in 
the fluorescence of the probe. The resultant fluorescence curve is used to determine 
the Tm of the protein (Pantoliano et al. 2001). 
 
The fluorescence dye Sypro Orange (Life Technologies) was used to monitor the 
fluorescence changes in protein solutions at 0.25 - 1 mg/mL in buffer 50 mM HEPES or 
MES (depending on the pH, from 6 to 7.9), 150 mM NaCl. Experiments were carried 
out using 96-well Thermo-Fast PCR plates (ABgene, Thermo Scientific) in a 
quantitative PCR (qPCR) machine IQ5 (Biorad) settled for performing a heating ramp 
from 20 to 85 ºC with a heating rate of 1 ºC/min. Fluorescence measurements were 
conducted using an excitation filter of 480 nm with a 20 nm bandwidth and an emission 
filter of 530 nm with a 30 nm bandwidth. Data were collected every 0.5 ºC and samples 
were assayed in duplicate. The Tm, corresponding to the midpoint of the transition, 
was calculated as the maximum of the first derivative of the fluorescence signal (F) with 
respect to the temperature (T) (dF/dT).  
 
17. Building atomic models of DP-PD fragments  
 
Homology modelling of the SR2 and SR7-SR9 of DP 
 
The atomic model of the SR2-like domain of DP was built by homology modelling with 
the JACKAL package (http://trantor.bioc.columbia.edu/jackal/index.html) running in 
FFAS03 (Jaroszewski et al. 2005). The crystal structure of the SR2 domain of BPAG1e 
(Gómez-Hernández and de Pereda, unpublished results) was used as template. 
Similarly, the structure of the SR7-SR9 region of DP was obtained by modelling using 
the crystal structure of the equivalent region of plectin (Ortega and de Pereda, 
unpublished results). 
 
Composite model of the SR7-SR9-GCN4 of DP 
 
The composite model of the dimer formed by the region 660-1060 of DP, which 
includes the SR7-SR9 and ~57 residues of the rod domain, fused to the coiled coil of 
GCN4 was built as follows. The SR7-SR9 region (660-1003) was modelled by 
homology as described above. The two protomers of the dimer were taken from the 
parallel arrangement of the two SR7-SR9 molecules in the asymmetric unit of the 
plectin structure. The N-terminal segment of the rod domain (region 1004-1060) was 
modelled by homology using as template the crystal structure of a dimeric N-terminal 
fragment of tropomyosin that forms a coiled coil (PDB entry 1IC2) (Brown et al. 2001). 
Finally, the dimeric crystal structure of the GCN4 coiled coil (PDB code 2ZTA) (O’Shea 
et al. 1991) was assembled at the C-terminus. 
 MATERIALS & METHODS   47 
18. Small angle X-ray scattering 
 
Small-angle X-ray scattering (SAXS) is a well-established method for structural 
characterization of biological macromolecules in solution. This technique provides 
three-dimensional low-resolution structures allowing the study of quaternary structure, 
domain organization, oligomeric state of proteins and protein complexes, kinetic 
processes, and responses to changes in conditions. Additionally, it is a powerful tool to 
complement and validate high resolution methods such as X-ray crystallography (see 
Mertens & Svergun, 2010 for a review about characterization of protein complexes by 
SAXS and Koch, Vachette, & Svergun, 2003 for a thorough explanation of the theory 
behind the technique).  
 
Briefly, to extract structural information from non-crystalline samples by SAXS, proteins 
in solution are exposed to a collimated and focussed X-ray beam and the scattered 
intensity is recorded by a detector as a function of the scattering angle. The scattered 
intensity must be corrected by subtraction of the contribution of the solvent to assure 
that the intensity is proportional to the scattering of a single particle averaged over all 
orientations. Represented as one-dimensional curves, scattering patterns provide 
important information about size, oligomeric state, and overall shape of molecules 
based on parameters such as the molecular weight (Mw), radius of gyration (Rg), 
hydrated particle volume (V) or maximum particle distance (Dmax). Additionally, 
computational methods are available to determine reliable three-dimensional low-
resolution models from scattering data by using ab initio methods or through the 
refinement of available high-resolution structures or homology models. 
 
Sample preparation and data collection 
 
Protein samples for SAXS analysis were additionally purified and equilibrated in 20 mM 
NaPi (pH 7.5), 150 mM NaCl, 5 % glycerol, 3 mM DTT by size exclusion 
chromatography using a Hi-Prep Sephacryl S300 26/60 column (GE Healthcare).  
Eventually, DP-CT-pET was equilibrated in 20 mM HEPES, 500 mM NaCl, 5% glycerol, 
2.5 mM DTT (pH 7.9). High concentrations of DTT and glycerol are added to prevent 
radiation damage in SAXS samples (Kuwamoto et al. 2004). DP constructs studied by 
SAXS are summarized in table M23. 
 
Table M23. DP fragments analysed by SAXS 
Construct name region aa boundaries 
DP-1-SR6-pET N-SR6 1-630 
DP-CT-pET SR7-SR9 660-1056 
DP-CT-GCN4-22b SR7-SR9-GCN4 660-1060-GCN4 
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SAXS measurements were performed at the EMBL high brilliance synchrotron 
BioSAXS beamline P12 on the storage ring PETRA-III (Deutsches Elektronen 
Synchrotron - DESY, Hamburg, Germany) with a Pilatus 2M detector (Dectris) using 
radiation of wavelength 1.24 Å. Data were collected at a sample-detector distance of 
4.1 m for a scattering vector (q) range from 0.01 to 0.35 Å-1 (q= (4π sin θ)/λ, where 2θ 
is the scattering angle). Exceptionally, DP-SR6-pET fragment was measured using a 
detector distance of 3.1 m (0.01 < q < 0.44 Å-1). Data collection was set to 10 °C for all 
the measurements. Data frames were recorded every 0.5 msec, for a total exposure 
time of 1 sec in a flow mode where the samples are moving through the capillary during 
the exposure time to reduce radiation damage. At least four different concentrations 
per sample were used to collet scattering data in a concentration range from ~0.90 to 
~30 mg/mL. Samples were prepared by sequential dilution in the equilibration buffer.  
 
SAXS data analysis 
 
Data reduction and analysis was performed using the ATSAS package (Petoukhov et 
al. 2012) according to standard procedures. Briefly, after assessing the absence of 
radiation damage by comparing successive curves of the same sample, the non-
damaged curves were averaged, the scattering from the buffer was subtracted and the 
curves were extrapolated to infinite dilution, unless otherwise indicated, using PRIMUS 
(Konarev et al. 2003). The Rg and the forward scattering intensity (I0)  were evaluated 
using the Guinier approximation (Guinier & Fournet 1955). The pair-distribution 
probability function (P(r)) was calculated by an indirect Fourier transform using the 
program GNOM (Svergun 1992) in the PRIMUS QT graphical interface. From the 
calculation of the P(r) distribution we also derived parameters such as the Rg, I0, and 
Dmax.  
 
Reconstruction of molecular envelopes of DP-PD fragments  
 
The scattering profiles of those fragments with limited conformational variability were 
used to calculate low-resolution structures using two independent ab initio methods 
implemented in the programs DAMMIF (Franke & Svergun 2009) and DALAI_GA 
(Chacón et al. 2000). Typically, fifteen independent ab initio reconstructions were made 
with each program. The multiple models of a given protein were superimposed with the 
program SUPCOMB (Kozin & Svergun 2001) and an averaged model that represents 
the most populated volume was obtained with DAMAVER (Volkov & Svergun 2003). 
For illustration, volumetric representations of the low resolution structures were 
calculated with the SITUS package (Wriggers 2010). When available, atomic models 
were superimposed onto low resolution reconstructions with SUPCOMB. 
 MATERIALS & METHODS   49 
Rigid body modelling  
 
The structure of DP-1-SR6 was also modelled by rigid body fitting against SAXS data 
with the programs CORAL (COmplexes with RAndom Loops) (Petoukhov et al. 2012) 
and BUNCH (Petoukhov & Svergun 2005). The atomic model of the SR2 domain (see 
above) and the crystal structure of the SR3-SR6 region, residues 178-627 (PDB entry 
3R6N, Choi & Weis 2011) were used as rigid bodies, whereas the N-terminal tail 
preceding the SR2 and the SR2-SR3 linker were modelled as flexible segments. Both 
methods start from arbitrary initial positions and orientations of the rigid domains linked 
by flexible regions made of dummy residues to build a final model where the positions 
of the rigid domains are defined.  
 
Evaluation of theoretical scattering profiles against experimental data  
 
The theoretical scattering profiles of atomic models were calculated and fitted to the 
experimental data by using CRYSOL (Svergun et al. 1995). The P(r) and Dmax of the 
atomic models were calculated with the program MOLEMAN 2 (Kleywegt et al. 2004).  
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1. Mapping of the PKP1a-interaction site in DP 
Two regions of DP-PD interact with PKP1a in co-IP assays  
 
The interaction between PKP1a and DP was analysed by co-IP in COS-1 cells 
transiently co-transfected with PKP1-FLAG and DP-PD-HA tagged constructs. 
Previous studies have shown that the N-terminal half of the DP-PD, region 1-584, 
interacts with desmosomal components such as plakoglobin or plakophilins (PKP1-3) 
(Bonné et al., 2003; Chen, Bonne, Hatzfeld, van Roy, & Green, 2002; Kowalczyk et al., 
1997; Kowalczyk, 1999). Surprisingly, our results showed that, in addition to the 
complete DP-PD and the N-terminal half (DP-NT, SR2-SR5 domains), the non-
overlapping C-terminal fragment corresponding to the SR6-SR9 domains (DP-CT) also 
interacted with PKP1a (Figure R1). 
 
 
Figure R1. Analysis of the interaction between PKP1a and DP by co-IP. A) Schematic domain 
representation of FLAG-tagged PKP1a full length (pCEFLAG vector) and HA-tagged DP fragments 
(pCEFLHA vector) used in co-IP assays. B) The interaction between PKP1a and DP-PD was analysed by 
co-IP of DP fragments with PKP1a full length tagged with FLAG (PKP1-FLAG) and incubated with anti-
FLAG agarose beads (+ lanes). Results were proved by western blotting using a polyclonal anti-HA 
antibody. In the negative control lanes (-) (COS-1 cells transfected with pCEFLAG empty vector instead of 
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PKP1-FLAG and incubated in the same conditions), no signal could be detected, suggesting a specific 
interaction between PKP1a and DP fragments (upper panel). Expression of PKP1-FLAG and DP-
fragments in the co-IP input (total lysates) was detected by western blotting, using monoclonal anti-FLAG 
and anti-HA antibodies for detecting PKP1a and DP-fragments, respectively. β-actin detection was used 
as a loading control.  
 
Co-IP assays suggested the existence of at least two PKP1a-binding sites within the 
DP-PD, each located on one half of the plakin domain. In order to validate the results 
obtained by co-IP and to confirm the novel second PKP1a-binding site located in the C-
terminal half of DP-PD we used fluorescence imaging microscopy.  
 
FLIM experiments only support one PKP1a-binding site in DP 
 
As a complement to the analysis by co-IP we studied the interaction between PKP1a 
and DP by fluorescence lifetime imaging microscopy (FLIM). For doing so, we co-
expressed CFP-tagged PKP1a constructs (made in our vector pcDNA3-CFP-C4) with 
Venus-tagged DP constructs (made in pcDNA3-Venus-C4 or pcDNA3-Venus-N3 
vectors, see materials and methods) in COS-7 cells. These two fluorophores are a 
FRET pair in which CFP and Venus (YFP variant) act as donor and acceptor, 
respectively. CFP lifetime was measured in at least 30 cells per condition. Differences 
between transfected cells and the control group (cells transfected with one PKP1-CFP 
fragment and free-Venus) were analysed using an unequal variance t-test (Welch´s 
correction). P-values ≤ 0.05 were considered statistically significant. 
 
Figure R2 shows one representative FLIM result of at least three independent 
experiments with the signification obtained in the unequal variance t-test. The CFP 
lifetime when the fluorophore was expressed alone in an empty vector was ~2.57 ns. 
When we co-transfected CFP and Venus in different vectors, CFP lifetime showed a 
slight decrease (~2.47 ns) that probably reflects intermolecular energy transfer 
between unlinked CFPs and YFPs (Grailhe et al. 2006). A new drop was observed 
when we co-transfected PKP1-CFP with free-Venus in a different and empty vector 
(~2.29 ns). Because Venus was not fused to any construct, the observed decrease in 
the CFP lifetime was just due to the higher overexpression of Venus in the 
surroundings of PKP1-CFP and might be considered the CFP lifetime drop as a result 
of the background. We considered that CFP lifetime as the reference value in a 
situation of non-specific interaction (negative control). Statistical significance is also 
referred to this value.  
 
Table R1 shows the average CFP lifetime measured in more than 40 different cells per 
condition and the dispersion of this measure. DP-PD and DP-NT produced a significant 
decrease in the CFP lifetime from ~2.3 ns to around 2.2 ns (p ≤ 0.01). On the other 
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hand, CFP lifetime was not reduced when PKP1-CFP was co-transfected with DP-CT 
(p > 0.05) suggesting that there is no interaction between them. Thus, in contrast to the 
co-IP results, FLIM experiments did not support an interaction between the C-terminal 
half of the DP-PD and PKP1a. 
 
 
 
Figure R2. Analysis of the interaction between PKP1a and DP by FLIM. A) Schematic domain 
representation of CFP-tagged PKP1a full length and Venus-tagged DP fragments used in FLIM assays. In 
the scheme, the fluorophore Venus is represented by the general acronym YFP. B) The PKP1a-DP 
interaction was analysed by FLIM in COS-7 cells. Results of one representative experiment are shown in 
scatter dot plots of the CFP lifetime with the mean and the standard deviation. Statistically significant 
differences (unequal variance t-test) are indicated by *** (p ≤ 0.001); ** (p ≤ 0.01); ns, not significant (p > 
0.05).  
 
Table R1. Descriptive statistics of the data shown in figure R2 
Donor Acceptor n Mean lifetime (ns) SD SEM 
CFP - 40 2.570 0.047 0.007 
CFP Venus 47 2.467 0.074 0.011 
PKP1-CFP Venus 45 2.290 0.111 0.017 
PKP1-CFP DP-PD-Venus 43 2.193 0.129 0.020 
PKP1-CFP DP-NT-Venus 40 2.199 0.141 0.022 
PKP1-CFP DP-CT-Venus 42 2.378 0.110 0.017 
n, number of values; SD, standard deviation; SEM, standard error of the mean 
58 
In order to gather more evidences about the interaction of PKP1a and DP-PD, we 
performed similar experiments but using the PKP1a-head domain as CFP-tagged 
fragment instead of PKP1a full length (Figure R3). It is well established that the region 
of PKP1a that interacts with DP is located within the head domain of PKP1a, which 
comprises the first 243 amino acids (Hofmann et al., 2000; Kowalczyk, 1999; Sobolik-
Delmaire, Katafiasz, & Wahl, 2006). 
 
 
Figure R3. Analysis of the interaction between PKP1a-head domain and DP by FLIM. A) Schematic 
domain representation of CFP-tagged PKP1a head domain (PKP1-head, region 1-243) and Venus-tagged 
DP fragments used in FLIM assays. In the scheme, the fluorophore Venus is represented by the general 
acronym YFP. B) The PKP1a-head/DP interaction was analysed by FLIM in COS-7 cells. Results of one 
representative experiment are shown in scatter dot plots of the CFP lifetime with the mean and the 
standard deviation. Statistically significant differences (unpaired unequal variance t-test) are indicated by 
**** (p ≤ 0.0001); ns, not significant (p > 0.05).  
 
Table R2 shows the descriptive statistics of the representative experiment plotted in 
figure R3. Experimental conditions and data analysis were the same as those 
previously explained. 
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Table R2. Descriptive statistics of the data shown in figure R3 
Donor Acceptor n Mean lifetime (ns) SD SEM 
CFP - 35 2.395 0.028 0.005 
CFP Venus 29 2.305 0.072 0.013 
PKP1head-CFP Venus 29 2.321 0.055 0.010 
PKP1head-CFP DP-PD-Venus 31 2.212 0.105 0.019 
PKP1head-CFP DP-NT-Venus 32 2.263 0.049 0.009 
PKP1head-CFP DP-CT-Venus 28 2.373 0.041 0.008 
n, number of values; SD, standard deviation; SEM, standard error of the mean 
 
The head domain of PKP1a reproduced the DP-interaction results obtained with the full 
length PKP1a in FLIM experiments. Summarizing, by using FLIM we confirmed the 
interaction between the PKP1a head and DP-NT, but we did not detect association 
between PKP1a and DP-CT. 
 
It may be possible that we did not detect the interaction between PKP1a and DP-CT 
because we were using DP-constructs with the fluorescent tag located in the N-
terminal region of the fusion protein. To test whether the interaction that we observed 
between PKP1a and DP-NT was dependent on the location of the fluorescent tag we 
performed FLIM experiments using new DP-fragments with Venus linked to the C-
terminal region by a flexible linker made of Gly-Ser repeats (pcDNA3-Venus-N3 
vector). We did not change the N-terminal location of CFP in PKP1a because, as we 
stated before, it is well established that PKP1a interacts with DP by means of its N-
terminal head domain. Moreover, we have not detected interaction of the ARM domain 
of PKP1a with DP in co-IP assays (see below, Figure R20). Results are summarized in 
figure R4 and table R3. They confirmed the interactions PKP1a-DP-PD and PKP1a-
DP-NT, whereas interaction between PKP1a and DP-CT was not observed. So, the 
analysis of the interaction between PKP1a and DP by FLIM was not dependent on the 
location of the fluorescent tag.  
 
Taking into account these results, the forthcoming FLIM experiments to map the 
PKP1a-DP interaction site were performed by using PKP1a and DP-fragments with 
CFP or Venus linked to the N-terminal region of the fusion proteins.  
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Figure R4. FLIM analysis of the interaction between PKP1a full length and DP-fragments tagged 
with C-terminal Venus. A) Schematic domain representation of CFP-tagged PKP1a full length and C-
terminal Venus-tagged DP fragments used in FLIM experiments. In the scheme, the fluorophore Venus is 
represented by the general acronym YFP. B) The PKP1a-DP interaction was analysed by FLIM in COS-7 
cells. Results of one representative experiment are shown in scatter dot plots of the CFP lifetime with the 
mean and the standard deviation. Statistically significant differences (unpaired unequal variance t-test) are 
indicated by ** (p ≤ 0.01); * (p ≤ 0.05); ns, not significant (p > 0.05). Notice that, although the statistical 
signification was lower using fusion proteins with the tag in the C-terminal end than when the tag was at 
the N-terminus, the overall result was the same, that is, PKP1a interacted with DP in a region located in 
the N-terminal half of the DP-PD. 
 
Table R3. Descriptive statistics of the data shown in figure R4 
Donor Acceptor n Mean lifetime (ns) SD SEM 
CFP - 28 2.469 0.021 0.004 
CFP Venus-N3 30 2.308 0.069 0.013 
PKP1-CFP Venus-N3 32 2.261 0.100 0.018 
PKP1-CFP DP-PD-Venus-N3 29 2.199 0.045 0.008 
PKP1-CFP DP-NT-Venus-N3 30 2.215 0.047 0.009 
PKP1-CFP DP-CT-Venus-N3 32 2.272 0.076 0.013 
n, number of values; SD, standard deviation; SEM, standard error of the mean 
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The subcellular localization of PKP1-CFP and DP-PD-Venus fragments evidences 
an interaction between PKP1a and DP-NT 
 
 
In order to clarify whether an interaction between PKP1a and both halves of DP-PD 
was possible we decided to look at the subcellular localization of these fragments 
tagged with CFP or Venus. With this purpose we transiently transfected COS-7 cells 
with PKP1a or DP-fragments. 
 
The PD of DP is known to target the protein to DMs (Bornslaeger et al. 1996; Smith & 
Fuchs 1998). When we transfected COS-7 cells with DP-PD, it appeared diffusely 
distributed throughout the cytoplasm, but also decorated the plasma membrane (Figure 
R5). DP-NT showed two different distributions in transfected cells. In some cells, it 
showed similar distribution with respect to the full plakin domain (DP-PD). On the 
contrary, other cells showed an aberrant distribution with DP-NT located only in 
prominent cytoplasmic aggregates. These aggregates were not positive for markers of 
lysosomes or the Golgi complex, nor co-localize with recycling endosome markers 
(data not shown). DP-PD and DP-NT were mostly excluded from the nucleus. On the 
other hand, DP-CT was clearly distributed over the plasma membrane, being excluded 
from the cytoplasm and nucleus. These results show clear domain dependence in the 
subcellular distribution of DP and suggest that the C-terminal half of DP-PD is required 
to target DP to the plasma membrane.  
 
 
 
Figure R5. Subcellular localization of DP-fragments in COS-7 cells. The subcellular localization of 
Venus-tagged DP fragments was investigated in COS-7 cells transiently expressing these constructs by 
confocal microscopy. DP localization was detected by exciting Venus at 514 nm. Arrows highlight the 
presence of DP-fragments containing the C-terminal half of the PD over the plasma membrane. Bar, 5 µm. 
Images are representative of the overall subcellular distribution of the studied fragments.  
 
COS-7 cells expressing PKP1-CFP showed an exclusively nuclear staining (Figure 
R6). PKP1a full length was localized to the nuclear karyoplasm and mostly excluded 
from nucleoli. PI counterstaining matched the PKP1-CFP signal, with exception of the 
PI nucleoli-staining. This subcellular distribution have been previously reported in 
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various cell types (Hatzfeld et al. 2000; Schmidt et al. 1997; Sobolik-Delmaire et al. 
2010) being the expected in cell types not containing prominent DMs, such as COS 
cells which form only a small number of immature DMs (Stappenbeck & Green 1992).  
 
Since PKP1-CFP by itself shows a very clear nuclear signal, from now on, nuclear 
counterstaining will not be shown in routine experiments where nuclei are brightly 
defined by PKP1-CFP signal.  
 
 
Figure R6. Subcellular localization of PKP1-CFP in COS-7 cells. Confocal microscopy images of COS-
7 cells transiently expressing PKP1-CFP. Twenty-four hours after transfection, cells were PFA-fixed, 
permeabilized, treated with RNase A and incubated with PI to obtain a nuclear counterstain (red). CFP-
tagged PKP1a full length was detected upon excitation of CFP at 442 nm (grey). PI and PKP1-CFP signals 
completely matched, demonstrating that PKP1-CFP has a specific and exclusive nuclear localization in 
COS-7 cells. Notice that PKP1-CFP was absent from nucleoli whereas PI staining was broadly distributed 
throughout the entire nucleus. 
 
Once we knew the subcellular distribution of the fluorescent-tagged PKP1a and DP-
fragments in COS-7 cells, we wanted to know whether the normal distribution of these 
constructs would be altered by the joint overexpression of PKP1a and DP. To assess 
this objective, we co-transfected COS-7 cells with PKP1a tagged with CFP (PKP1-
CFP) and each of the DP-fragments tagged with Venus. We studied their distribution 
by confocal microscopy using the same conditions and settings as those used with the 
single transfections (Figure R7).  
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Figure R7. Subcellular localization of PKP1a and DP-fragments co-transfected in COS-7 cells. The 
co-localization of PKP1a full length and DP-fragments was investigated in COS-7 cells overexpressing 
both proteins by confocal microscopy. PKP1a full length was detected upon excitation of CFP (442 nm) 
and is represented in red (left images). Overexpression of DP-fragments (middle images) was detected by 
exciting Venus at 514 nm and is represented in green. The overlay images (on the right) show the co-
localization of PKP1-CFP and DP-Venus fragments in yellow. Bar, 10 µm. Images are representative of 
the overall distribution of the studied fragments.  
DP-PD (upper images) and DP-NT (middle images) experienced dramatic changes in 
their subcellular distribution when they were co-transfected with PKP1a. Both DP 
fragments were recruited to the nucleus showing notable co-localization with PKP1a-
CFP (see yellow in merge images). Apparently PKP1a recruits more efficiently to the 
nucleus the complete PD than the N-terminal half (DP-NT), although it might be an 
effect of the abnormal expression of DP-NT-CFP explained before. Notice that in single 
transfections both DP constructs were mostly excluded from the nucleus. The fact that 
PKP1a promoted the recruitment of DP-PD and DP-NT to the nucleus demonstrated 
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that an interaction between PKP1a and DP was happening. On the other hand, co-
expression with PKP1a did not have a significant effect on the subcellular distribution of 
DP-CT that remained at the plasma membrane. Hence, PKP1a and DP-CT did not 
interact in COS-7 cells. 
 
Taken together, these results suggest that PKP1a interacts with DP by means of the N-
terminal region of the PD. The C-terminal region of DP-PD does not participate in the 
interaction with PKP1a but it seems important for the localization of DP over the 
plasma membrane. These observations are consistent with our previous FLIM results 
showing the interaction of PKP1a with DP-PD and DP-NT but not with DP-CT. 
 
Engineering fusion proteins carries the risk of affecting native proteins localization. We 
wanted to make certain that the observed subcellular distribution of PKP1a and DP-
fragments was tag independent. Localization artefacts can be minimized by using two 
or more different tags and/or different tagging locations in each protein. Moreover, 
comparing the results with those obtained by indirect immunofluorescence of 
endogenous or untagged proteins may help to validate the results obtained by using 
fluorescent proteins (Stadler et al. 2013). 
 
Good immunofluorescence images of endogenous proteins could not be obtained in 
COS cells, most likely due to the low expression levels of these proteins in this cell type 
(data not shown). Therefore, as an alternative, COS-7 cells were co-transfected with 
PKP1a full length and DP-PD tagged with FLAG and HA, respectively. Their 
localization was analysed by indirect immunofluorescence (Figure R8).  
 
 
 
Figure R8. Subcellular localization of PKP1-FLAG and DP-PD-HA co-transfected in COS-7 cells. The 
co-localization of PKP1a full length tagged with FLAG (pCEFLAG vector) and DP-PD tagged with HA 
(pCEFLHA vector) was studied in COS-7 cells overexpressing both proteins by confocal microscopy. 
PKP1a full length was detected using a monoclonal antibody against the N-terminal region of PKP1a 
(3G250, Thermo) and a secondary antibody conjugated with Texas Red (red). DP-PD-HA was detected 
with a polyclonal antibody against the C-terminal region of DP-PD (sc-18086, Santa Cruz) and a 
secondary antibody conjugated to Alexa-488 (green). The overlay image (on the right) shows the co-
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localization of PKP1-FLAG and DP-PD-HA in yellow. Bar, 15 µm. Images are representative of the overall 
distribution of the studied fragments. 
 
The subcellular distribution of the fusion proteins with HA- or FLAG-tags was the same 
as that observed with fluorescent tags. That is, PKP1a was restricted to the nucleus, 
DP-PD alone was in the cytoplasm (data not shown) and it was recruited to the nucleus 
by PKP1a when they were expressed together. The overlay image showed co-
localization of PKP1a and DP-PD in the nucleus, as observed with fluorescent fusion 
proteins. Thus, we can conclude that the subcellular distribution of PKP1a and DP-
fragments was not affected by the tags used. 
 
Analysis of the subcellular distribution of PKP1a and DP-fragments in 
keratinocytes 
 
We wondered whether the previous results obtained in COS-7 cells would be 
reproducible in DMs-bearing cell lines such as keratinocytes. To assess this question 
we analysed by confocal microscopy the subcellular distribution and co-localization of 
the fluorophore-tagged constructs, cloned in the pcDNA3-CFP-C4 and pcDNA3-Venus-
C4 vectors, in different keratinocyte cell lines. Results are summarized in Figures R9 
and R10.  
 
We used three different cell lines as keratinocytes models: Normal Human 
Keratinocytes (NHKs) (Niessen et al. 1996), the immortalized but highly differentiated 
HaCaT cell line (Boukamp et al. 1988), and a keratinocyte cell line obtained from a 
patient with junctional epidermolysis bullosa associated with pyloric atresia (JEB-PA), 
in which full-length integrin β4 was stably expressed by retroviral infection to generate 
PA-JEB/β4 (Niessen et al. 1996; Sterk et al. 2000). As before, we first made single 
transfections to analyse the subcellular distribution of the fusion proteins (Figure R9). 
The overall subcellular distribution of all the constructs was the same in the different 
keratinocytes cell lines and it was also very similar to the distribution in COS-7 cells. 
The main difference was observed for PKP1a that in differentiated keratinocytes 
(growing in medium with high calcium), in addition to the nucleus PKP1a was enriched 
laterally at cell-cell contact sites (see arrows), as expected due to the formation of 
DMs.  
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Figure R9. Subcellular localization of PKP1a and DP-fragments in keratinocyte cells lines. Confocal 
microscopy images of HaCaT (upper row), NHK (middle row), and PA-JEB/β4 (bottom row) ectopically 
expressing PKP1a full length and DP fragments tagged with CFP or Venus, respectively. PKP1a full length 
was detected upon excitation of CFP at 442 nm (red). DP-PD (second image of each row), DP-NT (third 
image of each row), and DP-CT (last image of each row) were detected by exciting Venus at 514 nm 
(green). Images are representative of the overall subcellular distribution of the studied fragments.  
 
Next, we co-transfected PKP1-CFP full length with DP-fragments tagged with Venus to 
address whether the presence of one of them affected the distribution of the other (see 
an example with PA-JEB/β4 in Figure R10). As we had seen before in COS-7 cells, 
when DP-PD or DP-NT was co-transfected with PKP1a, the distribution of the DP 
fragments was changed by the presence of PKP1a. Specifically, these DP fragments 
were co-imported to the nucleus. This behaviour evidences an interaction of PKP1a 
with DP-PD and DP-NT. On the other hand, DP-CT did not show delocalization in the 
presence of PKP1a, but remained in the cytoplasm and was accumulated mainly at the 
plasma membrane.  
 
Results obtained with NHK and HaCaT cells (data not shown) were very similar to 
those observed with PA-JEB/β4. Thus, we can conclude that the results regarding the 
localization of PKP1a and DP fragments in keratinocytes are consistent with the results 
obtained previously in COS cells.  
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Figure R10. Subcellular localization of PKP1a and DP-fragments co-transfected in PA-JEB/β4. 
Confocal microscopy images of PA-JEB/β4 co-expressing PKP1a full length and one DP fragment tagged 
with CFP or Venus, respectively. PKP1-CFP was detected upon excitation of CFP (red). Venus-tagged 
DP-PD (first row), DP-NT (second row), and DP-CT (third row) were detected by exciting Venus at 514 nm 
(green). The overlay images (on the right) show the co-localization of PKP1-CFP and DP-fragments-Venus 
in yellow. Bar, 10 µm. Images are representative of the overall subcellular distribution of the studied 
fragments in the three keratinocyte cell lines used (NHK, HaCaT, and PA-JEB/β4).  
 
Taken together the results of co-IP, FLIM, and co-localization analysis in COS cells and 
keratinocytes, they suggest that DP interacts with PKP1a through the N-terminal half of 
the plakin domain. DP and PKP1a are closer than 10 nm when they interact with each 
other, suggesting a direct binding. Furthermore, such interaction does not require the 
formation of DMs. 
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Mapping of the PKP1a-binding site in the N-terminal region of the PD of DP, role 
of the SR2 
 
Once the interaction between PKP1a and the N-terminal half of the PD of DP (DP-NT) 
was confirmed by using different approaches, we wanted to further map the PKP1a-
binding site within this region. For this purpose, we made several N-terminal deletion 
mutants of DP and assayed their interaction with PKP1a full length by co-IP (Figure 
R11). The DP-SR2-SR5 fragment, which lacks the N-terminal first 63 residues, 
interacted with PKP1a. On the other hand, removing the SR2, as in the DP-SR3-SR5 
fragment (region 180-545), compromised the association with PKP1a. Yet a faint band 
in the co-IP sample suggested that the SR3-SR5 might have a marginal contribution to 
the interaction. These results indicate that the SR2-like domain of DP-PD is necessary 
for the interaction with PKP1a.  
 
 
 
Figure R11. Analysis of the interaction between PKP1a and N-terminal fragments of DP by co-IP. A) 
Schematic domain representation of FLAG-tagged PKP1a full length and HA-tagged N-terminal DP 
fragments used in co-IP assays. B) The interaction of PKP1a with fragments of the N-terminal region of DP 
was analysed by co-IP. COS-1 cells were co-transfected with DP-HA fragments and PKP1-FLAG (+ lanes) 
or the empty pCEFLAG vector (- lanes). Lysates were immunoprecipitated with anti-FLAG agarose beads. 
 INTERACTION DOMAIN MAPPING OF THE DP-PKP1a COMPLEX   69 
The presence of DP proteins in the immunoprecipitate was detected with an anti-HA polyclonal antibody. 
Fragments that were co-immunoprecipitated with PKP1a were not detected in its absence (- lanes), 
indicating a specific interaction. The expression of PKP1-FLAG and the DP fragments in the total lysates 
(input) was detected by western blotting using monoclonal anti-FLAG and anti-HA antibodies, respectively. 
β-actin detection was used as a loading control.  
 
Next, we investigated the contribution of the different regions within the DP-NT to the 
interaction with PKP1a. Since the SR6 domain is part of a structural element that 
includes the SR3-SR4-SR5(SH3)-SR6 region (Choi & Weis 2011), we assayed 
whether it could contribute to the interaction. We created two fragments that extend to 
the SR6, one of them starts in the first residue, region 1-630 (DP-1-SR6), whereas the 
other lacks the SR2 domain, region 180-630 (DP-SR3-SR6). DP-1-SR6 interacted with 
PKP1-FLAG in co-IP assays, whereas the construct that lacks the SR2 failed to interact 
with PKP1a (Figure R12-B). Thus, we can conclude that the SR6 domain is not 
necessary for the establishment of the DP/PKP1a complex. 
 
In order to assess the contribution of the SR5(SH3) region to the interaction with 
PKP1a, we created a C-terminal deletion mutant of DP-NT that lacks the SR5(SH3) 
domain, residues 1-376 (DP-1-SR4). This fragment interacted with PKP1a in co-IP 
assays (Figure R12-C). The intensity of the DP-1-SR4 band in the immunoprecipitated 
sample was weaker than the intensity of other fragments that interacted with PKP1a. 
Nonetheless, it should be noted that this fragment was expressed to significant lower 
levels than the other fragments of the DP-NT region. Since the SH3 domain makes 
contact with the SR4 as seen in crystal structures of desmoplakin and plectin (Ortega 
et al. 2011; Choi & Weis 2011), the low expression levels of the fragment 1-SR4 could 
be related to a reduced stability of this protein caused by the loss of the SH3-SR4 
intramolecular contacts.  
 
To further narrow down the PKP1a-interacting region in DP, we studied whether the 
SR2-like domain was sufficient to mediate the DP-PKP1a interaction. DP-SR2-HA, 
which contains the SR2-like domain and the preceding N-terminal sequence, interacted 
with PKP1-FLAG to a similar extent than DP-NT did (Figure R12-D). 
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Figure R12. Analysis of the contribution of different regions of DP-PD to the interaction with PKP1. 
A) Schematic domain representation of FLAG-tagged PKP1a full length and HA-tagged N-terminal DP 
fragments used in co-IP assays. HA-tagged DP fragments were co-transfected with a plasmid coding for 
PKP1-FLAG (+ lanes) or the empty pCEFLAG vector (- lanes). Cell lysates were incubated with anti-FLAG 
agarose beads and the presence of HA-DP fragments in the immunoprecipitates was analysed by western 
blotting using a polyclonal antibody anti-HA. Expression of PKP1-FLAG and DP-HA fragments in the co-IP 
input (total lysates) was detected with monoclonal anti-FLAG and anti-HA antibodies, respectively. β-actin 
detection was used as a loading control. B) Analysis of the contribution of the SR6 domain of DP to the 
interaction of PKP1/DP-PD. C) Analysis of the contribution of the SR5(SH3) domain of DP to the 
interaction of PKP1/DP-PD. D) Analysis of the contribution of the SR2-like domain to the interaction of 
PKP1/DP-PD. Notice that the expression of HA-tagged DP fragments is shown by using two different 
detection methods due to the differences in the expression of the fragments. DP-NT and DP-SR3-SR5 
were detected with a peroxidase-tagged secondary antibody (upper membrane, ECL) whereas DP-SR2 
was detected with a 680-Dylight secondary antibody (bottom membrane, Odyssey). 
 
As before, we validated the results obtained in co-IP assays by using FLIM. For this 
purpose, we co-transfected COS-7 cells with one DP N-terminal fragment tagged with 
Venus and PKP1a full length tagged with CFP. Figure R13 summarizes the mapping of 
the PKP1a interaction site in DP-NT by FLIM. Table R4 depicts the descriptive 
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statistics of the plotted experiments, including the number of measurements, the 
average CFP lifetime, and the dispersion measures (SD and SEM).  
 
 
 
Figure R13. Analysis of the interaction between PKP1a and DP-NT by FLIM. A) Schematic domain 
representation of CFP-tagged PKP1a full length and Venus-tagged N-terminal DP fragments used in FLIM 
experiments. Venus is represented as YFP. B, C, D) PKP1a-DP interaction was analysed by FLIM in COS-
7 cells. Results of three independent representative experiments are shown in scatter dot plots of the CFP 
lifetime with the mean and the standard deviation. Statistically significant differences (unpaired unequal 
variance t-test) are indicated by **** (p ≤ 0.0001); ** (p ≤ 0.01); * (p ≤ 0.05); ns, not significant (p > 0.05).  
 
DP-PD and DP-NT produced a highly significant decrease in the CFP lifetime of PKP1-
CFP from ~2.31 ns to ~2.18 and ~2.20 ns, respectively (p ≤ 0.0001) (Figure R13-B). 
On the other hand, CFP lifetime was not significantly reduced when PKP1-CFP was 
co-transfected with DP-SR3-SR5 (p > 0.05). Thus, FLIM experiments supported the 
importance of the SR2-like domain (region 1-170) in the DP/PKP1a interaction.  
 
Next, we analysed the possible role of the SR5(SH3) region of the plakin domain of DP 
in the interaction with PKP1a. For doing so, we used DP-NT (1-545) that contains the 
N-terminal tail and the region SR2-SR5, DP-1-SR4 (1-376), and DP-SR3-SR5 (180-
545). CFP lifetime was severely reduced in cells co-transfected with PKP1a and DP-1-
SR4 (1-376), indicating that this region interacts efficiently with PKP1a (p ≤ 0.0001) 
(Figure R13-C).  
 
The severe drop observed in the CFP lifetime of the cells co-transfected with PKP1a 
and DP-1-SR4 suggests that the region 1-376 of DP is able to interact with PKP1a full 
length and that the SR5(SH3) region of the DP-PD is not necessary for such 
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interaction. These results are in accordance with the previous ones obtained by co-IP 
(Figure R12-C) and support the idea that the region SR5(SH3) is not directly involved 
in the interaction between DP and PKP1a. Before, we hypothesised about the 
possibility that the quite ineffective expression of HA-DP-1-SR4 might be related with 
the stability loss caused by the lack of the SH3 domain. Nonetheless, in the FLIM 
experiments the Venus-DP-1-SR4 construct was expressed at high levels, similarly to 
other small DP fragments tagged with Venus. This may be explained by the different 
tag, HA or Venus, that the recombinant DP-1-SR4 had in the constructs used in each 
experiment. 
 
In this case, DP-SR3-SR5 reduced CFP lifetime from ~2.33 ns to ~2.28 ns (p ≤ 0.05). 
This slight decrease is in agreement with the faint band observed in co-IP assays (see 
Figure R11).   
Table R4. Descriptive statistics of the data shown in figure R13 
Figure Donor Acceptor n Mean lifetime (ns) SD SEM 
R13-B 
CFP - 34 2.440 0.032 0.005 
CFP Venus 36 2.388 0.048 0.008 
PKP1-CFP Venus 36 2.309 0.095 0.016 
PKP1-CFP DP-PD-Venus 34 2.181 0.107 0.018 
PKP1-CFP DP-NT-Venus 35 2.203 0.078 0.013 
PKP1-CFP DP-SR3-SR5 35 2.294 0.097 0.016 
R13-C 
CFP - 34 2.479 0.048 0.008 
CFP Venus 35 2.429 0.052 0.009 
PKP1-CFP Venus 39 2.334 0.059 0.009 
PKP1-CFP DP-NT-Venus 39 2.275 0.050 0.008 
PKP1-CFP DP-SR3-SR5-Venus 39 2.278 0.116 0.019 
PKP1-CFP DP-1-SR4-Venus 36 1.748 0.208 0.035 
R13-D 
CFP - 21 2.250 0.030 0.007 
CFP Venus 21 2.226 0.019 0.004 
PKP1-CFP Venus 18 2.176 0.045 0.01 
PKP1-CFP DP-NT-Venus 20 2.112 0.071 0.016 
PKP1-CFP DP-SR2-Venus 20 1.759 0.306 0.068 
PKP1-CFP DP-SR3-SR5-Venus 22 2.124 0.099 0.021 
n, number of values; SD, standard deviation; SEM, standard error of the mean.  
 
 
We also studied by FLIM whether the SR2-like domain of DP was sufficient to interact 
with PKP1a. For this purpose we made a small DP fragment that comprehends the 
region 1-170 (DP-SR2). This fragment produced a decrease in the CFP lifetime from 
~2.18 ns to ~1.76 ns (p ≤ 0.0001) (Figure R13-D). DP-SR2 includes the SR2-like 
domain (region ~64-170) and the N-terminal segment that we have previously shown 
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that it is not required for the interaction with PKP1a (see examples in Figures R11 and 
R12). On the other hand, DP-SR3-SR5 (region 180-630) produced a slight decrease in 
the CFP lifetime (from ~2.18 ns to ~2.12ns). Thus, we can conclude that the SR2-like 
domain of DP is necessary and sufficient for the interaction with PKP1a. In addition, 
since the fragment SR3-SR5 caused a statistically significant small reduction in the 
CFP lifetime in two out of three experiments, it is likely that this region has an 
accessory contribution to the interaction with PKP1a. 
 
Both DP-1-SR4 and DP-SR2 produced a large reduction in the CFP lifetime when they 
were co-transfected with PKP1-CFP. Moreover, both showed high variability in the CFP 
lifetime measurements (SDs of 0.208 and 0.306, respectively). We wondered whether 
it might be related to the much higher expression levels of these small fragments, 
compared to larger constructs. High expression levels of one of the fragments in co-
transfection experiments may cause a significant imbalance in the donor-acceptor ratio 
that might affect the CFP-lifetimes determined by FLIM. Specifically, high 
concentrations of the acceptor may cause quenching of the donor due to proximity of 
the Venus-tagged protein to the CFP, within the Försters distance, in the absence of a 
molecular interaction (Grailhe et al. 2006). 
 
Thus, we analysed whether the CFP lifetime was affected by the expression levels of 
the fragments tagged with Venus. Since it was not possible to directly measure the 
concentration of the Venus-tagged fragments we measured the intensity of Venus that 
presumably reflects the intracellular content in recombinant protein, although not 
necessarily linearly (Gaigalas et al. 2001), and studied the correlation with the CFP 
lifetime (Figure R14).  
 
When PKP1-CFP was co-expressed with isolated Venus, DP-PD-Venus, DP-NT-Venus 
or DP-SR3-SR5-Venus, the lifetime of CFP showed a very small dependence with the 
intensity of Venus (Figure R14-A, B, C, D). On the other hand, when PKP1-CFP was 
co-expressed with DP-1-SR4-Venus or with DP-SR2-Venus, the CFP lifetime 
decreased at high values of Venus fluorescence intensity (Figure R14-E, F). 
Nonetheless, even at low Venus fluorescence intensity DP-SR2-Venus and DP-1-SR4-
Venus already caused a reduction in the CFP lifetime with respect to the isolated 
Venus. Since variation in the fluorescence lifetime of PKP1-CFP as a function of the 
intensity of isolated Venus, which is typically expressed in high levels, is negligible the 
concentration-dependent effect observed for the DP-SR2-Venus and DP-1-SR4-Venus 
constructs might be related to an increase in the association of these DP fragments to 
PKP1a. 
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Figure R14. Dependence of the CFP lifetime on the intensity of Venus fluorescence in FLIM 
experiments. CFP lifetime and Venus fluorescence intensity were measured in COS-7 cells co-
transfected with CFP-tagged PKP1a full length and different Venus-tagged DP fragments (see above each 
graph). For each DP construct, the Venus fluorescence intensity is approximately related to the protein 
levels in the cells (a.u., arbitrary units). Yet, the ranges of expression levels are not comparable between 
different constructs.  
 
In conclusion, the results obtained by using FLIM are in accordance with those 
obtained by co-IP, and support that the SR2-like domain of DP is necessary and 
sufficient to mediate the interaction with PKP1a. 
 
To complement the analysis made by co-IP and FLIM, we investigated by confocal 
microscopy the subcellular distribution of fragments of the N-terminal half of the plakin 
domain of DP. Initially, we made single transfections of DP-SR2 (region 1-170), DP-
SR3-SR5 (region 180-545), and DP 1-SR4 (region 1-376) tagged with Venus in COS-7 
cells. These three constructs showed a homogeneous distribution throughout the cell in 
most of the cells, and exhibited certain nuclear staining in cells expressing high levels 
of the fusion proteins (Figure R15). 
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Figure R15. Subcellular localization of DP N-terminal fragments in COS-7 cells. The subcellular 
localization of Venus-tagged DP N-terminal fragments was investigated by confocal microscopy in COS-7 
cells overexpressing these constructs. DP-Venus fragments were detected by using an Argon laser line at 
514 nm. Bar, 10 µm. Images are representative of the overall subcellular distribution of the studied 
fragments.  
 
Next, we analysed the effect of the co-expression of PKP1a on the distribution of these 
DP constructs. COS-7 cell were co-transfected with PKP1-CFP and one Venus-tagged 
DP N-terminal fragment, and their co-localization was studied by confocal microscopy 
(Figure R16). We used the nuclear recruitment or enrichment of DP fragments as an 
indication of the interaction with PKP1a. 
 
In the presence of PKP1a, a nuclear enrichment of the DP fragments DP-SR2 (1-170) 
and DP-1-SR4 (1-376) was observed compared to the distribution showed when they 
were expressed in the absence of PKP1a in single transfection experiments (see 
above).  
 
The construct DP-SR3-SR5 showed a dual pattern when co-expressed with PKP1-
CFP. In some cells, DP-SR3-SR5 was not recruited to the nucleus by PKP1a (Figure 
R16, second row). Yet, in other cells DP-SR3-SR5 was clearly enriched at the nucleus 
where it co-localized with PKP1a (Figure R16, third row). This dual behaviour might be 
explained if the interaction between DP-SR3-SR5 and PKP1a had only moderate or 
weak affinity, so that small differences in the expression levels could result in large 
differences in the association, not always being possible to detect it. 
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Figure R16. Subcellular localization of PKP1a and DP N-terminal fragments co-transfected in COS-7 
cells. Confocal microscopy images of COS-7 cells overexpressing PKP1a full length and one DP N-
terminal fragment tagged with CFP or Venus, respectively. PKP1-CFP was detected upon excitation of 
CFP at 442 nm and is represented in red. DP-SR2 (first row), DP-SR3-SR5 (second and third rows), and 
DP-1-SR4 (last row) were detected by using an Argon laser line at 514 nm (green). The overlay images 
(on the right) show the co-localization of PKP1-CFP and DP-Venus fragments in yellow. Bar, 10 µm. 
Images are representative of the overall subcellular distribution of the studied fragments.  
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Analysis of secondary PKP1a-interaction sites outside the SR2-like domain of DP 
 
Previous experiments suggested that the region SR3-SR5 of DP might have an 
accessory contribution to the interaction with PKP1a. In co-IP assays, a faint band was 
visible in the position of DP-SR3-SR5. Moreover, in FLIM experiments the DP-SR3-
SR5 fragment showed statistically significant results in some experiments, and co-
localization assays showed a dual distribution pattern of DP-SR3-SR5 when it was 
expressed in COS cells in the presence of PKP1a. Collectively, these results invited us 
to think that, in addition to the primary site in the SR2-like domain, secondary sites 
through the DP-NT domain might be taking part in the interaction with PKP1a. 
 
To further study this possibility, we made additional N-terminal deletion mutants of the 
PD of DP tagged with Venus and assayed their interaction with PKP1-CFP by FLIM 
(Table R5 and Figure R17). These DP mutants contain the SR6-SR9 region. 
Furthermore, they presented similar expression levels in COS cells, which avoided the 
potential complexity caused by the imbalance between PKP1-CFP and small DP 
Venus-tagged fragments. 
 
DP-PD and the construct SR2-SR9, which lacks the N-terminal 63 residues that 
precede the SR2, produced a marked reduction in the CFP-lifetime of PKP1-CFP, 
~2.14 ns and ~2.17 ns, respectively, compared to the reference value in the presence 
of Venus (~2.31 ns) (p ≤ 0.0001). Interestingly, the CFP lifetime in the presence of the 
fragment DP-SR3-SR9 (residues 272-1056), ~2.26 ns, was also significantly shorter (p 
≤ 0.001) than that of the control. On the contrary, fragments beginning at the SR4, 
SR5, and SR6 domains did not show any significant decrease in the CFP lifetime with 
respect to the control (p > 0.5).  
 
Table R5. Descriptive statistics of the data shown in figure R17 
Donor Acceptor n Mean lifetime (ns) SD SEM 
CFP - 41 2.471 0.063 0.010 
CFP Venus 39 2.314 0.097 0.016 
PKP1-CFP Venus 42 2.310 0.062 0.010 
PKP1-CFP DP-PD-Venus 42 2.139 0.077 0.012 
PKP1-CFP DP-SR2-SR9-Venus 32 2.169 0.054 0.010 
PKP1-CFP DP-SR3-SR9-Venus 38 2.267 0.027 0.004 
PKP1-CFP DP-SR4-SR9-Venus 38 2.335 0.078 0.013 
PKP1-CFP DP-SR5-SR9-Venus 34 2.320 0.073 0.013 
PKP1-CFP DP-CT-Venus 34 2.342 0.069 0.012 
n, number of values; SD, standard deviation; SEM, standard error of the mean 
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Figure R17. Analysis of the interaction between PKP1a and DP N-terminal deletion mutants by 
FLIM. A) Schematic domain representation of CFP-tagged PKP1a full length and Venus-tagged DP N-
terminal deletion mutants used in FLIM assays. Venus is represented by the acronym YFP. B) The 
PKP1a-DP interaction was analysed by FLIM in COS-7 cells. Results of one representative experiment are 
shown in scatter dot plots of the CFP lifetime with the mean and the standard deviation. Statistically 
significant differences (unpaired unequal variance t-test) are indicated by **** (p ≤ 0.0001); *** (p ≤ 0.001); 
ns, not significant (p > 0.05). 
 
Taken together, these results indicate that in addition to the SR2-like domain, DP-PD 
possibly interacts with PKP1a by means of secondary sites that most likely involve the 
SR3 sub-domain. 
 
To complement the analysis by FLIM, we studied the subcellular distribution of PKP1-
CFP and the DP-Venus N-terminal mutants transiently transfected in COS-7 cells. 
First, we made single transfections of the DP fragments described in figure R17-A 
(Figure R18). 
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Figure R18. Subcellular distribution of DP N-terminal deletion mutants transfected in COS-7 cells. 
The subcellular localization of ectopically expressed Venus-tagged DP N-terminal fragments (described in 
figure R17-A) was investigated in COS-7 cells by confocal microscopy. DP fragments were detected by 
exciting Venus at 514 nm. Bar, 10 µm. Images are representative of the overall subcellular distribution of 
the studied fragments.  
 
Except for DP-CT (region 544-1056), all the fragments of the plakin domain of DP 
showed similar distribution. They were diffusely distributed throughout the cytoplasm 
and appeared mostly excluded from the nucleus though not in every cell. They were 
also present at the plasma membrane. DP-CT was mainly enriched at the cell borders 
as we had observed before (see Figure R5).  
 
Next, we analysed the subcellular distribution of these DP fragments when they were 
co-expressed with CFP-tagged PKP1a, which shows an exclusively nuclear localization 
(Figure R19). The complete plakin domain of DP (DP-PD-Venus, residues 1-1056) and 
a similar construct that lacks the first 63 residues upstream of the SR2 (DP-SR2-SR9-
Venus, residues 64-1056) were markedly recruited to the nucleus in the presence of 
PKP1a (see white arrows). On the contrary, DP-SR4-SR9-Venus (region 272-1056), 
DP-SR5-SR9-Venus (region 376-1056), and DP-CT-Venus (region 544-1056) were 
completely excluded from the nucleus (see grey arrows), suggesting that an interaction 
of PKP1a with these DP-fragments is not occurring. Interestingly, DP-SR3-SR9-Venus 
(region 180-1056) showed an intermediate behaviour with some cells where this 
fragment was recruited to the nucleus and co-localized with PKP1a and cells where it 
did not (see red arrows).  
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Figure R19. Sub-
cellular distribution of 
PKP1-CFP and amino-
terminal deletion 
mutants of the plakin 
domain of DP co-
transfected in COS-7 
cells. CFP-tagged 
PKP1a and Venus-
tagged DP-deletion 
mutants were co-
transfected in COS-7 
cells and studied by 
confocal microscopy. 
PKP1a full length 
(PKP1-CFP, region 1-
726) was detected upon 
excitation of CFP (442 
nm) and is represented 
in red. Venus-tagged 
DP-PD fragments were 
detected by using an 
Argon laser line at 514 
nm. DP distribution is 
shown in green. Merge 
images (right column) 
show the co-localization 
of PKP1-CFP and DP-
fragments-Venus in 
yellow. Bar, 10 µm. The 
displayed images are 
representative of the 
subcellular distribution of 
the studied fusion 
proteins. 
 
 
 
 
 
 
 
Taking together, these results illustrate that the interaction between PKP1a and DP is 
primarily mediated by the SR2-like of DP. Yet, the adjacent SR3 domain might also 
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participate in the interaction but to a lesser extent, establishing secondary interactions 
with PKP1a, which are not sufficient to support the efficient association in the absence 
of the SR2. 
 
2. Mapping of the DP-binding site in PKP1a 
 
Once that we knew the specific region of DP that interacts with PKP1a, we investigated 
the regions of PKP1a that are important for the interaction with DP. Our goal was to 
obtain a detailed picture of the interaction domain mapping of the DP-PKP1a complex.   
 
DP interacts with the head domain of PKP1a 
 
Previous studies had shown that the N-terminal head domain of PKP1a (region 1-243), 
interacts with DP (Hofmann et al., 2000; Kowalczyk, 1999; Sobolik-Delmaire, Katafiasz, 
& Wahl, 2006). We wanted to test our experimental approximation that includes co-IP, 
FLIM, and co-localization analysis to prove the interaction between DP and the head 
domain of PKP1a. 
 
Initially, the interaction between DP and PKP1a was analysed by co-IP in COS-1 cells 
transiently co-transfected with DP-HA and PKP1-FLAG constructs. We used DP-PD-
HA (region 1-1056) and DP-NT-HA (region 1-545) that we confronted with PKP1-FLAG 
(1-726), PKP1-head-FLAG (region 1-243), and PKP1-ARM-FLAG (region 244-726) or 
the pCEFLAG empty vector as negative control (Figure R20). 
 
Both DP-PD and DP-NT interacted with PKP1a full length and the head domain but 
they did not interact with the armadillo domain of PKP1a.  
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Figure R20. Analysis of the DP-binding site in PKP1a by co-IP. A) Schematic domain representation of 
FLAG-tagged PKP1a and HA-tagged DP fragments used in co-IP assays. B) HA-tagged DP fragments 
were co-transfected with FLAG-tagged constructs (PKP1a full length, PKP1-head domain, or PKP1-
armadillo domain) or with the empty pCEFLAG vector (negative control). Samples were 
immunoprecipitated using anti-FLAG agarose beads. Co-IP results were investigated by western blotting 
with a polyclonal antibody anti-HA. DP fragments did not co-immunoprecipitated when the empty 
pCEFLAG vector was used. Expression of PKP1-FLAG and DP-HA fragments in the input samples (total 
lysates) was detected by western blotting, using monoclonal antibodies anti-FLAG and anti-HA, 
respectively. β-actin detection was used as a loading control.  
 
 
We also wanted to analyse the interaction of the head domain of PKP1a with DP by 
using FLIM. To do so, we co-transfected COS-7 cells with DP-PD or DP-NT and one 
PKP1-fragment (PKP1, PKP1-head or PKP1-ARM) tagged with the FRET pair 
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CFP/Venus and we measured the fluorescence lifetime of CFP (Figure R21 and Table 
R6). 
 
 
Figure R21. Analysis of the interaction between DP-PD or DP-NT and PKP1a by FLIM. A) Schematic 
domain representation of CFP-tagged PKP1a fragments used in FLIM experiments. DP-PD-Venus (B) and 
DP-NT-Venus (C) were used to analyse the interaction with PKP1a by FLIM. Results of one representative 
experiment using each DP-fragment are represented in scatter dot plots of the CFP lifetime with the mean 
and the standard deviation. Statistically significant differences (unpaired unequal variance t-test) are 
indicated by **** (p ≤ 0.0001); ns, not significant (p > 0.05). 
 
First, we performed the experiments by using the complete plakin domain of DP (DP-
PD, region 1-1056). The CFP lifetime was significantly decreased from ~2.44 ns in the 
control (isolated CFP and Venus) to ~2.28 ns or ~2.29 ns when DP-PD-Venus was co-
transfected with PKP1-CFP or PKP1-head-CFP, respectively (p ≤ 0.0001). On the 
contrary, CFP lifetime was not significantly altered, with respect to the control, when 
DP-PD-Venus was co-transfected with PKP1-ARM-CFP (p > 0.05). 
 
Similar results were obtained when we used the N-terminal half of DP (DP-NT, region 
1-545). When DP-NT was co-transfected with PKP1a or PKP1-head the CFP lifetime 
was decreased by ~0.3 ns with respect to the control (p ≤ 0.0001). This drop was not 
observed when DP-NT was co-transfected with PKP1-ARM-CFP (p > 0.05). 
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Table R6. Descriptive statistics of the data shown in figure R21 
Figure Donor Acceptor n Mean lifetime (ns) SD SEM 
R21-B 
CFP - 38 2.529 0.035 0.006 
CFP Venus 48 2.443 0.057 0.008 
PKP1-CFP DP-PD-Venus 35 2.284 0.066 0.011 
PKP1-head-CFP DP-PD-Venus 35 2.292 0.061 0.010 
PKP1-ARM-CFP DP-PD-Venus 35 2.457 0.042 0.007 
R21-C 
CFP - 32 2.416 0.041 0.007 
CFP Venus 34 2.353 0.065 0.011 
PKP1-CFP DP-NT-Venus 35 2.021 0.102 0.017 
PKP1-head-CFP DP-NT-Venus 32 2.072 0.060 0.011 
PKP1-ARM-CFP DP-NT-Venus 33 2.330 0.028 0.005 
n, number of values; SD, standard deviation; SEM, standard error of the mean.  
 
To complete the picture, we also looked at the subcellular distribution of PKP1a and 
DP-fragments when they are co-transfected in COS-7 cells. We have previously 
demonstrated that DP is recruited to the nucleus by means of its interaction with 
PKP1a. Here we looked at how the subcellular distribution of DP-NT was affected by 
different PKP1a fragments. COS-7 cells were transiently transfected with DP-NT and 
each of the PKP1a constructs (PKP1 full length, head domain or ARM-domain) and the 
subcellular distribution of each fragment was analysed by using confocal microscopy 
(Figure R22).  
 
When DP-NT was transfected alone in COS-7 cells, it mainly showed a cytoplasmic 
distribution with slight presence at the plasma membrane (see Figure R5). However, 
when it was co-transfected with PKP1a full length (region 1-726) or PKP1-head domain 
(region 1-243), DP-NT was markedly recruited to the nucleus suggesting that an 
interaction between DP-NT and PKP1/PKP1-head was taking place. This DP-
recruitment is in agreement with the conclusions of co-IP and FLIM experiments 
regarding that the interaction of DP and PKP1 needs of the PKP1a head domain.  
 
On the other hand, PKP1-ARM-CFP was distributed throughout the cytoplasm and was 
not present at the nucleus (we will deepen over this in the next section). Therefore, the 
recruitment of DP fragments to the nucleus could not be used as an indication of 
interaction with PKP1-ARM.  
 
PKP1-ARM-CFP and DP-NT-Venus co-localized when they were co-expressed. 
Nonetheless, these two constructs were already present at the cytoplasm when they 
were independently expressed, suggesting that the overlap between PKP1-ARM-CFP 
and DP-NT-Venus is most likely fortuitous, due to the sharing of the same subcellular 
compartment, rather than due to a real interaction between these two proteins. In this 
respect, the random localization of two proteins in the same compartment does not 
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imply actual co-localization because their spatial distributions are independent of each 
other (Costes et al. 2004). 
 
 
 
Figure R22. Subcellular localization of DP-NT and PKP1a fragments co-transfected in COS-7 cells. 
Confocal microscopy images of COS-7 cells ectopically expressing DP-NT and one PKP1a fragment 
tagged with Venus or CFP, respectively. PKP1a-fragments overexpression was detected upon excitation 
of CFP (442 nm) and is represented in red. DP-NT was detected by using an Argon laser line at 514 nm 
and is represented in green. The overlay images (merge) show the co-localization of DP-NT-Venus and 
the PKP1a-fragments in yellow. Bar, 10 µm. Images are representative of the overall subcellular 
distribution of the studied fragments.  
 
In summary, we have shown that combination of co-IP, FLIM, and subcellular 
distribution analysis is a valid approach to analyse the interaction between DP and the 
head domain of PKP1a. 
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Mapping of the DP-binding site within the head domain of PKP1a 
 
We wanted to go one step further to more closely delimit the DP-interacting region in 
PKP1a. With this purpose, we made several FLAG-tagged fragments of the head 
domain of PKP1. We designed two fragments that halve the head domain in two 
segments of similar size, regions 1-120 and 121-243. We also created a shorter N-
terminal fragment 1-51 (PKP1-1-51) that contains the HR2 motif and has also been 
implicated in the recruitment of DP to the plasma membrane (Sobolik-Delmaire et al. 
2006). In addition, we created the complementary 52-243 fragment (PKP1-52-243). We 
assayed the interaction of these PKP1 fragments with DP-NT-HA by co-IP (Figure 
R23).  
 
 
 
Figure R23. Mapping of the interaction site of DP in the head domain of PKP1 by co-IP. A) 
Schematic domain representation of HA-tagged DP-NT and FLAG-tagged PKP1-head fragments used in 
co-IP assays. B) The DP interaction site in PKP1-head was analysed by co-IP of DP-NT-HA by five 
constructs of the head domain of PKP1a (head, 1-120, 1-51, 52-243, and 121-243) using anti-FLAG 
agarose beads. As a control (lane: FLAG), cells were co-transfected with DP-NT-HA and the empty 
pCEFLAG vector. The presence of DP-NT-HA in the immunoprecipitated samples was investigated by 
western blotting using a polyclonal antibody anti-HA. The expression of PKP1-FLAG and DP-HA 
fragments in the total cell lysates used for the co-IP (input) was proved using monoclonal antibodies anti-
FLAG and anti-HA, respectively. β-actin detection was used as a loading control. Notice that it was not 
possible to see PKP1-1-51 (residues 1-51) in the western blot because of its small molecular weight (~6 
kD).  
 
DP-NT interacted with PKP1-1-120 to a similar extent than with the complete PKP1 
head domain. On the other hand, the complementary fragment PKP1-121-243 did not 
interact with DP. DP-NT interacted with the PKP1-1-51 and PKP1-52-243 fragments, 
but the intensity of the band in the co-IP was significantly weaker for the shorter 
fragment compared with the band observed for PKP1-52-243, which was 
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undistinguishable from the band of the complete head domain of PKP1. Taken 
together, these results suggest that DP-NT interacts with the N-terminal half of the 
head domain of PKP1, and that while the first 51 residues of PKP1 associate with DP-
NT, the major DP-interaction occurs through a region comprehended between residues 
52-120.  
 
We wanted to verify the proposed DP-binding region in PKP1 (residues 52-120) by 
using FLIM. With this purpose we designed PKP1 fragments tagged with CFP and co-
transfected them with DP-NT-Venus in COS-7 cells. In this case, taking into account 
the potential inaccuracies observed in FLIM assays when using small fragments (see 
Figure R14), we decided to make the fragments as N-terminal deletion mutants of 
PKP1 full length.  
 
The co-transfection of DP-NT-Venus with PKP1-CFP (region 1-726), PKP1-head-CFP 
(region 1-243), or PKP1-52-CFP (region 52-726) produced a similar and statistically 
significant decrement of the CFP lifetime with respect to the control sample. 
Specifically, the CFP lifetime dropped from ~2.3 to ~2.2 ns (p ≤ 0.0001) (Table R7 and 
Figure R24). On the contrary, when DP-NT-Venus was co-transfected with PKP1-121-
CFP (region 121-726) or PKP1a-ARM-CFP (region 244-726) the CFP lifetime remained 
similar to that of the control ~2.3 ns (ns, p > 0.5).  
 
Table R7. Descriptive statistics of the data shown in figure R24 
Donor Acceptor n Mean lifetime (ns) SD SEM 
CFP - 31 2.424 0.028 0.005 
CFP Venus 32 2.344 0.055 0.010 
PKP1-CFP DP-NT-Venus 30 2.246 0.055 0.010 
PKP1-head-CFP DP-NT-Venus 31 2.225 0.086 0.015 
PKP1-52-CFP DP-NT-Venus 31 2.220 0.087 0.016 
PKP1-121-CFP DP-NT-Venus 29 2.333 0.040 0.007 
PKP1-ARM-CFP DP-NT-Venus 30 2.385 0.056 0.010 
n, number of values; SD, standard deviation; SEM, standard error of the mean 
 
Our analysis by FLIM supports that the N-terminal 51 residues of PKP1 are 
dispensable for the interaction with DP, which is mediated by the region 52-120 of the 
head domain. These results are in agreement with those observed by co-IP. 
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Figure R24. Mapping of the DP-interaction site within the head domain of PKP1a by FLIM. A) 
Schematic domain representation of the CFP-tagged PKP1a fragments and the Venus-tagged DP-NT 
fragment used in FLIM experiments. Venus is represented by the acronym YFP. B) The interaction 
between DP-NT and PKP1a fragments was assessed by analysing the fluorescent lifetime of CFP using 
FLIM. Results of one representative experiment are represented in scatter dot plots of the CFP lifetime 
with the mean and the standard deviation. Statistically significant differences (unpaired unequal variance t-
test) are indicated by **** (p ≤ 0.0001); ns, not significant (p > 0.05). 
 
Co-IP and FLIM experiments showed that the region 52-121 of the head domain of 
PKP1a was crucial to enable the association with DP. To complete this analysis we 
analysed the co-localization of PKP1a and DP fragments by confocal microscopy. We 
co-transfected COS-7 cells with Venus-tagged DP-NT and the CFP-tagged PKP1-
fragments: PKP1-head (region 1-243), PKP1-52 (region 52-726), and PKP1-121 
(region 121-726) and analysed their subcellular localization (Figure R25).  
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Figure R25. Subcellular localization of DP-NT and PKP1a fragments co-transfected in COS-7 cells. 
Confocal microscopy images of COS-7 cells ectopically expressing DP-NT and one PKP1a fragment 
tagged with Venus or CFP, respectively. PKP1a-fragments overexpression was detected upon excitation 
of CFP (442 nm) and is represented in red. DP-NT-Venus was detected by using an Argon laser line at 
514 nm and is represented in green. The overlay images (merge) show the co-localization of DP-NT and 
PKP1a-fragments in yellow. Bar, 10 µm. Images are representative of the overall subcellular distribution of 
the studied fragments.  
 
As we had seen before, when DP-NT was co-expressed with the head domain of 
PKP1a in COS-7 cells, it was recruited to the nucleus by PKP1a exhibiting a marked 
co-localization. Co-expression of DP-NT with PKP1-52 (52-726) resulted in a similar 
co-localization of both proteins at the nucleus. However, although PKP1-121 (121-726) 
also showed certain nuclear localization, it was not able to efficiently recruit DP-NT to 
the nucleus and the two proteins did not co-localized, neither at the nucleus nor in 
another cellular compartment.  
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In summary, co-localization assays are in agreement with co-IP and FLIM results and 
suggest that residues 52-120 of PKP1a mediate the formation of the DP-PKP1a 
complex.  
 
Precise mapping of the DP-interaction site within the region 52-120 of PKP1a  
 
Once we identified the region of PKP1a that is critical for the interaction with DP, we 
tackled the mapping of shorter segments in PKP1 required for the formation of the DP-
PKP1a complex. To address this objective we combined co-expression of PKP1a and 
DP fragments with fluorescent tags with FLIM.  
 
We created several additional constructs of PKP1a tagged with CFP that carried 
varying deletions from the N-terminus, we confronted them with DP-PD tagged with 
Venus and analysed comparatively the lifetime of CFP. The design and analysis of 
these new PKP1a deletion mutants was an iterative process, where results contributed 
by the earliest mutants directed the design of the upcoming ones.  
 
Initially, we created two constructs PKP1-75 (region 75-726) and PKP1-98 (region 98-
726) that together with the previous fragments 52-726 and 121-726 allowed us to trim 
the region 52-120 in three segments of equal length (23 residues). In addition, we 
created three shorter fragments: 133-726, 151-726, and 181-726 (Figure R26-A). 
When DP-PD was co-transfected with PKP1a N-terminal deletion mutants trimmed up 
to residue 98 (51-726, 75-726, and 98-726), the CFP lifetime was significantly reduced 
compared to the control sample (p ≤ 0.0001) (Figure R26-B and Table R8). Moreover, 
the CFP lifetime of these deletion mutants in the presence of DP-PD-Venus was similar 
to that observed for the full length PKP1a. On the contrary, the CFP lifetime of shorter 
PKP1a deletion mutants (121-726, 133-726, 151-726, and 181-726) was not reduced 
by DP-PD-Venus, suggesting that they did not interact with (p > 0.5). 
 
Our previous results suggested that the region 98-120 of PKP1a was important for the 
interaction with DP. To further narrow down the interaction site within this region we 
created three more deletion mutants of PKP1a-CFP. Each new fragment starts 6 
residues downstream of the previous one (104-726, 110-726, and 116-726). In 
addition, we created the PKP1a mutant 127-726 (Figure R26-C). We analysed the CFP 
lifetime of this set of PKP1-CFP constructs using DP-PD-Venus. When DP-PD-Venus 
was co-expressed with the PKP1a fragments 75-726, 98-726, and 104-726, the CFP 
lifetime was again significantly reduced compared to the control (p ≤ 0.0001) (Figure 
R26-D and Table R8). However, DP-PD-Venus did not cause a significant reduction of 
the CFP lifetime of the shorter PKP1a fragments: 116-726, 121-726, 127-726, and 151-
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726 (p > 0.5). The fragment PKP1-110 showed an intermediate behaviour with a 
significant result but not as accused as with the larger fragments (p ≤ 0.05).  
 
To summarize, the analysis of CFP lifetimes by FLIM suggested that the region 104-
116 of the head domain of PKP1a is a major determinant of the interaction with DP. 
 
 
Figure R26. Precise mapping of the DP-interaction site within the region 52-120 of PKP1a by FLIM. 
A, C) Schematic domain representations of the CFP-tagged PKP1a N-terminal deletion mutants used in 
FLIM experiments. B, D) The DP-PKP1a interaction was analysed by studying the effect of the DP 
fragments on the fluorescence lifetime of CFP in COS-7 cells using FLIM. Results of representative 
experiments are represented in scatter dot plots of the CFP lifetime with the mean and the standard 
deviation. Statistically significant differences (unpaired unequal variance t-test) are indicated by **** (p ≤ 
0.0001); *** (p ≤ 0.001); * (p ≤ 0.05); ns, not significant (p > 0.05). 
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Table R8. Descriptive statistics of the data shown in figure R26 
Figure Donor Acceptor n Mean lifetime (ns)      SD       SEM 
R26-B 
CFP - 26 2.296 0.028 0.006 
CFP Venus 27 2.222 0.082 0.016 
PKP1-CFP DP-PD-Venus 25 2.159 0.084 0.017 
PKP1-62-CFP DP-PD-Venus 25 2.146 0.077 0.015 
PKP1-75-CFP DP-PD-Venus 25 2.119 0.084 0.017 
PKP1-98-CFP DP-PD-Venus 26 2.132 0.010 0.020 
PKP1-121-CFP DP-PD-Venus 25 2.225 0.042 0.008 
PKP1-151-CFP DP-PD-Venus 25 2.247 0.041 0.008 
PKP1-181-CFP DP-PD-Venus 25 2.253 0.030 0.006 
PKP1-ARM-CFP DP-PD-Venus 25 2.226 0.056 0.011 
R26-D 
CFP - 32 2.434 0.049 0.009 
CFP Venus 33 2.361 0.075 0.013 
PKP1-75-CFP DP-PD-Venus 33 2.156 0.082 0.014 
PKP1-98-CFP DP-PD-Venus 34 2.292 0.084 0.014 
PKP1-104-CFP DP-PD-Venus 34 2.263 0.087 0.015 
PKP1-110-CFP DP-PD-Venus 41 2.257 0.090 0.014 
PKP1-116-CFP DP-PD-Venus 41 2.318 0.085 0.013 
PKP1-121-CFP DP-PD-Venus 37 2.353 0.074 0.012 
PKP1-127-CFP DP-PD-Venus 33 2.353 0.070 0.012 
PKP1-151-CFP DP-PD-Venus 44 2.356 0.071 0.011 
n, number of values; SD, standard deviation; SEM, standard error of the mean.  
 
 
To complement the analysis by FLIM, we looked at the subcellular distribution of CFP- 
and Venus-tagged constructs by confocal microscopy to study the capability of PKP1a 
fragments to recruit DP to its localization, as an indication of the formation of a PKP1a-
DP complex. 
 
Based in our previous data, we focused the study on the PKP1-deletion mutants that 
start within the region 52-121. Thus, we co-transfected COS-7 cells with Venus-tagged 
DP-PD and CFP-tagged PKP1-98 (98-726), PKP1-104 (104-726) or PKP1-116 (116-
726) (Figure R27). Additionally, we included PKP1-151 (151-726) in our analysis as a 
negative control, because we have already shown that deletion of the first 120 N-
terminal residues, as in the construct PKP1-121, prevented the co-localization with DP 
(see Figure R25). When DP-PD-Venus is expressed alone it shows a diffuse 
cytoplasmic distribution (see Figure R5). Confocal microscopy images of the co-
transfections showed that PKP1-98 and PKP1-104 co-localized with, and apparently 
enriched, DP-PD at the nucleus (see the overlay images). PKP1-116 and PKP1-151 
showed a less marked co-localization with DP-PD at the nucleus, suggesting that this 
shorter fragment interacts less efficiently or do not interact with DP-PD. 
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Figure R27. Subcellular localization of DP-PD and PKP1a fragments co-transfected in COS-7 cells. 
Confocal microscopy images of COS-7 cells ectopically expressing DP-PD and one PKP1a fragment 
tagged with Venus or CFP, respectively. PKP1a fragments were detected upon excitation of CFP at 442 
nm and are represented in red. DP-PD-Venus was detected by using an Argon laser line at 514 nm and is 
represented in green. The overlay images (merge) show the co-localization of DP-PD and PKP1a-
fragments in yellow. Bar, 10 µm. Images are representative of the overall subcellular distribution of the 
studied fragments.  
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In summary, by applying three complementary methodologies (co-IP, FLIM, and 
confocal microscopy) we have precisely identified that the region 98-116 of the head 
domain of PKP1a is critical for the interaction with DP. Moreover, analysis of the 
interaction using FLIM suggests that the crucial segment for the formation of the DP-
PKP1 complex is even narrower, being composed by the residues 104-116. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
S e c t i o n  B 
 
Analysis of the PKP1a-nuclear 
localization determinants 
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Subcellular distribution of CFP-tagged PKP1a, PKP2a, and PKG in DMs-bearing 
and non-bearing cell lines 
 
In addition to their role in the assembly and maintenance of the DMs, endogenous and 
overexpressed PKPs, prominently localise to the nucleus (Bonné et al. 1999; Mertens 
et al. 1996; Schmidt et al. 1997). To date, the specific DMs-independent functions of 
PKPs at the nucleus remain largely unknown. 
 
To better understand the nuclear-localization of PKP1a, we analysed the subcellular 
distribution of PKP1a in various cell lines. On the one hand, we examined COS-7 cells, 
which do not form prominent DMs and, on the other hand, we studied normal human 
keratinocytes (NHK) as a model of a DM-bearing cell line. Cells were transiently 
transfected with PKP1a full length tagged with CFP and the fluorescence distribution 
was monitored by confocal microscopy (Figure R28).  
 
 
 
 
Figure R28. Subcellular distribution of PKP1-CFP in different cell lines. The subcellular localization of 
ectopically expressed CFP-tagged PKP1a full length was investigated in DMs-bearing (NHK) and non-
bearing (COS-7) cell lines by confocal microscopy. This PKP1a construct was created in the pcDNA3-
CFP-C4 vector that adds CFP to the N-terminus of the coded protein. PKP1-CFP was detected upon 
excitation of CFP (442 nm). NHK were analysed in two different growing conditions: undifferentiated NHK 
growing in low-calcium medium (SFM, 0.09 mM calcium concentration) and differentiated NHK after 24 
hours growing at high calcium concentration conditions (DMEM, 1.2 mM calcium concentration). Bar, 10 
μm. 
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PKP1-CFP transiently expressed in COS-7 cells showed an exclusively nuclear 
staining. This nuclear distribution was observed in all the cells expressing PKP1-CFP. 
In the close up images (upper row) is it possible to appreciate that PKP1a full length 
was localised to the nuclear karyoplasm and mostly excluded from nucleoli. This 
subcellular distribution has been previously reported in various cell types (Hatzfeld et 
al. 2000; Schmidt et al. 1997; Sobolik-Delmaire et al. 2010) being the expected in cell 
types not containing prominent DMs, such as COS-7 cells.  
 
Undifferentiated NHKs growing at low-calcium concentration (SFM), which do not 
assemble DMs, showed the same exclusively nuclear localization of PKP1-CFP 
observed in COS-7 cells. However, after 24 hours growing in DMEM (1.2 mM calcium 
concentration), PKP1-CFP localised both to the nucleus and to the plasma membrane 
where it concentrated in punctuated structures. Probably, the latter is caused by the 
incorporation of PKP1-CFP into DMs that are assembled in keratinocytes when they 
grow at high-calcium concentration or at high-density (Bikle et al. 2013; Kimura et al. 
2007). The PKP1-CFP relocation observed upon NHKs differentiation demonstrated 
that CFP does not prevent PKP1a from incorporating into DMs. 
 
Collectively, these results suggest that PKP1-CFP localises to the nucleus of DM-
bearing and non-bearing cells lines. Moreover, PKP1-CFP is functional in the sense 
that its subcellular distribution is the expected on both cells that assemble DMs and 
cells that do not. In addition, PKP1-CFP takes part of DM-like structures when they are 
formed.  
 
Since the nuclear targeting of PKP1a appears to be DM-independent we wondered 
whether COS-7 cells would be a valid model to study the nuclear localization 
determinants of PKP1a. To further analyse this question, we investigated the 
distribution of other desmosomal proteins in this cell line and in keratinocytes.  
 
First, we transiently transfected COS-7 cells with un-linked CFP or with CFP-tagged 
PKP1a, PKP2a, or PKG full length and studied their subcellular localization by confocal 
microscopy (Figure R29). Each of the analysed proteins showed a specific subcellular 
distribution. COS-7 cells transiently transfected with an empty vector coding only for 
CFP showed a diffuse cytoplasmic localization. CFP was also present in the nucleus 
but to a lesser extent than in the cytoplasm. PKP1-CFP was strictly restricted to the 
nucleus, as we have shown before. The localization of PKP1-CFP strongly contrasted 
with the distribution of PKP2-CFP that was excluded from the nucleus and mainly 
accumulated at the plasma membrane. This is in agreement with previous observations 
in which the extent of nuclear localization of PKPs is very different between the three 
variants, being PKP1 the most nuclear-prominent (see an example with A431 and UM-
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SCC-38 cells in Sobolik-Delmaire et al. 2010). Overexpressed CFP-tagged PKG 
showed a dual localization being present at both nucleus and cytoplasm.  
 
 
 
Figure R29. Subcellular distribution of un-linked CFP and CFP-tagged PKP1a, PKP2a, and PKG in 
COS-7 cells. COS-7 cells were transfected with constructs coding for free CFP or CFP-tagged full length 
PKP1a, PKP2a, or PKG (vector pcDNA3-CFP-C4). The subcellular localization of the individually 
expressed proteins was analysed by confocal microscopy. CFP fluorescence was detected upon excitation 
of CFP at 442 nm and is represented in different colours in each case: un-linked CFP, red; PKP1a, 
orange; PKP2a, grey; PKG, yellow. Bar, 10 μm.  
 
The fact that several proteins tagged with the same fluorophore showed different and 
specific subcellular distributions highlighted that the CFP tag was not having a 
significant effect on the behaviour of the recombinant proteins and suggested that the 
combination of CFP-fusion proteins and COS-7 cells is a valid model to analyse the 
nuclear-localization determinants of PKP1a.  
 
Next, we analysed the subcellular localization of the same desmosomal proteins in 
keratinocytes growing in SFM. For this purpose, keratinocytes were transfected with 
CFP-tagged PKP1a, PKP2a, or PKG full length and the subcellular distribution of the 
fusion proteins was analysed by using confocal microscopy upon excitation of CFP 
(Figure R30). 
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Figure R30. Subcellular distribution of CFP-tagged PKP1a, PKP2a, and PKG in keratinocytes. NHK 
were transiently transfected with constructs coding for CFP-tagged full length PKP1a, PKP2a, or PKG 
(vector pcDNA3-CFP-C4) and the subcellular localization of the fusion proteins was investigated by 
confocal microscopy. Keratinocytes were grown in low calcium SFM. CFP fluorescence was detected upon 
excitation of CFP at 442 nm and is represented in different colours for each fusion protein: PKP1a, orange; 
PKP2a, grey; PKG, yellow. Bar, 10 μm.  
 
The subcellular distribution of overexpressed PKP1a, PKP2a, and PKG in 
keratinocytes growing in SFM (low calcium) was almost equal to those observed in 
COS-7 cells. Again, PKP1a and PKP2a showed a clear different localization; PKP1a 
was restricted to the nucleus, whereas PKP2a was mostly at the plasma membrane. 
PKG showed a broader distribution and was present at both nucleus and cytoplasm.  
 
In summary, PKP1-CFP localised to the nucleus both in COS-7 cells and in NHKs. 
Similarly, PKP2a and PKG showed resembling and specific subcellular distribution in 
both cell lines. In addition, PKP1-CFP was recruited to cell-cell contact sites in NHKs in 
conditions that promote DM assembly, indicating that CFP-tagged PKP1a is functional 
and capable of incorporating to junctional complexes. Therefore, the study of the 
PKP1a-nuclear determinants can be undertaken in the transfection-friendly COS-7 
cells by using CFP-tagged proteins. 
 
Subcellular distribution of endogenous desmosomal proteins in keratinocytes   
 
We also wanted to know whether the distribution of the transfected fusion proteins was 
similar to the distribution of the endogenous proteins or, by the contrary, it was 
influenced by the higher expression levels of the ectopic proteins. For this purpose we 
studied the main desmosomal proteins by immunofluorescence in both COS-7 cells 
and keratinocytes.  
 
Immunofluorescence analysis of COS-7 cells did not provide useful results (data not 
shown), most likely due to the low expression levels of the desmosomal proteins in this 
cell line. Since the expression levels of desmosomal proteins in keratinocytes are 
higher compared with those in COS-7 cells, we were able to obtain good 
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immunofluorescence images from keratinocytes. The subcellular localization of 
endogenous desmosomal proteins was analysed in NHKs growing in low-calcium SFM 
and under differentiation conditions to promote the establishment of cell-cell contacts 
(DMEM, high-calcium medium).  
 
First, we studied the subcellular distribution of E-cadherin and the desmosomal 
proteins DSGs (DSG-1 and DSG-2), DP and PKG in NHKs (Figure R31). E-cadherin, 
which is the major transmembrane protein of the AJs (Hartsock & Nelson 2009), 
showed a membrane lining pattern in low and high calcium. Additionally, it was also 
observed in discrete cytoplasmic particles distributed throughout all the cytoplasm in 
low-calcium conditions and closer to the membrane when keratinocyte differentiation 
was promoted (high-calcium conditions). In contrast, DSGs and DP showed a diffuse 
distribution in low calcium and were translocated to the plasma membrane upon 
stimulation of DM-assembly. PKG showed a peripheral staining in low calcium media 
that was enriched when cells were grown in the presence of high calcium 
concentration.  
 
Next, we studied the subcellular distribution of endogenous PKP1 and PKP2 in 
keratinocytes (Figure R32). In this case, two different immunolocalization procedures 
were used (see materials and methods). On the one hand, we used a standard 
immunostaining procedure where keratinocytes growing in glass coverslips were fixed 
before Triton X-100 membrane permeabilization. With this protocol we were not able to 
appreciate any nuclear signal, either for PKP1 or for PKP2. Both proteins showed 
cytoplasmic and diffuse peripheral staining in undifferentiated keratinocytes growing in 
SFM. PKP1 was also enriched in areas of cell-cell contact and was present in discrete 
cytoplasmic particles (see arrows) that are similar to those described for other 
desmosomal proteins (Godsel et al. 2005; Jones & Goldman 1985). In keratinocytes 
grown for 24 hours in the presence of high calcium concentration (DMEM), PKP1 and 
PKP2 showed a more prominent staining of the plasma membrane and were 
particularly enriched at cell-cell contact sites, most likely due to their incorporation into 
DMs (Figure R32-A).  
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Figure R31. Subcellular 
distribution of endogenous 
E-cadherin, DSGs, DP, and 
PKG in keratinocytes. 
Confocal microscopy images of 
the subcellular distribution of 
endogenous E-cadherin and 
the desmosomal proteins: 
DSGs (DSG-1 and DSG-2), 
DP, and PKG. Protein 
distributions were investigated 
in keratinocytes growing in 
SFM (low-calcium) and DMEM 
(high-calcium) by immuno-
fluorescence using a standard 
procedure. Endogenous E-
cadherin was detected using a 
monoclonal antibody against 
the C-terminal region of the 
human E-cadherin (610182, 
BD Biosciences), blue; 
desmosomal cadherins were 
detected using a monoclonal 
antibody anti-DSGs (isoforms 
DSG-1 and DSG-2) (DG3.10, 
Acris Antibodies), green; 
endogenous DP was detected 
with a polyclonal antibody 
against the C-terminal region 
of the plakin domain of DP (sc-
18086, Santa Cruz), red; and 
endogenous PKG was 
detected using a polyclonal 
antibody raised against a 
peptide mapping the C-
terminus of the human PKG 
(sc-1497, Santa Cruz), yellow. 
Bar, 10 μm. 
 
Since neither endogenous PKP1 nor PKP2 were detected at the nucleus in any 
growing condition (Figure R32-A), we were warned about the possibility that the PKP 
nuclear localization was being affected by technical issues with the standard indirect 
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immunofluorescence procedure used. Detecting nuclear staining of PKPs is greatly 
dependent on the processing of cell samples for immunofluorescence. Therefore, we 
further investigated about different immunostaining procedures proposed to detect 
PKPs in the nucleus, at the plasma membrane or to obtain an optimal dual localization 
(see examples in Mertens et al., 1996; Rickelt, 2012; Schmidt et al., 1997). In brief, 
most of them are based on treating the cells with a permeabilization agent before 
fixation. Thus, using a protocol in which cells were permeabilized with 0.2% Triton X-
100 in PBS for five minutes before fixation with 2-4% PFA, endogenous PKP1 was 
detected in the nucleus and at the plasma membrane, but PKP2 was still only detected 
at cell-cell contact sites (Figure R32-B). These results are in agreement with the 
previously reported varying degree of nuclear localization showed by the PKPs in 
several cell lines, being PKP1 the most nuclear-prominent.  
 
 
 
 
Figure R32. Subcellular distribution of endogenous PKP1 and PKP2 in keratinocytes. The 
subcellular localization of endogenous PKP1 and PKP2 was investigated in keratinocytes growing in SFM 
(low calcium) and DMEM (high calcium) by immunostaining and confocal microscopy. Two different 
immunofluorescence procedures were used: A) Standard indirect immunofluorescence protocol: cells 
growing in glass coverslips were fixed before Triton X-100 membrane permeabilization; B) Cells were 
treated with 0.2% Triton X-100 in PBS for five minutes before PFA fixation. Notice that only the second 
immunostaining procedure (B) revealed the dual localization of PKP1 at the nucleus and plasma 
membrane.  Bar, 10 μm.  
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To summarize, in NHKs growing in desmosome-promoting conditions, endogenous 
PKP1 and PKP2 were located at the plasma membrane, similarly to other desmosomal 
proteins. In addition, PKP1 was also present in the nucleus despite the formation of 
DMs, whereas PKP2 was not significantly detected at the nucleus. Finally, transiently 
expressed PKP1-CFP and PKP2-CFP showed similar subcellular distribution 
compared to the endogenous proteins. 
 
The region 116-132 of the head domain of PKP1a is important for the nuclear 
targeting in COS-7 cells 
 
Sequence analysis of PKP1a did not reveal any obvious NLS, either canonical or 
bipartite. Moreover, none of the known PKP1 interacting partners contain NLS that 
could indirectly target PKP1a to the nucleus. Thus, the processes that target and 
transport PKP1a to the nucleus together with its nuclear role remain largely 
uncharacterized. 
 
It has been shown that the head domain of PKP1a is required for the nuclear 
localization of PKP1a in COS (Kowalcyk et al. 1999), HaCaT, and HeLa cells (Hatzfeld 
et al. 2000). Within the head domain, the amino acids 55-125 are important for the 
nuclear localization in A431 cells (Sobolik-Delmaire et al. 2010). Yet, the amino-acid 
sequences directly responsible for the nuclear localization are poorly understood. 
 
To better understand the nuclear localization of PKP1a and to identify the amino acids 
responsible for PKP1a nucleus-cytoplasm shuttling; we performed an exhaustive 
analysis using an extensive repertory of PKP1a N-terminal deletion mutants. As we 
demonstrated before, COS-7 cells are an appropriate model to tackle these studies. 
Thus, we transiently transfected these cells with CFP-tagged PKP1 mutants that 
carried varying deletions from the N-terminus (made in pcDNA3-CFP-C4) (Figure R33), 
and studied their subcellular distribution by confocal microscopy (Figure R34).  
 
Fragments trimmed up to residue 110 were localized only to the nucleus, showing a 
distribution indistinguishable from that of PKP1a full length and PKP1-head. The 
fragment starting in the residue 116 showed a prominent nuclear localization, although 
it was also weakly detected in the cytoplasm of some cells. The cytoplasmic-nuclear 
distribution ratio further increased in fragments with larger deletions up to the construct 
133-726, which was almost equally distributed between cytoplasm and nucleus in most 
of the cells, not showing a predominant nuclear localization. This pattern was even 
clearer in the 151-726 fragment that showed a homogeneous cytoplasmic-nuclear 
distribution with no single cells with a predominant nuclear presence of PKP1. 
Fragments carrying additional N-terminal deletions such as the fragment 181-726 or 
 ANALYSIS OF THE PKP1-NUCLEAR DETERMINANTS   105 
the fragment completely ablated of the head domain (region 244-726) showed the 
same dual localization as the 151-726 fragment, not being enriched in the nucleus 
albeit present. The observed nuclear localization of the ARM-domain is in agreement 
with previous reports (Sobolik-Delmaire et al. 2010).  
 
 
                                 
Figure R33. CFP-tagged N-terminal deletion mutants of PKP1a. Schematic domain representation of 
the PKP1a N-terminal deletion mutants generated to analyse the nuclear localization determinants in 
PKP1a. The constructs coding for these fragments were created in the pcDNA3-CFP-C4 vector that adds 
a CFP-tag to the N-terminus. The HR2 motif within the head domain is shown as a grey box (residues 21-
45). The design and analysis of the PKP1a-deletion mutants was an iterative process, where results 
contributed by the earliest mutants directed the design of the upcoming ones.  
 
Collectively, these results prove that the head-domain of PKP1a is necessary for 
maintaining the nuclear targeting of PKP1a. Within the head-domain of PKP1a, the first 
109 residues are dispensable for the nuclear localization because fragments lacking 
the region 1-109 showed an indistinguishable distribution from that of the PKP1a full 
length and the head-domain. In contrast, fragments starting at the position 151 and 
beyond lose their exclusively nuclear localization, being equally distributed throughout 
the cytoplasm and nucleus. This result suggests that the segment 110-132, and 
106 
probably the region 133-150, play an important role in the nuclear-to-cytoplasmic 
redistribution of PKP1a.   
 
 
 
 
Figure R34. Subcellular distribution of CFP-tagged PKP1a N-terminal deletion mutants in COS-7 
cells. Confocal microscopy images of COS-7 cells transfected with each of the PKP1a N-terminal deletion 
mutants. The localization of the PKP1 fragments was detected upon excitation of CFP at 442 nm. Bar, 10 
μm. 
 
The region 116-132 of PKP1a is not sufficient to target PKP1a to the nucleus 
 
Once we precisely delimited that the sequence 116-132 was a key region for 
maintaining PKP1a in the nucleus, we wondered whether this small segment would be 
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also sufficient to target PKP1a to this compartment. To address this question we 
studied by confocal microscopy the subcellular localization of the CFP-tagged 
fragments PKP1-1-115 (region 1-115), PKP1-1-132 (region 1-132), and PKP1-116-132 
(region 116-132). All of them are made in pcDNA3-CFP-C4 (Figure R35).  
 
 
 
Figure R35. Subcellular distribution of CFP-tagged PKP1a N-terminal fragments in COS-1 cells. A) 
Confocal microscopy images of free-CFP, PKP1-head, and PKP1-116-132 ectopically expressed in COS-1 
cells. B) Subcellular distribution of CFP-tagged PKP1-1-115 and PKP1-1-132. Three representative 
images of the distribution of each of these constructs are shown. CFP fluorescence was detected upon 
excitation of CFP (442 nm). Bar, 10 µm.  
 
The region 116-132 of the head domain of PKP1a was not sufficient to drive nuclear 
accumulation of the protein. This fragment showed a diffuse subcellular distribution 
similar to that observed with the isolated CFP (Figure R35-A). Thus, it might be 
possible that the localization of this very small sequence of PKP1 (18-residue long) 
was dominated by the unspecific distribution of the CFP tag.  
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In order to avoid potential problems due to the small size of the 116-132 fragment, we 
analysed the subcellular distribution of two longer fragments: PKP1-1-115 and PKP1-1-
132 (Figure R35-B). Both fragments were present at the nucleus and cytoplasm. 
Nonetheless, they were enriched in the nucleus and apparently the PKP1-1-132 
nuclear signal was more prominent than that of the shorter fragment. In summary, the 
region 116-132 of PKP1a is not sufficient for nuclear targeting, which requires the 
contribution of additional segments of the head domain.  
 
The region 110-150 of PKP1a is dispensable for targeting PKP1a to the nucleus 
in the presence of other regions of the head domain  
 
Given the cooperative behaviour of the 116-132 segment with other parts of the head 
domain for targeting PKP1a to the nucleus, we questioned whether the residues 116-
132 were required for nuclear localization when segments up- and downstream of this 
motif were present. Thus, we generated internal deletion mutants that lack the 116-132 
sequence and analysed its subcellular distribution (Figure R36). This deletion was 
introduced in CFP-tagged constructs of the full length protein (PKP1-Δ116-132) and of 
the head domain (PKP1-head-Δ116-132) cloned into pcDNA3-CFP-C4. Both deletion 
mutants showed exclusive nuclear staining similar to that of the WT PKP1a full length 
and PKP1-head. 
 
During the analysis of the N-terminal deletion mutants, the segment 116-132 was the 
most important region for the nuclear-to-cytoplasm balance of PKP1a (see before). 
Nonetheless, we had observed that residues preceding and succeeding this region 
also contributed to the subcellular distribution. Thus, we generated and analysed the 
localization of two additional internal deletion mutants that lack the segment 110-150. 
In the context of the full length PKP1a, deletion of the 110-150 segment did not affect 
the exclusive nuclear localization. On the contrary, the head domain mutant PKP1-
head-Δ110-150 was detected in the cytoplasm in some cells, despite a predominant 
nuclear staining. Collectively, our results indicate that the nuclear targeting of PKP1 
involves the contribution of multiple segments of the head domain. 
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Figure R36. Subcellular distribution of CFP-tagged PKP1a internal deletion mutants in COS-1 cells. 
Confocal images of CFP-tagged PKP1a, PKP1a-Δ116-132, PKP1a-Δ110-150, PKP1-head, PKP1-head- 
Δ116-132, and PKP1-head-Δ110-150 ectopically expressed in COS-1 cells. The localization of the PKP1 
fragments was detected upon excitation of CFP at 442 nm. Bar, 10 µm.  
 
PKP1a-deletion mutants lacking the N-terminal nuclear determinant do not enter 
to the nucleus by association with endogenous PKP1 
 
We have shown that fragments lacking the first 116 to 132 residues of PKP1a lost their 
restricted nuclear localization and appeared equally distributed throughout the 
cytoplasm and nucleus. Those results suggested that the region 116-132 was a major 
determinant for targeting PKP1a to the nucleus (see above). However, the remaining 
nuclear staining observed in the constructs lacking the 116-132 region was intriguing. 
Previous reports have suggested that PKP1 might have at least two NLS (Sobolik-
Delmaire et al. 2010). However, we considered other possibilities, for example, PKP1a 
deletion mutants might be entering into the nucleus via homo-association with 
endogenous PKP1 present in the cells, or even via hetero-association with PKP2 or 
PKP3 (Hofmann, Mücke, et al. 2000). 
 
To study the possibility that PKP1a-deletion mutants were recruited to the nucleus via 
dimerization with endogenous PKP1, we compared the subcellular distribution of the 
mutants in two cell lines, one expressing endogenous PKP1 and another lacking PKP1 
expression. We used NHK as model cell line that expresses endogenous PKP1, and 
PKP1-null keratinocytes, which are established from a patient with skin fragility-
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ectodermal dysplasia syndrome whit total ablation of PKP1 (South et al. 2003). Both 
cell lines were transfected with selected CFP-tagged PKP1 N-terminal mutants and 
their subcellular localization was evaluated by confocal microscopy (Figure R37). 
 
 
 
Figure R37. Subcellular distribution of CFP-tagged PKP1a N-terminal deletion mutants in 
keratinocytes. The subcellular distribution of ectopically expressed CFP-tagged PKP1a N-terminal 
deletion mutants was investigated in NHKs and PKP1-null keratinocytes by confocal microscopy. The 
subcellular localization of the PKP1 fragments was detected upon excitation of CFP (442 nm). Bar, 10 µm.  
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The subcellular distribution of the PKP1a deletion mutants was comparable in both cell 
lines. Moreover, this distribution was also similar to the localization previously observed 
in COS-7 cells. PKP1a full length (region 1-726), PKP1-head domain (region 1-243), 
and PKP1-98 (region 98-726) showed restricted nuclear localization. PKP1-121 (region 
121-726) was detected in the cytoplasm but still conserved the predominant nuclear 
staining. However, PKP1-151 (region 151-726) and PKP1-ARM (region 244-726) lost 
the predominant nuclear localization, being equally distributed throughout cell.  
 
The fact that the PKP1a-deletion mutants showed the same distribution in cells that 
express PKP1 and cells that do not, indicates that the dimerization with endogenous 
PKP1 is not the reason why the mutants lacking the residues implicated in the nuclear 
targeting of PKP1a were entering to the nucleus. 
 
Effect of fusion tags on the localization of the armadillo domain of PKP1a 
 
Since we were as yet unsure about why the CFP-PKP1a deletion constructs that lack 
the first 116 to132 residues (i.e. 133-726, 151-726, 181-726, and ARM-domain) were 
entering to the nucleus. We looked again to a possible effect of the fusion tag. We had 
observed that our CFP-tagged constructs of PKP2a, PKG, and DP showed a specific 
subcellular distribution; including PKP2a, which did not exhibit any nuclear signal (see 
Figures R29, R30, and R32). So, it was very unlikely that the same CFP-tag was 
recruiting to the nucleus the CFP-PKP1a deletion constructs that lack the first 116 
to132 residues (i.e. 133-726, 151-726, 181-726, and ARM-domain). We had previously 
tested the effect of the tag on the subcellular distribution of PKP1a and DP (see Figure 
R8). However, in this case we used PKP1 full length that intrinsically shows restricted 
nuclear localization. Thus, to further analyse the influence of the fusion tag on the 
presence in the nucleus of PKP1-ARM and similar deletion fragments, we created 
equivalent PKP1a constructs (PKP1 full length and PKP1-ARM) tagged with HA or 
FLAG at the N-terminus. The FLAG-tagged constructs were created using the 
pCEFLAG vector, while the HA-tagged ones were done in the vectors pCEFLHA and 
pcDNA3-HA. These constructs were transiently expressed in COS-1 cells and their 
subcellular localization was investigated by immunofluorescence and confocal 
microscopy (Figure R38).  
 
Full length PKP1a (amino acids 1-726) with FLAG or HA tags showed nuclear-
restricted distribution, as observed with the CFP-labelled construct. Similarly, the ARM 
domain (PKP1-ARM) tagged with HA in the pcDNA3-HA vector showed the same 
distribution as the CFP-tagged version, that is, equal distribution of the signal between 
nucleus and cytoplasm (see above). However, PKP1-ARM was excluded from the 
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nucleus when the PKP1-ARM was tagged with FLAG or with HA using the pCEFLAG 
or the pCEFLHA vectors, respectively, being only present at the cytoplasm. 
 
Since the armadillo domain was not present in the nucleus when expressed using the 
pCEFLHA vector, we re-created several representative N-terminal deletion mutants of 
PKP1a in this vector and analysed their subcellular distribution by immunofluorescence 
(Figure R39). The HA-tagged constructs PKP1-75 (75-726) and PKP1-116 (116-726) 
showed an almost exclusive nuclear staining, while the PKP1-121 (121-726) construct 
had a dual localization in the nucleus and cytoplasm. On the other hand, the shorter 
constructs PKP1-151 (151-726) and PKP1-181 (181-726) showed diffuse staining in 
the cytoplasm and were excluded from the nucleus. Collectively, these results are 
analogous to those observed with similar constructs tagged with CFP (see Figure R34), 
and highlight the role of the 116-151 region of the head domain of PKP1a in the 
nuclear targeting of this protein. 
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Figure R38. Sub-cellular localization of FLAG- and HA-tagged PKP1a and PKP1a-ARM in COS-1 
cells. Immunofluorescence images of PKP1a full length (1-726) and PKP1-ARM (244-726) with two 
different tags. In red is shown the subcellular distribution of the constructs tagged with FLAG expressed 
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using the vector pCEFLAG. FLAG-fusion proteins were detected with a monoclonal antibody anti-FLAG 
(Clone M2, Sigma). In green are shown these same constructs but tagged with HA instead of FLAG, using 
the vectors pCEFLHA (middle panel) or pcDNA3-HA (bottom panel). HA-tagged fragments were detected 
by using a monoclonal antibody anti-HA (16B12, Covance). DAPI nuclear counterstain is shown in blue. 
Bar, 10 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R39. Sub-cellular localization of FLAG-tagged PKP1a fragments cloned in pCEFLHA. 
Immunofluorescence images of PKP1a N-terminal deletion mutants cloned in pCEFLHA (HA-tag). PKP1a 
fragments were detected with a monoclonal antibody anti-HA (16B12, Covance). DAPI nuclear 
counterstain is shown in blue. Bar, 10 µm.  
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The subcellular distribution of PKP2a is determined by specific residues in the 
head domain 
 
Given that the subcellular localization of PKP1a is controlled by its head domain, we 
analysed whether this was also the case for PKP2a. With this purpose, we generated a 
construct coding for full length PKP2a and several N-terminal deletion mutants tagged 
with CFP (Figure R40) and looked at their subcellular distribution in COS-7 cells by 
using confocal microscopy (Figure R41). 
 
 
 
Figure R40. CFP-tagged N-terminal deletion mutants of PKP2a. Schematic domain representation of 
the PKP2a fragments generated to look for localization determinants in the head domain of PKP2a. The 
constructs coding for these fragments were created in the pcDNA3-CFP-C4 vector that adds a CFP-tag to 
the N-terminus. The HR2 motif within the head domain is shown as a grey box in the scheme. 
 
PKP2a mutants lacking the N-terminal half of the head domain, that is, fragments 
PKP2-65 (region 65-838) and PKP2-151 (region 151-838), showed predominant 
localization at the plasma membrane, similar to that of the full length PKP2a. However, 
further N-terminal deletions, as in the fragment PKP2-220 (region 220-838) and the 
isolated armadillo domain (PKP2-ARM, region 349-838) resulted in the loss of the 
specific localization at the plasma membrane. These fragments appeared diffusely 
distributed throughout the cell. Interestingly, the armadillo domain of PKP2a showed 
prominent nuclear presence (see arrows), similar to that observed for the CFP-tagged 
armadillo domain of PKP1a.  
 
In summary, similarly to PKP1a and in spite of the different subcellular distribution of 
these two proteins, the localization of PKP2a is also determined by sequences in the 
head domain. In PKP2a, the central segment (151-220) of the head domain is required 
for the peripheral localization of PKP2a. Finally, the nuclear distribution of CFP-tagged 
constructs of PKP2a that lack the functional targeting sequences, probably does not 
correspond to a native function. 
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Figure R41. Subcellular distribution of CFP-tagged PKP2a N-terminal deletion mutants in COS-7 
cells. The subcellular distribution of ectopically expressed PKP2a and its N-terminal deletion mutants 
tagged with CFP was investigated in COS-7 cells by confocal microscopy. CFP fluorescence was detected 
upon excitation of CFP at 442 nm and is represented in grey. Nuclear counterstaining was made by using 
TO-PRO-3 stain and is represented in blue. Bar, 10 µm.  
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Structure of the PD of DP
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1. Structural analysis of the N-terminal region of the PD of DP 
 
Sequence analysis of the N-terminal region of the PD of DP suggests the 
presence of a SR-like domain 
 
Mammalian plakins share a similar multi-modular structural organization that bears in 
its N-terminal region the so-called plakin domain (PD) (Sonnenberg & Liem 2007; 
Jefferson et al. 2007). The PD consists of several SRs arranged in tandem that vary in 
number depending on the plakin-protein, but seven SRs (SR3-SR9) are present in all 
mammalian plakins. Upstream the SR3, plectin and the BPAG1 variants a, b, and n, 
have two additional SRs (SR1-SR2), whereas BPAG1e only harbours the SR2.  Recent 
studies have suggested that the N-terminal region of DP that precedes the SR3 
(residues 1–179) is unstructured (Al-Jassar et al. 2011).  
 
In order to investigate the possible presence of a SR or SR-like structure in DP 
upstream of the SR3, we studied several PD sequences by using profile hidden Markov 
models (HMM profiles). First, we created a multiple sequence alignment of the SR2 
domain of plectin, BPAG1, MACF1, periplakin, and envoplakin, which contain bona fide 
SR2 domains, we constructed the HMM profile and searched for homology against the 
human proteome and against the DP sequence. These strategies did not identify any 
canonical SR2 domain in DP. Next, we generated a more general HMM profile using all 
the sequences of all the SR domains of mammalian plakins, with the exception of the 
SR6s because of their divergent structure (Sonnenberg et al. 2007; Choi & Weis 2011). 
Results obtained by searching for homology in the human DP sequence using this 
HMM profile are summarized in table R9. 
 
Table R9. HMM-based search for SR in human DP-PD 
a
 
Domain Score E-value Alignment region Envelope region 
b
 
SR2 -4.1 1 106-147 65-157 
SR3 38.7 6.80E-14 192-272 182-273 
SR4 56.7 1.80E-19 270-375 269-376 
SR5 45 7.70E-16 377-547 377-549 
SR7 35 9.90E-13 664-729 664-741 
SR8 56.1 2.80E-19 770-884 769-885 
SR9 68.8 3.30E-23 887-1017 887-1028 
a, the HMM-based search was done with the program HMMER. 
b, an envelope is a subsequence of the target sequence that appears to contain 
alignment probability mass for a likely domain. 
  
The six canonical SR domains of DP (SR3-SR5, SR7-SR9) were identified by the 
HMM-based search; this was expected as their sequences were represented in the 
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HMM profile. In addition, the HMM-based search suggested the presence of an 
additional SR-like domain upstream of the SR3. Hence, we refer to it as SR2. Despite 
the lower score and statistical significance (the lower the E-value, the more significant 
the hit) of the SR2, the HMM-based search suggested that residues 65-157 (envelope 
region) have, at least, a SR signature, being unlikely to correspond to a disordered 
region. The envelope region represents the sequence that includes most of the 
posterior probability for a given homologous domain being the region where the 
domain’s alignment most probably lies. 
 
The presence of a SR-like domain in the N-terminal segment of the DP-PD might have 
not been noticed in previous reports because by default inclusion thresholds usually 
require E-values of 0.01 or less; therefore this hit would go unnoticed in an 
unsupervised sequence analysis. In addition, the use of a HMM profile specific for the 
plakin domain might have increased the amount of information necessary to identify 
potential SR homology in DP.  
 
Since the statistical significance of the SR hit in the N-terminal segment of DP fell in a 
twilight zone, we further characterised its presence. First, we used secondary structure 
prediction methods based on sequence analysis to identify putative structural elements 
in the DP region upstream of the SR3 (residues 1-180).  
 
The PredictProtein and the Jpred 3 servers (Yachdav et al. 2014; Cole et al. 2008) 
indicated the presence of three helices in the DP region 65-156 (Figure R42-A) that 
coincides with the limits of the SR2-like domain suggested by the search using HMM-
profiles. Outside of this region only another short helix is predicted around residues 11-
18. When the sequence of the SR2 of plectin was aligned to that of the N-terminal 
region of DP, the three α-helices of plectin match the position of the helices predicted 
in DP (Figure R42-B). Nonetheless, the sequence similarity between DP, plectin, and 
BPAG1e is lower towards the end of the SR2, e.g. beyond residue 153 in DP, where 
helix C of plectin extends longer than the predicted helix of DP. 
 
In order to illustrate the α-helical properties of the putative helices in the DP region 65-
156, we represented their sequences by using helical wheels diagrams (Figure R42-C). 
In such diagrams the secondary structure is plotted in a swivel manner where the angle 
of rotation between consecutive amino acids is 100°, obtaining a final representation 
that looks down the helical axis. This revealed an asymmetric distribution of polar and 
nonpolar residues. Most of the hydrophobic residues are concentrated on one side of 
the helix and occupy the a and d positions of the helical heptad repeat. This is 
characteristic of amphipathic helices as those that form canonical SRs, where the 
helices pack with the hydrophobic sides oriented towards the centre of the bundle. 
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Notably, residues conserved among DP, plectin, and BPAG1e mainly occupy the a and 
d positions of the heptads. 
 
Collectively, the analysis of the DP sequence suggests that the region ~65-156 
consists of three amphipathic α-helices that likely adopt a SR fold, and supports the 
hypothesis that the N-terminal region of DP-PD harbours a SR2-like domain. 
 
Figure R42. Sequence analysis of the SR2-like domain of DP. A) Amino acid sequence of the region 1-
180 of the DP-PD. Below the sequence are represented by coloured boxes the secondary structure 
predictions made by using Jpred 3 (blue) and PredicProtein (grey). B) Multiple sequence alignment of the 
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SR2 of plectin (Uniprot entry Q15149-2), BPAG1e (Q03001-3) and DP (P15924). Symbols below the 
alignment represent the conservation among the sequences. Specifically, asterisks (*) indicate positions 
which are fully conserved, colons (:) indicate conservation between groups of strongly similar properties 
and periods (.) conservation between groups of weakly similar properties. The DP sequence expected to 
be a SR2-like domain is mostly conserved with groups of similar properties among the three sequences. 
Alpha-helices predicted in DP by the PredictProtein server and α-helices of the crystal structure of plectin 
(PDB code 2ODU) are represented as grey-shaded regions. The positions a and d of the heptad repeat in 
the structure of plectin are indicated on the top of the sequences. C) Helical wheels diagrams showing the 
distribution of the amino acids in the α-helices predicted in DP. Amino acid properties are represented by 
using a colour code for non-polar (yellow), polar uncharged (green), acidic (pink) and basic (light-blue) 
amino acids. Helices A and C are represented with the C-terminus towards the back of the page, while 
helix B is plotted with the C-terminus towards the reader; this corresponds to the orientations of the helices 
in canonical SRs. Hydrophobic residues occupy mainly the positions a and d of the heptad and have been 
oriented towards the centre of the helical bundle; while polar residues predominate on the outside of the 
bundle. 
 
Taking into account all the previous evidences based on sequence analysis we created 
two different constructs of the putative SR2 of DP in the bacterial expression vector 
pETEV15b: 
 
i) A short construct, DP-SR2-S-pET (residues 64-155), that corresponds approximately 
to the domain limits indicated by the HMM-based search. 
ii) A long construct, DP-SR2-L-pET (residues 64-164), in which the C-terminal limit was 
extended to account for a possible larger extension of the third α-helix.  
 
The two DP-SR2 constructs were expressed soluble in E. coli as His-tagged fusion 
proteins, were purified by affinity chromatography, and the His-tag was removed by 
proteolysis.  
 
Biophysical analysis of the SR2-like domain of DP 
 
In order to analyse the secondary structure of the recombinant fragments of the SR2 of 
DP we measured the far-UV circular dichroism (CD) spectra of DP-SR2-L and DP-
SR2-S (Figure R43). 
 
The shape of the far-UV CD spectra allows to qualitatively determining the secondary 
structure content of proteins. Both spectra are characterized by a double negative 
minima at ~208 and ~224 nm and a maximum at ~193 that are characteristic of α-
helices (Ranjbar & Gill 2009). The spectra of the two constructs are almost identical 
with only minor differences in the amplitude of the maxima at ~193, suggesting that 
they have almost equal secondary structure content with a major presence of α-helices. 
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Figure R43. Far-UV CD spectra of purified DP-SR2 fragments. Far-UV CD spectra of the fragments 
DP-SR2-L (residues 64-164, solid line) and DP-SR2-S (residues 64-155, dashed line) represented in 
terms of mean residue molar ellipticity ([θ]). Each spectrum is a combination of spectra acquired using 
cells with optical paths of 1.0 mm and 0.1 mm using protein samples at two different concentrations in 20 
mM NaPi (pH 7.5), 150 mM NaCl, 0.3 mM TCEP. DP-SR2-L samples at 0.83 mg/mL and 2.49 mg/mL were 
measured in the 1.0 mm and 0.1 mm cells, respectively. Similarly, DP-SR2-S samples at 0.66 mg/mL and 
2.65 mg/mL were measured in the 1.0 mm and 0.1 mm cells, respectively. Spectra were measured at 20 
°C. 
 
The secondary structure content of DP-SR2-L and DP-SR2-S was estimated from their 
far-UV CD spectra using four methods implemented in the programs K2D3, SELCON, 
CONTIN, and CDSSTR (Table R10). All methods predicted a major presence of α-
helical structure, ranging between ~70 and 85 %, and only a negligible presence of β-
sheet that is likely to be not significant. The contents in α-helix estimated from the CD 
spectra were similar to the α-helical fractions predicted from the sequence (71 % for 
DP-SR2-L and 78 % for DP-SR2-S according to PredictProtein) and they were 
compatible with a SR fold. 
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Table R10. Estimation of the secondary structure content from the far-UV CD spectra 
  Fraction of secondary structures (%) 
a
  
Fragment Method α-helix β-sheet turns random rmsd 
b
 
DP-SR2-L K2D3 
c
 68.4 1.6 - 30.0 - 
(64-164) SELCON 76.4 0.1 9.3 14.2 0.035 
 CONTIN 77.3 1.1 9.0 12.6 0.028 
 CDSSTR 83.0 2.0 6.0 7.0 0.009 
DP-SR2-S K2D3 68.6 0.9  30.5 - 
(64-155) SELCON 80.5 2.9 4.6 17.8 0.058 
 CONTIN 77.0 1.1 6.6 15.2 0.014 
 CDSSTR 79.0 1.0 6.0 13.0 0.007 
a, data from 190 nm to 240 nm were used for all estimations 
b, root mean square deviation 
c, K2D3 only estimates the α-helix and β-sheet content and it does not distinguishes between turns and random coil 
 
Temperature induced denaturation provide useful and reliable information about 
conformational stability of a folded protein. To shed light on the structural organization 
of the putative SR2, we analysed the thermal stability of the DP-SR2-L and DP-SR2-S 
fragments by CD and with a thermal shift assay (also known as differential scanning 
fluorimetry or Thermofluor). 
 
For the CD thermal denaturation we measured the molar ellipticity of the samples at 
222 nm, which is proportional to the α-helical content, during a temperature ramp from 
20 to 90 ºC (Figure R44). Both proteins showed similar molar ellipticity at 20 ºC and 
presented a comparable linear increase in the signal in the initial segment of the ramp. 
At higher temperatures we observed rapid increases in the molar ellipticity that 
revealed highly cooperative reactions, characteristic of compact and well-ordered 
structures. After a first denaturation ramp the DP-SR2-L sample was cooled down and 
a second heating cycle yielded the same denaturation profile, indicating that the 
unfolding reaction was reversible. The denaturation curves were analysed assuming a 
two-state transition from a folded to an unfolded state, which allowed for the 
determination of the Tm of the fragments, equivalent to the midpoint of the transition. 
The Tm of DP-SR2-L (64-164) was 74.2 ± 0.3 °C, whereas that of the shorter construct 
DP-SR2-S (64-155) was 61.1 ± 0.1 °C.  
 
The large difference (~13 °C) in the Tm of the two fragments indicates that the 
segment 156-164 greatly contributes to the conformational stability of the SR2 of DP, 
and suggests that it is part of the structure of this domain. 
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Figure R44. Denaturation profiles of DP-SR2 fragments. The denaturation profiles of DP-SR2-L (64-
164, solid line) and DP-SR2-S (64-155, dashed line) were determined by measuring the mean residue 
molar ellipticity at 222 nm while the temperature was increased from 20 to 90 ºC with a heating rate of 40 
ºC/hour. After the first denaturation cycle, the DP-SR2-L sample was cooled down and a second 
denaturation profile was recorded (DP-SR2-L*, dotted line). This second denaturation profile was almost 
identical to the first cycle indicating that the denaturation of DP-SR2-L is a reversible process that can be 
understood as a balance between the folded and unfolded states. 
 
To further characterize the thermal stability of the DP-SR2 constructs we used a 
thermal shift assay (Thermofluor) that is based on changes in the fluorescence of the 
probe Sypro Orange upon binding to hydrophobic regions of the proteins that become 
accessible upon denaturation. The melting curves of the DP-SR2 fragments are 
characterized by a rapid increase in the fluorescence of the probe followed by a sharp 
decrease that is probably related to dissociation of the dye or aggregation of the 
protein. The Tm of the DP-SR2-L and DP-SR2-S at neutral pH were ~ 66 °C and ~ 55 
°C, respectively. This confirmed the higher thermal stability of the 64-164 fragment with 
respect to the 64-155 one (Figure R45-A). We also analysed the effect of the pH in the 
stability of the two DP-SR2 constructs, yet we did not observed noticeable changes in 
the thermal stability between pH 6.0 and 8.0 (Figure R45-B, C). 
 
The melting temperatures determined in the thermal shift assays were lower than those 
observed by CD. These differences likely reflect that each method provides information 
of different steps of the unfolding process. The far-UV CD assay is sensitive to the 
stability of the helices, whereas the Thermofluor assay responds to the exposure of 
hydrophobic patches, such as opening of the SR helical bundle, which might occur at 
lower temperatures than those required to unfold the α-helices. 
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Figure R45. Thermofluor analysis of the stability of DP-SR2 fragments. A) Denaturation profiles of 
DP-SR2-L (64-164, solid line) and DP-SR2-S (64-155, dashed line) in 50 mM HEPES pH 7.5, 150 mM 
NaCl in the presence of Sypro Orange (10 arbitrary units, as defined by the manufacturer). The 
temperature of the samples was increased at a rate of 60 °C/hour. The fluorescence of the probe was 
measured using 480 nm excitation and 530 nm emission filters (left panel). The Tm was estimated from 
the maximum of the first derivative of the fluorescence (F) with respect to the temperature (T) (dF/dT) (right 
panel). B) Denaturation curves of DP-SR2-L at pH 6.0 (blue), 7.0 (black) and 8.0 (red). C) Denaturation 
curves of DP-SR2-S at pH 6.0 (blue), 7.0 (black) and 8.0 (red). 
 
Summarizing, our results indicate that the region 64-164 of DP forms a well ordered 
and stable structural domain with high α-helical content likely to consist of three 
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amphipathic α-helices and with sequence similarity to the SR domains. Hence, our data 
is compatible with the presence of a non-canonical SR2 in this region of DP.   
 
Structure of the N-terminal region of the PD of DP: analysis by small angle X-ray 
scattering (SAXS) 
 
Attempts to crystallize the N-terminal region of the PD of DP (region 1-630) were 
unsuccessful. Thus, the structure of this region was investigated by SAXS. Analysis of 
SAXS data provides low-resolution structural information of biomolecules in solution in 
a straightforward manner including accurate shape and size information.  
 
Scattering profiles of DP-1-SR6 were measured at five different concentrations 
between 29.2 and 1.825 mg/mL. Preliminary analysis detected radiation damage, 
strong interparticle attraction, and possible aggregation at high concentration. 
Therefore, subsequent analyses were performed using only the most diluted curve at 
1.825 mg/mL, which did not suffer from radiation damage. The resultant scattering 
profile after buffer subtraction and normalization is shown in Figure R46-A. This curve 
was used to calculate the radius of gyration (Rg) and the forward scattering intensity 
(I0) using the Guinier approximation (Figure R46-B). Other informative parameters, 
such as the Porod Volume (Vp), the pair-distribution probability function (P(r)), and the 
maximum particle size (Dmax) were also calculated from the scattering data. 
 
The apparent molecular weight of DP-1-SR6 calculated from the Vp (Vp/1.6; 
Petoukhov et al., 2012; Rambo & Tainer, 2011) was 77.4 kDa, which is in agreement 
with the molecular mass calculated from its sequence (73641 Da) and confirms that 
this fragment of DP is a monomer in solution. Guinier analysis of the scattering data 
revealed that DP-1-SR6 has a Rg of 62 ± 3 Å (Figure R46-B), which is consonant with 
the Rg of 64.9 ± 0.3 Å determined in the calculation of the P(r) using data covering a 
range of the scattering vector from 0.0075 to 0.2970 Å-1. The P(r) presented a 
maximum at small distances with a tail extending up to a Dmax of ~220 Å. This shape 
is characteristic of elongated molecules (Figure R46-C). The dimensionless Kratky 
representation of the scattering data showed a maximum of ~2.2 at q*Rg ~6.5, which is 
displaced from the expected maximum for globular compact particles (~1.1 at q*Rg 
~1.73). This deviation may reflect that DP-1-SR6 is a high anisometric structure. This is 
in agreement with the shape of the P(r) function (Figure R46-D).  
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Figure R46. SAXS analysis of the N-terminal region of DP-PD. A) Scattering profile of DP-1-SR6, 
region 1-630, at 1.825 mg/mL. B) Guinier analysis of the scattering curve shown in A. The Rg and I0 
calculated by the Guinier analysis are 62 ± 3 Å and 1660, respectively. C) Pair-distance distribution curve 
estimated from the SAXS data using the program GNOM. D) Dimensionless Kratky analysis of the DP-1-
SR6 scattering data showing a displacement of the maximum of the plot towards higher levels of q*Rg 
than that predicted for compact globular particles.  
 
From the scattering data of the DP-1-SR6 fragment we calculated low-resolution shape 
reconstructions using an ab initio method implemented in the program DALAI_GA. We 
made ten independent reconstructions. After superimposition of the ten models, the 
normalized spatial discrepancy (NSD, a parameter that measures the similarity of 3D 
structures, being zero for identical structures and >1 for objects different from one 
another) was 0.91 ± 0.03, which indicates that the method yields repetitively similar 
reconstructions. The resulting average model, which is the volumetric representation of 
the most probable envelope, has a slightly bent rod-like shape (Figure R47). 
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Figure R47. SAXS reconstruction of the N-terminal region of DP-PD. Spheres representation of the 
low resolution structures of the fragment 1-630 of DP obtained by ab initio methods with the program 
DALAI_GA. Two orthogonal views are shown. Ten models, which were superimposed, are shown in semi-
transparent representation. The areas with darker colour correspond to parts of the structure more 
frequently present in the set of models. 
 
In addition, the structure of DP-1-SR6 was modelled by rigid body fitting against the 
SAXS data using two different methods implemented in the programs CORAL and 
BUNCH. On the one hand, we used CORAL to obtain a mixed composite model 
comprising the atomic model of the SR2 (built by homology modelling using the SR2 of 
BPAG1e as template) and the crystal structure of DP-SR3-SR6 (PDB entry 3R6N). 
CORAL starts from arbitrary initial positions and orientations of the rigid domains to 
build a final model in which the linkers that connect the rigid bodies are modelled using 
a library of self-avoiding random loops. In all the models obtained with CORAL the SR2 
domain is placed on one side of the SR3, whereas the N-terminal tail (residues 1-63) is 
built in an extended conformation that project away from other parts of the structure 
(Figure R48-A). It should be noted that the specific relative position of the SR2 with 
respect to the SR3 cannot be inferred in the absence of additional restraints; yet, the 
repetitive positioning of the SR2 adjacent to the SR3 suggests that these two domains 
could establish lateral interactions and adopt a compact arrangement. The composite 
models obtained with CORAL match the shape estimated by ab initio modelling against 
the SAXS data (Figure R48-B). The theoretical scattering profile of the rigid body model 
fits the experimental data (Figure R48-C). Similarly, the P(r) and kratky dimensionless 
plots of the CORAL model also reproduce approximately those obtained from the 
experimental data (Figure R48-D, E).  
 
130 
 
Figure R48. Composite model of the region 1-630 of DP obtained by rigid body fitting with the 
program CORAL. A) Representation of five rigid body models of DP-1-630. The segment SR3-SR6, 
which is identical in all models, is shown in grey. The SR2 in each model is shown in a different colour. 
The N-terminal tail and the linker between the SR2 and SR3 domains were modelled as dummy residues 
whose Cα atoms are shown as spheres of the same colour as the corresponding SR2 domain. B) 
Superimposition of a representative model of A onto the average molecular envelope calculated from the 
reconstructions obtained with DALAI_GA. For clarity, the N-terminal tail is not shown. C) Experimental 
SAXS profile of DP-1-SR6 (circles) and fit of the theoretical scattering of a representative model obtained 
with CORAL (red line). B) P(r) function calculated from the SAXS data (black line) and theoretical P(r) 
calculated from the CORAL model (red line). C) Dimensionless Kratky plot of the experimental scattering 
data (black line) and of the scattering data calculated for the model (red).  
 
Alternatively, we used the program BUNCH, which performs modelling of multi-domain 
proteins against SAXS data using a combined rigid body and ab initio modelling 
approach in which inter-domain linkers are represented by dummy residues (Figure 
R48-D). Similarly to the rigid body model obtained with CORAL, in the models 
produced by BUNCH the SR2 lies adjacent to the SR3 (Figure R49-A). The models 
match the shape obtained by ab initio modelling and the theoretical scattering of the 
models fit the experimental curves (Figure R49-B-C). Similarly, the P(r) reproduces the 
experimentally determined function and the kratky dimensionless plot is very similar to 
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that of the experimental data (Figure R49-D-E). The position of the SR2 in the different 
models obtained with BUNCH has lower variability than in the models generated with 
CORAL. This probably reflects that BUNCH explores a more limited conformational 
space than CORAL, which examines much more possible inter-domain organizations 
that fit the experimental SAXS data.  
 
 
 
Figure R49. Composite model of the region 1-630 of DP obtained by rigid body fitting with the 
program BUNCH. A) Representation of five models obtained with BUNCH. The segment SR3-SR6, which 
is identical in all models, is shown in grey. The SR2 in each model is shown in a different colour. The N-
terminal tail and the SR2-SR3 linker were modelled as dummy residues whose Cα atoms are shown as 
spheres of the same colour as the corresponding SR2 domain. B) Superimposition of a representative 
model of A onto the average molecular envelope calculated from the reconstructions obtained with 
DALAI_GA. For clarity, the N-terminal tail is not shown. C) Experimental SAXS profile of DP-1-SR6 
(circles) and theoretical scattering of a representative model obtained with BUNCH (red line). D) P(r) 
function calculated from the SAXS data (black line) and theoretical P(r) calculated from the BUNCH model 
(red line). E) Dimensionless Kratky plot of the experimental scattering data (black line) and of the 
scattering data calculated for the model (red). 
 
Collectively, the analysis of the SAXS data suggests that the N-terminal region of the 
DP-PD (residues 1-630) has an elongated shape in which the SR2 could be folded 
back onto the SR3.  
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2. Structure of the C-terminal region of the PD of DP 
 
Homo-association of the C-terminal region of the PD of DP in cell culture  
 
Downstream the PD, plakins contain a rod domain thought to form homo-dimers by 
means of coiled-coil interactions (Green, Virata, et al. 1992; O´Keefe et al. 1989). Our 
DP-CT construct (region 544-1056) includes the SR6-SR9 region (544-1025) and the 
initial segment of the rod domain (1026-1056). We wondered whether this N-terminal 
part of the rod domain would be sufficient to mediate the dimerization of the PD. To test 
this hypothesis, the ability of DP to self-associate was investigated by co-IP. COS1 
cells were transiently co-transfected with constructs coding DP fragments with HA or 
FLAG tags. FLAG-precipitates were subsequently analysed for the presence of HA-
tagged fragments (Figure R50). 
 
 
 
Figure R50. Analysis of the homo-association of the C-terminal region of the PD of DP by co-IP. A) 
Schematic domain representation of two fragments of the C-terminal half of the PD of DP. The longer 
construct DP-CT (544-1056) was tagged either with FLAG or HA, the shorter construct DP-CT-1025 was 
cloned only with a HA tag. B) The homo-association of DP-CT was analysed by co-transfection of COS-1 
cells with DP-CT tagged with FLAG (or the empty pCEFLAG vector in the control samples) and either the 
same construct or DP-CT-1025 tagged with HA. Twenty-four hours after transfection total lysates were 
incubated with anti-FLAG agarose beads (DP lanes). Immunoprecipitated proteins were investigated by 
western blotting with a polyclonal anti-HA antibody. DP-CT (544-1056) interacts with itself but does not 
immunoprecipitate the 544-1025 fragment. Expression of DP-fragments in the input total lysates was 
detected by western blotting using anti-FLAG (Sigma) and anti-HA antibodies (Santa Cruz). β-actin 
detection was used as a loading control.  
 
Analysis of FLAG-immunoprecipitates showed self-association of the larger DP 
fragment, residues 544-1056, that includes the initial part of the rod domain (~1026-
1056). However, the shorter fragment 545-1025, that completely lacks the rod domain, 
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did not co-precipitate with DP-CT. pCEFLAG empty vector did not show any unspecific 
association with HA-tagged constructs, serving as a valid negative control. These 
results suggest that the initial ~30 residues of the rod domain are sufficient to mediate 
self-association of DP in cultured cells. 
 
Structure of the SR7-SR9 region of DP-PD, monomeric state 
 
Next, we decided to further study the structure of C-terminal fragments of the DP-PD 
by using biophysical techniques. With this purpose, we created a construct in the 
vector pETEV15b that codes for the fragment DP-CT (region 660-1056). This fragment 
includes the SR7-SR9 domains of the PD and approximately the first 30 residues of the 
rod domain. This recombinant protein was synthesised soluble in E. coli and was 
purified by using affinity chromatography (see materials and methods for details). 
Attempts to crystalize this fragment were not successful enough and we only got 
microcrystals, not suitable to obtain useful diffraction data (data not shown). To 
overcome this limitation, we applied SAXS to obtain the low-resolution structure of this 
C-terminal region of the PD of DP.   
 
SAXS profiles of DP-CT (660-1056) were measured at the EMBL BioSAXS beamline 
P12 (Hamburg, Germany) at four different concentrations between 3.61 and 0.90 
mg/mL. Initial analysis of the scattering curves revealed the absence of radiation 
damage. After buffer subtraction and normalization by the concentration, the resultant 
scattering profile was extrapolated to infinite dilution (Figure R51-A).  
 
Guinier analysis of the scattering data extrapolated to infinite dilution revealed a Rg of 
45 ± 0.8 Å (Figure R51-B). The Rg did not show dependence on the concentration and 
only with the most concentrated curve is it possible to appreciate a slight increase of 
the Rg. The Rg value calculated by Guinier was very similar to the Rg of 49 ± 1 Å 
determined in the calculation of the P(r) using data covering a range of the scattering 
vector from 0.012 to 0.222 Å-1. The P(r) presented a maximum at small distances with 
a tail extending up to a Dmax of ~165 Å. This shape is characteristic of elongated 
molecules (Figure R51-C). The dimensionless Kratky representation of the scattering 
data showed a maximum of ~2.2 at q*Rg ~5 (Figure R51-D), which is displaced from 
the expected maximum for globular compact particles (~1.1 at q*Rg ~1.73). This 
deviation suggested a high anisometric structure, in agreement with the shape of the 
P(r) function. 
 
The apparent molecular weight of this fragment calculated from the Porod volume 
(Vp/1.6; Petoukhov et al., 2012; Rambo & Tainer, 2011) was 42.3 kDa, which is similar 
to the molecular mass calculated from its sequence (46772 Da). Thus, the region SR7-
134 
SR9 of DP in solution is a monomer and does not oligomerize. This result contrasts 
with the results obtained by co-IP experiments and suggests that N-terminal segment 
of the rod domain, region 1025-1056, is not sufficient to promote DP homo-association 
in vitro.  
 
 
 
 
Figure R51. SAXS analysis of the C-terminal region of DP-PD. A) Scattering profile of the SR7-SR9 
region, residues 660-1056. B) Guinier analysis of the scattering curve shown in A. In the insert is 
represented the Rg determined by Guinier´s analysis at every concentration. The Rg and I0 calculated by 
the Guinier analysis are 45 ± 0.8 Å and 338, respectively. C) Pair-distance distribution curve estimated 
from the SAXS data using the program GNOM. The Rg and Dmax calculated by the GNOM analysis are 
48.7 ± 0.3 Å and 165, respectively. D) Dimensionless Kratky plot of the DP-SR7-SR9 scattering data 
showing a displacement of the maximum of the plot towards high levels of q*Rg.  
 
By similarity with the crystal structure of the SR7-SR9 of plectin, this region of DP 
forms a continuous tandem array of SRs, where the C-terminal helix of the SR9 is 
predicted to be fused to the helix of the rod domain. Therefore, this fragment is 
expected to have only very small conformational variability. Thus, we calculated low-
resolution structures from the scattering data using ab initio methods implemented in 
DAMMIF. We made 14 independent reconstructions that were very similar to each 
other (Figure R52-A), having a NSD of 0.78 ± 0.03. After averaging the 14 models, the 
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resulting envelope, which represents the most probable volume occupied by the model, 
resembles a slightly bent rod-like shape. An atomic model of the SR7-SR9 of DP was 
built by homology modelling using the crystal structure of the equivalent region of 
plectin as template. The atomic model fitted inside the SAXS average envelope with 
the exception of the final part of the C-terminal helix (Figure R52-B). The theoretical 
scattering profile calculated from the atomic model showed a good fit to the 
experimental data (Figure R52-C) and, similarly, the P(r) calculated from the 3D 
coordinates reproduced the SAXS-derived P(r) pair distance distribution function 
(Figure R52-D). Finally, the dimensionless Kratky representation of the calculated 
scattering data matched the experimental curve (Figure R52-E), suggesting that the 
deviation in the position of the maximum with respect to compact and spherical 
particles was due to the elongated shape of the SR7-SR9 and probably was not 
caused by flexibility in this fragment. In summary, the analysis of SAXS data of the 
SR7-SR9 (660-1056) of DP indicates that in vitro this region is a monomeric rod-like 
structure. 
 
 
 
Figure R52. Low-resolution models of the SR7-SR9 region of DP-PD. A) Ab initio reconstructions of 
the structure of the 660-1056 fragment of DP from the SAXS data with the program DAMMIF. Fourteen 
models are shown after superimposition. The models consist of dummy atoms that are shown as semi-
transparent spheres. B) Homology model of the atomic structure of this region (shown in ribbon 
representation) docked into the molecular envelope calculated as the average of the fourteen DAMMIF 
models (grey surface). C) Experimental scattering profile of the SR7-SR9 region (circles) and fit of the 
136 
theoretical profile calculated for the atomic model (red line) D) Comparison of the P(r) distribution functions 
estimated from the experimental data (black line) and that determined for the atomic model (red line). D) 
Dimensionless Kratky plot of the experimental (black line) and theoretical (red line) scattering data. 
 
Structure of the SR7-SR9 region of DP-PD, dimeric state 
 
Since the DP-CT (region 660-1056) did not dimerize in solution but it is well established 
that DP and other plakins form dimers via coiled-coil interactions of the rod domain, we 
stabilized the homo-dimerization by adding a leucine zipper of the yeast transcriptional 
activator GCN4 at the C-terminus. The segment 249-281 of GCN4 (hereafter referred 
as GCN4) forms an extensively characterized homo-dimeric parallel coiled coil (O’Shea 
et al. 1991). Similarly to other amphipathic helices, the coiled coil sequences show a 7-
residues repetition, termed heptads, in which the positions a and d are most frequently 
occupied by hydrophobic residues that mediate inter-chain contacts. A DP-CT-GCN4 
fusion protein was design in such a way that the predicted heptad repeats of the DP 
sequence were in frame with the GCN4 heptad (Figure R53). 
 
 
 
Figure R53. Design of the DP-GCN4 fusion protein. A) Ribbon representation of the crystallographic 
structure of the GCN4 homo-dimer (PDB entry 2ZTA). The side chains of the residues that occupy the a 
and d positions of the heptad repeats are shown as sticks. The GCN4 sequence is shown on top. B) 
Region where the DP and the GCN4 sequences are fused in the DP-CT-GCN4 construct. The a and d 
positions of the heptads are labelled on top. For the DP sequence the heptads were assigned with the 
program PAIRCOIL2 (McDonnell et al. 2006). 
 
The structure of DP-CT-GCN4 (DP region 660-1060) was analysed by SAXS. 
Scattering profiles were measured at three different concentrations between 3.56 and 
0.89 mg/mL. No radiation damage was observed. After buffer subtraction and 
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normalization by the concentration, the resultant scattering profile was extrapolated to 
infinite dilution (Figure R54-A). The molecular mass estimated from the Porod volume 
(Vp ~190000 Å3) was ~119 kD, which is approximately twice the theoretical molecular 
weight of DP-CT-GCN4 (51.2 kD) indicating that the GCN4 effectively stabilizes the 
homo-dimer. Guinier analysis of the scattering curves at different concentrations 
showed a slight dependence at high concentration. The Rg calculated by Guinier 
analysis of the data extrapolated at infinite dilution was 61 ± 1 Å (Figure R54-B). The 
calculation of the P(r) yielded a similar Rg of 66 Å and a Dmax of ~245 Å (Figure R54-
C). The dimensionless Kratky representation of the scattering data showed a maximum 
at ~5 qRg that is in agreement with the position of the maxima observed for other 
elongated DP fragments (Figure R54-D). 
 
 
 
Figure R54. SAXS analysis of a dimeric fragment of the C-terminal region of DP-PD. A) Scattering 
profile extrapolated to infinite dilution of the dimeric SR7-SR9-GCN4 region, residues 660-1060 fused to 
GCN4. B) Guinier analysis of the scattering curve shown in A. The Rg and I0 calculated by the Guinier 
analysis are 61 ± 1 Å and 2440, respectively. The Rg determined by Guinier´s analysis at each individual 
concentration is shown in the insert. C) Pair-distance distribution function, P(r), estimated from the SAXS 
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data using the program GNOM. The Rg and Dmax calculated by the GNOM analysis are 66 ± 0.4 Å and 
245, respectively. D) Dimensionless Kratky analysis of the dimeric DP-SR7-SR9-GCN4 scattering data.  
 
Next, we calculated low-resolution structures from the scattering data using ab initio 
methods implemented in DAMMIF. Since the coiled coil was expected to induce a two-
fold symmetric arrangement of the protomers, P2 symmetry was imposed for the 
generation of the ab initio reconstructions. Ten independent reconstructions were made 
and the most probable volume was calculated by averaging all these structures (Figure 
R55-A). The structure has an overall elongated and flat structure being narrow towards 
one of the longitudinal ends with an overall dimensions of approximately 240 Å x 105 Å 
x 45 Å. 
 
In addition, we created a composite atomic model of DP-CT-GCN4 as follows. The 
SR7-SR9 region was modelled by homology using the structure of the equivalent 
region of plectin as template. The arrangement of the two protomers in the dimer was 
taken from the organization of the plectin dimer in the crystal lattice, in which the two 
copies of the SR7-SR9 lay parallel possibly establishing lateral contacts along the three 
SR sub-domains. The segment of the rod domain was modelled using a crystal 
structure of a tropomyosin dimeric fragment (PDB entry 1IC2) (Brown et al. 2001). The 
GCN4 dimer was modelled using its crystal structure (PDB code 2ZTA). There is a 
good overall agreement between the composite atomic model and the ab initio 
envelope (Figure R55-B). Despite the P(r) of the atomic model reproduces the features 
of the experimental P(r), comparison of the theoretical scattering profile with the 
experimental SAXS data revealed differences (also observed in the dimensionless 
Kratky representation of the data) (Figure R55-D-E). In summary, the analysis of the 
SAXS data from DP-CT-GCN4 is compatible with a close arrangement of the DP dimer 
in which inter-protomer contacts extend through the last three SR of the plakin domain. 
Nonetheless, the specific arrangement of the two DP molecules might be slightly 
different from that observed in the plectin crystal structure. 
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Figure R55. Low-resolution models of the SR7-SR9 region of DP-PD. A) Ab initio reconstructions of 
the structure from the SAXS data of DP-CT-GCN4 generated with the program DAMMIF, shown after 
superimposition. The models consist of dummy atoms that are shown as semi-transparent spheres. B) 
Surface representation of the ab initio molecular envelope that corresponds to the average of ten 
reconstructions. The composite atomic model is shown in ribbon representation after docking into the low 
resolution structure. C) Scattering profile of the dimeric SR7-SR9 region, residues 660-1060 and GNC4,  
(circles) and fit of the theoretical curve calculated from the atomic model (red line). D) Pair-distance 
distribution function, P(r), estimated from the experimental SAXS data (black line) and that calculated from 
the 3D structure of the atomic model (red line). E) Dimensionless Kratky representation of the experimental 
and theoretical scattering data shown in B.  
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Mapping of the interacting domains in the DP-PKP1a complex 
 
Despite the study of the desmosomal architecture extends back beyond a century and 
there is a conventional understanding of the intra-desmosomal protein interactions, the 
precise protein-protein relationships that orchestrate fully functional DMs are still not 
completely understood. Knowing how desmosomal proteins are connected is 
fundamental to understanding how cells maintain their shape and polarity, regulate 
movement, adhesive potential, and strength, or mechanotransduce signals originated 
at junctional complexes.  
 
Previous studies had established four types of interactions between desmosomal 
proteins: i) desmosomal cadherins binding their peers on adjacent cells, ii) plaque 
proteins binding the cytosolic tails of cadherins at the inner dense plaque, iii) plaque 
proteins binging other plaque proteins, and iv) plaque proteins binding intermediate 
filaments (IFs) at the outer dense plaque. In this study, we focused on the DP-PKP1a 
interaction, which takes place between these two plaque proteins at the inner dense 
plaque. We report a precise mapping of the interacting domains in the DP-PKP1a 
complex. By using a multi-methodological approach, we have narrowed the molecular 
definition of the DP-PKP1a recognition sites in both molecules.  
 
Unravelling the PKP1-binding site in DP 
 
The interaction between endogenous DP and PKP1 had been demonstrated in 
keratinocytes by immunoprecipitation (IP) and sucrose gradient centrifugation 
(Hofmann, Mertens, et al. 2000). IP experiments in different cells lines and yeast two 
hybrid assays working with fusion proteins limited the PKP1-binding site to the N-
terminal half of the plakin domain of DP (region 1-584) (Hatzfeld et al. 2000; Kowalczyk 
et al. 1999; Bornslaeger et al. 2001). Most of the studies that, directly or indirectly, 
analysed the association of DP with PKP1 or other desmosomal proteins, such as co-
localization and recruitment assays or DMs assembly experiments, considered the N-
terminal region of DP as a functional unit (Kowalczyk et al. 1997; Kowalczyk et al. 
1998; Godsel et al. 2005; Chen et al. 2002). Yet, a precise mapping of the domains of 
DP that mediate the interaction with other desmosomal proteins, and particularly with 
PKP1, was still missing. The recent elucidation of the 3D structure of fragments of the 
PD of DP and other plakins paved the way for a more precise analysis of the 
interaction sites. 
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PKP1a interacts with the N-terminal half of the PD of DP 
 
We created an extensive collection of fragments of the PD of DP and assayed their 
interaction with PKP1a by using three complementary approaches. First, we looked for 
biochemical data by doing co-immunoprecitations (co-IP) of HA-tagged DP fragments 
using PKP1-FLAG as bait with agarose anti-FLAG beads. Second, we used 
fluorescence lifetime imaging microscopy (FLIM) to analyse the interaction. Finally, we 
compared the subcellular distribution and behaviour of PKP1a and DP fragments in 
DM-bearing and non-bearing cell lines.  
 
Initially, we assayed the interaction between PKP1a and both halves of the DP-PD. 
Based on the crystal structure of the SR3-SR6 domain of DP (Choi & Weis 2011), we 
modified the boundaries of the previously reported DP N-terminal fragment (residues 1-
584) and chose the limits 1-545 to match the end of the SR5. Thus, our DP-NT 
fragment comprises the N-terminal tail and the SR2-SR5 domains. The complementary 
DP-CT fragment (544-1056) comprises the SR6-SR9 domains and includes an initial 
segment of the rod domain (~1026-1056).  
 
Surprisingly, our co-IP results showed that, in addition to the complete N-terminal half 
of DP (SR2-SR5 domains), the non-overlapping C-terminal fragment corresponding to 
the SR6-SR9 domains (DP-CT) also interacted with PKP1a, suggesting the existence 
of two PKP1-binding sites within the DP-PD, each located on one half of the plakin 
domain (Figure R1). Nonetheless, when we analysed the interaction between PKP1a 
and DP-fragments by using constructs tagged with fluorescent proteins in combination 
with FLIM, we did not observe association between the C-terminal half of DP-PD and 
PKP1a (Figures R2 and R3).  
 
Trying to understand such discrepancy, we moved the Venus-tag from the N- to the C-
terminus of the DP fragments to rule out the possibility that the lack of FRET observed 
between DP-CT and PKP1a may have been due to a distance between the CFP-Venus 
pair in the putative complex larger than the Förster distance. Yet, independently of the 
position of the Venus tag, we did not detect interaction of DP-CT-Venus with PKP1a-
CFP (Figure R4). 
 
The reason for the observed co-immunoprecipitation of DP-CT-HA with PKP1-FLAG is 
unclear. We can exclude an unspecific interaction with the anti-FLAG M2-resin, since 
DP-CT-FLAG did not co-immunoprecipitate in the control samples without PKP1-FLAG. 
It has been described that nucleic acids present in the input cell lysates can mediate 
indirect binding in co-IP experiments, resulting in false positives (Nguyen & Goodrich 
2006). This hypothesis is interesting because PKP1a has been described to interact 
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with single stranded DNA (Sobolik-Delmaire et al. 2010). Nonetheless, DP-CP is 
unlikely to associate to PKP1a via nucleic acids; the DP-CT is a slightly acidic protein 
(the theoretical isoelectric point, pI, is ~6.5, similar to the pI ~6.1 of the DP-NT 
fragment), and it has not been described its association with nucleic acids. 
 
During FLIM experiments we noticed that Venus-tagged DP-NT (region 1-545) and DP-
CT (region 544-1056) fragments showed clearly different subcellular localizations in 
COS-7 cells. To further study this differential behaviour we looked at the subcellular 
localization of these fragments by confocal microscopy (Figures R5 and R6).  
 
In COS-7 cells the complete plakin domain of DP (DP-PD, region 1-1056) appeared 
diffusely distributed throughout the cytoplasm, but also decorated the plasma 
membrane. It is known that DP-PD targets DP to the plasma membrane where, when 
DP is incorporated into DMs, typically shows a fine and regularly spaced punctate 
pattern (Bornslaeger et al. 1996; Smith & Fuchs 1998; Godsel et al. 2005). However, 
our DP-PD fragment was present in extensive stretches at cell-cell borders as if dots 
were stitched together. This kind of pattern had been reported before in non-bearing 
DMs cell lines (Kowalczyk et al. 1997) or in cells with high expression of the fusion 
fragments (Bornslaeger et al. 2001; Hatzfeld et al. 2000).  
 
DP-NT (region 1-545) showed two different distributions in transfected cells. In some 
cells, DP-NT showed a similar distribution with respect to the full plakin domain (DP-
PD). On the contrary, other cells showed an aberrant distribution with DP-NT located 
only in prominent cytoplasmic aggregates. We hypothesized whether it could be newly 
synthesized protein that is in the endoplasmic reticulum and Golgi complex and is in 
the process of being transported to the plasma membrane. Yet, these aggregates were 
not positive for markers of lysosomes or the Golgi complex, nor co-localize with the 
recycling endosome marker Rab11 (data not shown). Thus, although the nature of 
these clusters is unclear we thought that most likely they are a drawback of the 
overexpression and we ruled out cells with this characteristic expression pattern for 
subsequent experiments.  
 
DP-CT (region 544-1056) was clearly distributed over the plasma membrane, being 
excluded from the cytoplasm and nucleus.  
 
Taken together, our results show a clear domain dependence in the subcellular 
distribution of the PD of DP. Based on the differences in the subcellular distribution of 
these fragments, it seems that the C-terminal half of the PD of DP is needed to retain 
the fully functional properties of the plakin domain. On the one hand, the N-terminal 
half of the PD harbours binding sites for the association with other desmosomal 
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proteins. Yet, the isolated DP-NT region apparently lacks some regulatory or stabilizing 
elements that presumably lie on the C-terminal half of the PD, resulting in an aberrant 
subcellular distribution in some cells when it is ectopically expressed. On the other 
hand, the membrane-targeting observed with the isolated C-terminal half apparently 
reflects a non-physiological behaviour, because this region does not recruit the 
complete PD to the plasma membrane to a similar extent. The PD of DP adopts a 
mostly extended structure in which the two halves do not make contact (Al-Jassar et al. 
2011); therefore, it is unlikely that, in the complete PD, the N-terminal half could be 
masking a putative membrane targeting site in the C-terminal half. In addition, no 
membrane targeting motif has been described in the C-terminal half of the PD. Finally, 
the plasma membrane decoration of the DP-CT does not imply that this fragment was 
assembling new DMs or participating from DMs previously established. 
 
As a third method to evaluate the interaction between DP and PKP1a, we analysed the 
ability of PKP1a to relocate DP fragments. Assays where ectopically expressed 
proteins are targeted to specific cellular organelles to study the relocation of binding 
partners have been extensively used to demonstrate protein-protein interactions. A 
recent example with a close related protein is shown by Munoz et al. (2014), who 
targeted PKP3 to the mitochondrial outer membrane (MOM) and showed that it recruits 
the transcription factor ETV1. 
 
In COS-7 cells, ectopically expressed PKP1a-CFP showed an exclusively nuclear 
staining. This subcellular distribution had been previously reported in various cell types 
(Hatzfeld et al. 2000; Schmidt et al. 1997; Sobolik-Delmaire et al. 2010) being the 
expected in cell types not containing prominent DMs, such as COS cells. Interestingly, 
when DP-fragments were co-expressed with PKP1a, DP-PD and DP-NT were recruited 
to the nucleus, independently of the tag (Figures R7 and R8). This phenomenon was 
also reported by others (Hatzfeld et al. 2000) and strongly supports a bona fide 
interaction between PKP1a and the N-terminal half of the DP-PD observed with the 
others methods. On the other hand, PKP1a failed to recruit DP-CT to the nucleus, 
further supporting the lack of specific interaction between them.  
 
We wondered whether these results would be reproducible in DM-bearing cell lines. 
Thus, we performed similar experiments in keratinocytes cell lines (Figures R9 and 
R10). The main difference in the subcellular distribution of the analysed proteins 
between COS and keratinocytes was observed for PKP1a. In keratinocytes growing in 
differentiation conditions (high calcium concentration), in addition to the nucleus, 
PKP1a was enriched laterally at cell-cell contact sites, as expected due to the 
formation of DMs. When the complete plakin domain (DP-PD) or the N-terminal half 
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(DP-NT) were co-expressed with PKP1a, both were co-imported to the nucleus and 
plasma membrane. Again, DP-CT did not change its distribution after PKP1a co-
expression. 
 
In summary, we have established a multi-methodological experimental approach that 
combines co-IP, FLIM, and co-localization analysis in COS cells and keratinocytes to 
study the interaction between DP and PKP1a. Collectively, our data confirmed that DP 
interacts with PKP1a through the N-terminal half of the plakin domain. Our results also 
revealed that DP and PKP1a are closer than 10 nm when they interact with each other, 
suggesting a direct binding. Furthermore, such interaction does not require the 
formation of DMs. 
 
Mapping of the PKP1a-binding site in DP-NT, role of the SR2-like domain 
 
Once the interaction between PKP1a and the N-terminal half of the DP-PD was 
confirmed, we applied our experimental approach to further map the PKP1a-binding 
site within this region of DP. For this purpose, we made several constructs of DP and 
assayed their interaction with PKP1a. By co-IP, we dismissed the need for the SR6 and 
the SR5(SH3) regions of DP to associate with PKP1a. The N-terminal first 63 residues 
that precede the SR2 are not required for the interaction with PKP1a, either. However, 
removing the SR2 compromised the association with PKP1 in co-IP assays. These 
results indicate that the SR2-like domain of DP-PD is necessary for the interaction with 
PKP1a. Moreover, a HA-tagged construct containing the SR2-like domain and the 
preceding N-terminal sequence, region 1-170 (DP-SR2), interacted with PKP1-FLAG to 
a similar extent than the DP-NT fragment. This supports that the SR2-like domain of 
DP is sufficient to mediate the interaction with PKP1a, and constitutes a major 
interaction site (Figures R11 and R12).  
 
The important role of the SR2 in the interaction with PKP1a was further validated by 
using FLIM (Figure R13). FLIM results were in complete accordance with the 
biochemical data of the co-IP assays. Summarizing, Venus-tagged DP-PD and DP-NT 
produced a severely decrease in the CFP lifetime of PKP1-CFP, due to the proximity of 
the two fluorescent proteins. The effect of DP-Venus over the CFP lifetime of PKP1-
CFP was abolished or highly reduced when we eliminated the SR2 segment, 
suggesting that this region directly participates in the interaction DP-PKP1a. Lastly, the 
SR2-like domain of DP was sufficient to interact with PKP1a in our FLIM assays, 
similarly as observed in co-IP experiments. Interestingly, both methods suggested that 
the region SR3-SR5 might have an accessory contribution to the interaction with 
PKP1a. 
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To complement the analysis of the DP-PKP1a interaction, we investigated by confocal 
microscopy the subcellular distribution of fragments of the N-terminal half of the plakin 
domain of DP and their co-localization with PKP1a. We used the nuclear recruitment or 
enrichment of DP fragments as an indication of the interaction with PKP1a. In single 
transfections, N-terminal fragments of DP showed a diffuse distribution throughout the 
cell. In addition, likely due to the high level of expression of these small fragments, it 
was also possible to appreciate some nuclear staining in specific cases. In the 
presence of PKP1a, a nuclear enrichment of the DP fragments DP-SR2 (1-170) and 
DP-1-SR4 (1-376) was observed compared to the distribution showed when they were 
expressed alone. Interestingly, the construct DP-SR3-SR5 showed a dual pattern when 
co-expressed with PKP1-CFP. In some cells, DP-SR3-SR5 was not recruited to the 
nucleus by PKP1a. Yet, in other cells DP-SR3-SR5 was clearly enriched in the nucleus 
where it co-localized with PKP1a. This dual behaviour could be explained if the 
interaction between DP-SR3-SR5 and PKP1a had only moderate or weak affinity, so 
that small differences in the expression levels could result in large differences in the 
association, not always being possible to detect it (Figures R15 and R16). 
 
A preceding study had also tried to narrow the PKP1-binding site in DP (Smith & Fuchs 
1998). These authors had identified the first 176 residues of the DP-PD as a region 
containing a desmosome-recognition site. They addressed the ability of this segment of 
DP to associate with other desmosomal components by using overlay assays. They 
concluded that the first 176 residues of DP interact with the DSC1a cytoplasmic tail, DP 
itself, PKP1, as well as PKG, though weakly. Mapping the PKP1a interaction site in DP 
was not the scope of these authors, so they did not make an exhaustive analysis and 
did not prove the interaction of PKP1 with more fragments of DP-PD. Nevertheless, our 
results are in agreement with those findings. Interestingly, Smith and Fuchs located the 
desmosomal recognition site in the segment 86-176 of DP, which roughly corresponds 
to the SR2-like domain (residues 64-164) that we have shown to be a key element of 
the interaction with PKP1a. 
 
The location of the PKP1a-interaction region near the N-terminus of DP is reminiscent 
of the location of protein-binding sites in other plakins. For example, the N-terminal 
actin binding domain of plectin binds to multiple proteins including the integrin α6β4, 
nesptin-3α, actin, and calmodulin (reviewed in Castañón et al. 2013). Furthermore, the 
integrin β4 binding site in the epithelial variant of BPAG1 (BPAG1e) has been mapped 
to the first 92 residues (Koster et al. 2002). Despite internal regions of the plakin 
domain also mediate protein interactions, the frequent location of binding sites near the 
N-terminus suggest that these regions might have evolved to support specific 
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functions, while the SR3-SR9 region of the plakin domain, which shown a lower 
modular variability, might have a predominant structural role.  
 
Interestingly, the binding site for p0071 had also been mapped within the plakin domain 
of DP (Setzer et al. 2004). Like PKPs, p0071 is a member of the p120-catenin 
subfamily. p0071 normally localises to AJs but it is also able to associate with DMs 
through interactions with the PD of DP (Keil et al. 2013; Calkins et al. 2003). The dual 
localization of p0071 in actin- and IF-attached junctions raises the possibility that p0071 
plays a role in the mutual regulation of DMs and AJs. In fact, it has been shown that 
overexpression of p0071 affects the balance between desmosomal and AJs adhesion. 
Interestingly, this function is specific for p0071 and it is not shared with close related 
proteins (Setzer et al. 2004). 
 
The mechanisms by which p0071 promotes AJs formation at the expense of DMs 
assembly are not understood. Previous reports had shown that p0071 interacts with 
classical cadherins by means of its ARM-domain, whereas its head domain is able to 
interact with desmosomal proteins such as DP or PKG (Calkins et al. 2003; Hatzfeld 
2003). Using yeast two-hybrid assays, Calkin et al found that a small N-terminal 
fragment of DP, residues 1-160, was sufficient to interact with p0071, whereas the 
region 160-584 did not interact (Calkins et al. 2003).  
 
When p0071 associates with DMs it binds to the first 160 residues of DP, exactly the 
same region that we have identified as the main PKP1a-binding site in DP. Taking into 
account that the function of p0071 is in striking contrast to the role of PKP1; it might be 
possible that p0071 and PKP1a bind to DP in a mutually exclusive manner. This would 
shift the balance between the formation of DMs and AJs depending on p0071 
interactions. Thus, the overlapping of binding regions might be considered as a 
regulatory mechanism that contributes to the cross-talking between junctions.  
 
Our model combines three different sources of information: i) preceding observations 
that demonstrated that p0071 has a key role in regulation the balance between DMs 
and AJs, ii) previous work on the interactions between p120-catenin family proteins and 
cadherins, and iii) our mapping of the interaction between DP and PKP1a. We 
hypothesize that when the DMs formation is somehow negatively regulated, p0071 
binds the N-terminal region of DP displacing or preventing the formation of the PKP1a-
DP complex. In such scenario, the balance between junctions would favour the AJs, 
where p120-catenin would be attached to classical cadherins. However, since PKP1a 
is a key determinant in the assembly of DMs, and it recruits DP to cell-cell contacts 
sites and promotes lateral associations between desmosomal cadherins and 
desmosomal plaque proteins; when DMs assembly is required, PKP1a-DP complex 
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formation would be favoured at expense of the DP-p0071 binding. The release of 
p0071 from the complex with DP might also regulate the p120-catening/cadherins 
interactions at the AJs. Data currently available are compatible with this model but 
further investigation is required to assess whether p0071 and PKP1 actually compete 
for the binding to DP and to fully understand the role of the simultaneous stabilization 
of some interactions and inhibition of others in the interplay and cross-talking between 
DMs and AJs.  
 
Regarding to the possible regulation of junctions by mutually exclusive binding sites, 
the different interaction of DP mutants with PKP1 and PKG is of interest. Mutations in 
DP, among other desmosomal proteins, cause ARVC, a complex myocardial disorder 
associated with right-sided cardiomyopathy and arrhythmia, and characterized by 
gradual loss of myocytes and replacement by fatty and fibrous tissue (Corrado et al. 
1997). The ARVC-linked mutation Q90R lies in the region that we have identified as the 
main PKP1a-binding site in DP. Yet, this mutation does not compromise the interaction 
between PKP1a and DP (data not shown). On the other hand, the mutation Q90R 
affects the interaction of DP with PKG (Yang et al. 2006). Similarly, the DP mutation 
V30M also abolishes the interaction between DP and PKG, but has not effect over the 
PKP1-DP interaction (Yang et al. 2006). In addition, Calkins et al. (2003) had showed 
that PKG is able to interac with different fragments of the N-terminal region of DP, such 
as, DP-1-160 (residues 1-160) and DP-160-584 (residues 160-584). These results 
suggest that, contrary to the case of p0071 and PKP1, PKG and PKP1 do not interact 
with DP by the same region or at least not in an exclusive manner. Apparently, the 
PKG-binding site in DP involves a more extended region than that of PKP1a. This 
might be related with the fact that PKG interacts with DP by means of its ARM-domain, 
whereas PKP1a does by means of its N-terminal head domain. Finally, the fact that 
both ARM-proteins may interact simultaneously with DP is in agreement with their 
function at the DMs, since PKG and PKP1 have an additive effect in cellular adhesion 
strengthen.  
 
Structure of the SR2-like domain of DP 
 
Ironically, from a structural point of view the existence of the SR2 domain of DP, which 
apparently mediates important functions in the interaction with ARM-proteins, had been 
controversial to date. Based on sequence conservation the plakin domain of DP had 
been predicted to have seven spectrin repeats (SR3-SR9) and a SH3 (Al-Jassar et al. 
2011; Sonnenberg et al. 2007). The organization of the SR3-SR6 region was unveiled 
by the crystal structure (Choi & Weis 2011). On the other hand, the sequence upstream 
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of the SR3 (region 1-179) has been proposed to be unstructured (Al-Jassar et al. 2011; 
Choi & Weis 2011).  
 
In order to investigate the possible presence of a SR or SR-like domain in DP upstream 
of the SR3, we analysed several PD sequences by using profile hidden Markov models 
(HMM profiles). Using as template the bona fide SR2 domains of plectin, BPAG1, 
MACF1, periplakin, and envoplakin our profile-based search did not identify any 
canonical SR2 domain in DP. However, HMM profiles generated by using the 
sequences of all the SR domains of mammalian plakins, with the exception of the SR6s 
because of their divergent structure (Sonnenberg et al. 2007; Choi & Weis 2011), 
identified a region upstream of the SR3 (residues 65-157), which have at least a weak 
SR signature. It should be noted that the level of sequence identity and similarity 
between different repeats is rather low and, apparently, the structural homology 
between them is sustained by few conserved residues (Choi & Weis 2011). 
Furthermore, the SR2 domain of other plakins, such as plectin, lacks some of the 
structural features of the canonical SRs (Sonnenberg et al. 2007). 
 
In any case, since the statistical significance of the SR2-like fell in a doubtful zone, we 
further scrutinized this region in search for other SR-like signatures. First, sequence-
based secondary structure predictions made with two independent methods suggested 
the presence of three helices in the region 65-156 (Figure R42-A). Moreover, the limits 
of the three predicted helices in DP match the position of the three α-helices of the SR2 
of plectin in sequence alignments (Figure R42-B). These predicted helices have 
amphipathic character. Hydrophobic residues cluster on one side of the helix and 
occupy the first and fourth positions in the helical heptad repeat (positions a and d), 
while polar groups are more frequent in the opposite side. The predicted short loops 
that connect the helices suggest that the helices in the region 65-156 of DP pack in a 
helical bundle, compatible with a SR like fold.  
 
Next, we synthesised in E. coli, purified, and characterized by biophysical methods two 
constructs of the putative SR2 of DP with different lengths: DP-SR2-S-pET (region 64-
155) and DP-SR2-L-pET (region 64-164). Far-UV CD analysis revealed that both 
fragments have almost equal secondary structure. Based on the CD spectra they have 
a major content of α-helical structure, estimated between 68 and 83 %, with marginal 
presence of β-sheet content. This high α-helical content is compatible with a SR fold 
(Figure R43). 
 
To shed light on the structural organization of the SR2-like domain, we analysed the 
thermal stability of the DP-SR2-L and DP-SR2-S fragments by using CD and 
Thermofluor. By CD both proteins showed sigmoidal denaturation profiles that revealed 
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cooperative transitions similar to those observed during the denaturation of folded and 
well-ordered structures (Figure R44). In fact, the denaturation curves could be 
analysed using a two-state transition from a folded to an unfolded state, which fitted the 
experimental data. The Tm of the short (64-155) and the long (64-164) constructs were 
~61 °C and ~74 °C, respectively. These fragments are more thermostable than the 
fragments SR4-SR6, SR7-SR8, and SR8-CT of DP, that have reported Tm of 50, 60, 
and 52 °C, respectively (Al-Jassar et al. 2011). The higher thermal stability of the 64-
164 fragment with respect to the 64-155 was confirmed using Thermofluor assays, in 
which the Tm of the DP-SR2-L and DP-SR2-S at neutral pH were ~66 °C and ~55 °C, 
respectively. 
 
The large difference between the Tm of the short and long constructs of the putative 
SR2-like domain was striking (~13 °C in the CD melting curves), and revealed that the 
156-164 greatly contributes to the stability of the SR2. The secondary structure 
predictions suggest that this final stretch is not helical; yet, it could be possible that the 
156-164 segment would stabilize the final turns of helix C. Alternatively, the 156-164 
could act as a cap that tights the helical bundle via electrostatic interactions. This 
segment contains a patch of three basic residues R160, R162, and R163, which could 
interact with an electronegative area that includes acidic residues at the C-terminus of 
helix A (E86 and E92) and the N-terminus of helix B (E106 and E109). Interestingly, we 
did not observed changes in the Tm of this fragment in a range of pH between 6.0 and 
8.0. This is compatible with a predicted stable protonation state of Glu and Arg within 
this range of pH. 
 
We have obtained evidences supporting that the region 64-164 of DP forms a helical 
bundle, probably very similar to other SRs. The very low similarity with the SR2 
domains of other plakins suggests that this region of DP might have a different origin 
than other SR2 domains or that it has evolved in a divergent way from them. In 
summary, we consider the DP-PD having eight SRs (SR2-SR9). The SR2-SR3 
domains are separated by a linker of ~20 residues, whereas the rest of the SRs are 
connected by fussing the helix C from one repeat to the helix A of the following. 
 
Secondary PKP1a-interactions in the DP-PD 
 
Our data suggested that the region SR3-SR5 of DP has an accessory contribution to 
the interaction with PKP1a. Similar to how proteins in a complex cooperatively bind to 
each other to achieve specific functions, there is also such cooperation among 
domains in the same protein. When the interaction between DP-Venus and PKP1a-
CFP was analysed by FLIM, the complete DP-PD, and the regions DP-SR2-SR9 and 
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DP-SR3-SR9 caused significant reductions of the CFP lifetime with respect to the 
control samples, indicating that these fragments of DP interact with PKP1a. Yet, 
shorter fragments starting at the SR4, SR5, or SR6 did not interact noticeably (Figure 
R17). Similar results were obtained by looking at the subcellular distribution and co-
localization of PKP1a and DP fragments ectopically expressed in COS-7 cells, 
although in this analysis the fragment DP-SR3-SR9 showed a mixed behaviour, it co-
localized with PKP1a in some cells but not in others (Figure R19). Thus, it seems that 
in addition to the primary site located in the SR2-like domain, the SR3 sub-domain 
possibly cooperates in the association providing secondary sites for the interaction with 
PKP1a. These secondary interactions are not sufficient to drive the proper association 
of DP and PKP1 by their own, as it was highlighted by the co-localization analysis, but 
are likely to reinforce the binding mediated for the SR2-like domain.  
 
We tried to understand the structural basis of the cooperation between the SR2 and the 
SR3. The SR3 is part of an apparently rigid structural unit formed by the repeats SR3-
SR6. Unfortunately, attempts to crystallize the N-terminal region of the PD of DP 
(region 1-630) were unsuccessful. Thus, the structure of this region was investigated 
by SAXS. This region has an overall elongated shape, as indicated by the form of the 
P(r) function, the dimensionless Kratky representation of the scattering data, and the 
rigid body modelling. The presence of two putative non-helical segments in the N-
terminal half of the plakin domain of DP, one upstream the SR2-like and a second 
connecting the SR2-like and the SR3, suggested that a priori there could be significant 
conformational variability in this region. Yet, multiple rounds of rigid body refinement 
against SAXS data of the region 1-630 of DP using two independent modelling 
methods (implemented in the programs CORAL and BUNCH) yielded models with 
repetitive features. The refinement was done using two rigid bodies (the SR2 and the 
SR3-SR6 region) and two flexible segments (the 63 residues long N-terminal tail and 
the ~20 residues long linker between the SR2-SR3 domains). In all the models 
obtained with both programmes, the SR2 domain is placed on one side of the SR3, 
whereas the N-terminal tail (residues 1-63) is built in an extended conformation that 
project away from other parts of the structure (Figures R48-A and R49-A). The 
repetitive positioning of the SR2 adjacent to the SR3 suggests that these two domains 
could establish lateral interactions and adopt a compact arrangement. Notably, the ab 
initio reconstructions of the 1-630 structure from the SAXS data yielded low resolution 
envelopes with a slightly bent rod-like shape (Figure R47) that are in good agreement 
with the atomic models obtained by rigid body fitting. 
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The role of the linker connecting the SR2 and SR3 domains and the structural 
organization of this region of DP are unknown. In this respect, the crystal structure of 
the SR3-SR4 of BPAG1e (PDB entry 2IAK) includes 16 residues upstream of the SR3, 
which adopt an extended conformation and pack alongside against the SR3 in between 
helices A and B (Jefferson et al. 2007). By analogy, the SR2-SR3 linker in DP may also 
adopt a relatively ordered structure. Nonetheless, this linker is sensitive to proteolytic 
digestion with trypsin and chymotrypsin, which cleave DP after K167 and Y172, 
respectively (Choi & Weis 2011). This suggests that the linker has a loose structure, at 
least in part. 
 
The folded-back organization of the SR2 onto the SR3 has implications for the 
interaction of this region with PKP1a. This closed arrangement could generate a 
binding site for PKP1a or it could favour the correct display of two sub-sites in each 
domain. In addition, binding of PKP1a to DP could induce a change in the arrangement 
of the SR2-SR3 region which could be linked to the modulation of DP function, for 
example exposing cryptic binding sites. Conversely, changes in the organization of the 
SR2-SR3 arrangement could modulate the affinity for PKP1a or other ligands that bind 
to the N-terminal region of the plakin domain. For example, stretching of DP would alter 
the organization of the SR2-SR3 region, which in turn could modify the way this region 
interacts with other proteins, suggesting that DP might act as a mechanosensor in a 
similar form as focal adhesion proteins (Ciobanasu et al. 2013). 
 
Unravelling the DP-binding site in PKP1a 
 
It had been shown that the head domain of PKP1a mediates the interaction with DP 
(Hofmann et al., 2000; Kowalczyk, 1999; Sobolik-Delmaire, Katafiasz, & Wahl, 2006). 
Initially, we used this well-established interaction to assess the effectiveness of our 
multi-methodological approach, which includes Co-IP, FLIM, and co-localization 
analysis, to map the DP-interaction site in PKP1a. Association of the head domain of 
PKP1a with DP-PD and DP-NT was observed in Co-IP and FLIM assays, whereas the 
ARM domain of PKP1 did not interact with this DP fragments (Figures R20 and R21). 
Furthermore, DP-NT was markedly recruited to the nucleus when co-transfected with 
PKP1a full length or head domain. PKP1-ARM-CFP was diffusely distributed 
throughout the cytoplasm and was not markedly present at the nucleus. This precluded 
the use of the co-localization with DP-NT as an indication of interaction, since both 
proteins were already located at the same subcellular compartment.  
 
The head domain of the three PKPs is considered mainly disordered with only a small 
fragment near the N-terminus (HR2) believed to form an α-helix. Interestingly, the head 
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domain is much larger in PKPs than in the rest of the ARM-proteins. PKG, for instance, 
has a merely 79 amino acids head domain, also predicted to be intrinsically disordered 
(Choi et al. 2009). Accordingly, the function of the head domain in PKPs is opposed to 
that of this same domain in the rest of the ARM-proteins. Typically, ARM-proteins 
interact with their binding partners by means of their ARM-domains, which form an 
elongated superhelical structure that facilitates protein associations as shown by the 
crystallographic structures of several ARM-domains (Liu et al. 2009; Huber et al. 1997; 
Choi & Weis 2005). PKPs, however, use the amino-terminal head domain to drive all 
their known interactions. 
 
In recent years, it has been recognized that PKPs are multifunctional proteins that 
promote cell adhesion at the DMs but also participate in several signalling-related 
functions in the cytoplasm and nucleus (reviewed in Hatzfeld et al. 2014; see examples 
in Godsel et al. 2010; Hatzfeld et al. 2000; Hofmann et al. 2006; Koetsier et al. 2014; 
Mertens et al. 2001; Sklyarova et al. 2008; Wolf et al. 2010). During this time, the study 
of the function and structure of inherently disordered proteins has also come to the 
fore. These proteins are characterised for their remarkable capacity to interact with 
many molecular species, participating in numerous processes within cells (Zhuang et 
al. 2011). Thus, PKPs might be stretching this plasticity by adopting suitable 
conformations upon interaction with their different binding partners, resulting in distinct 
structures and promiscuity in functions. Another tool for achieving the required flexibility 
needed by PKPs to cover their different functions may be related with post-translational 
modifications (PTMs). The head domain of the three PKPs possesses a very high 
number of phosphorylable residues. Specifically for PKP1, they have been reported 
~60 phosphorylation-sites in its head domain (http://www.phosphosite.org; Hornbeck et 
al. 2004) distributed in hot-spots of phosphorylation around residues ~50-70, ~78-85, 
~98-110, ~118-121, and ~180-190. The high number of phosphorylation-sites in the 
head domain of PKPs suggests that this PTM may play an important role in the 
structure-to-function acquisition (Hatzfeld et al. 2014). Recently, Wolf et al. (2013) have 
reported an interesting example of how phosphorylation induced by insulin signalling 
switches PKP1 function from stabilizing cell adhesion to promoting cell proliferation. In 
this case, phosphorylation in S118 by Akt2 results in the delayed degradation of PKP1. 
The higher protection of p-PKP1 (phosphorylated PKP1) against degradation might be 
correlated with the secondary structure acquisition, although much further investigation 
is required in this field.  
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Precise mapping of the DP-binding site within the head domain of PKP1a 
 
Non-structured proteins are often involved in molecular interactions mediated by 
localized binding sites, sometimes as narrow as 10 amino acid residues or less 
(Dunker et al. 2008). We wondered whether the DP-recognition site in PKP1a would 
also be a short sequence. Thus, we used our multi-methodological approach with N-
terminal deletion mutants of PKP1a to identify the minimal region that supports the 
interaction with DP. This was narrowed down in several stages.  
 
First, we delimited the major DP-interaction determinant in PKP1a to a region 
comprehended between residues 52-120. A previous report had proposed that the 
PKP1 region 1-34 was essential to mediate the interaction with DP (Sobolik-Delmaire 
et al. 2006). In contrast, our data revealed that the N-terminal 51 residues, which 
contain the HR2 motif, were dispensable for the interaction, albeit this segment 1-51 
was sufficient to moderately pull-down DP-NT in Co-IP assays (Figure R23). 
 
Next, we narrowed the DP-interaction site within the 52-120 region of PKP1a. Using 
FLIM we mapped the DP-recognition site to the region 98-120 of PKP1a. Further 
analysis within this segment suggested that the major determinant of the interaction 
with DP is located in the region 104-116 of the head domain of PKP1a (Figure R26). 
Co-localization assays did not allow such precise mapping but agreed with FLIM 
results identifying the region 98-116 of the head domain of PKP1a as critical for the 
interaction with DP (Figure 27). 
 
Interestingly, this minimal DP-recognition site in PKP1a appears to require only ~10 
residues, which are sufficient to mediate this interaction. We do not exclude that other 
segments of the head domain of PKP1 upstream of this site might additionally 
contribute to the interaction. Our approach was directed to the identification of a 
minimal site. More quantitative analysis will be required to assess whether DP engages 
with multiple sites in PKP1a other than the 104-116 segment, and if so, whether DP 
binds simultaneously to these multiple sites in PKP1a. 
 
In DMs PKP1a functions as a multi-linker protein, interacting concurrently with several 
proteins to promote lateral associations. Thus, it is plausible a model where small and 
localized interaction sites for different proteins are arranged along the head domain of 
PKP1a. This arrangement would provide a multiple-interaction surface favouring the 
formation of multi-protein complexes. Yet, the precise interacting-regions for other 
PKP1-binding partners have not been identified to date.  
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Identification of one nuclear-targeting sequence in PKP1-head 
 
It had been extensively reported that endogenous and overexpressed PKPs, in addition 
to DMs, also localise to the nucleus (Bonné et al. 1999; Mertens et al. 1996; Schmidt et 
al. 1997). This localization is independent of DMs formation, occurring in DM-bearing 
and non-bearing cells lines (Hatzfeld et al. 2014).  
 
To date, the specific nuclear functions of PKPs remain largely speculative. Only 
recently they have been reported interactions between PKP2 and the RNA polymerase 
III, between PKP3 and the ETV1/ER81 transcription factor, as well as between PKP1 
and ssDNA (Mertens et al. 2001; Sobolik-Delmaire et al. 2010; Munoz et al. 2014). 
 
Out of the three PKPs, PKP1 is the most nuclear-prominent. The PKP1a isoform is 
present at both nucleus and DMs, whereas PKP1b is only detected in the nucleus 
(Schmidt et al. 1997). The sequences of both PKP1 isoforms do not contain any 
obvious NLS (nuclear localization signal), nor any canonical NES (nuclear exporting 
signal). PKP1b only differs from PKP1a in an additional exon, which adds 21 amino 
acids after the residue 411 in the ARM-domain. Considering that the rest of the 
sequence is identical in both isoforms and all PKP1-interaction partners reported so far 
bind PKP1 within his head domain, the processes that target, transport, and maintain 
one of the isoforms in the nucleus remain completely uncharacterized.  
 
An initial cue to understand the prominent nuclear localization of PKP1a derives from 
the differential behaviour of PKP1a in DM-bearing and non-bearing cell lines (Figure 
R28). In cells that do not form DMs, PKP1a is completely localized to the nucleus. That 
is the case also for keratinocytes growing in serum-free medium, which remain in an 
undifferentiated state where DMs are not formed. However, when keratinocytes are 
stimulated to differentiation, PKP1a is relocated into cell-cell junctions, yet still present 
at the nucleus. Thus, although PKPs had been proposed as desmosomal proteins 
since the beginning and the non-desmosomal functions of these proteins just arose 
during the last years; now, it seems plausible that the primary location of PKP1a is the 
nucleus, and therefore, they have a prominent nuclear function. In fact, a recent study 
has suggested that the Wnt-signaling related functions of catenin proteins might have 
arisen earlier in evolution than their roles in adhesion (Dickinson et al. 2011).  
 
To shed light on the processes that govern the relocation of PKP1a in the cell and the 
cytoplasm/nucleus shuttling, we aimed to identify the region of PKP1a that mediates 
the nuclear targeting. We studied the nuclear determinants of PKP1a in COS-7 cells, 
which do not form prominent DMs. In addition, we used normal human keratinocytes 
(NHK) as a model of DM-bearing cell line. In COS-7 and undifferentiated NHKs 
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(growing at low-calcium concentration), PKP1-CFP showed an exclusively staining of 
the nuclear karyoplasm, being mostly excluded from nucleoli, in agreement with 
previous reports (Hatzfeld et al. 2000; Schmidt et al. 1997; Sobolik-Delmaire et al. 
2010). When keratinocytes were induced to differentiate by rising calcium 
concentration in the growth medium, PKP1-CFP localised both to the nucleus and to 
the plasma membrane where it concentrated in punctuated structures, characteristic of 
DMs (Figure R28). The relocation of PKP1-CFP at cell-cell contact sites upon 
differentiation demonstrated that CFP does not prevent PKP1a normal subcellular 
trafficking and that PKP1a nuclear localization is DM-independent. This also revealed 
that the study of the nuclear determinants in PKP1a can be done by using CFP-tagged 
constructs transiently transfected in COS-7 cells.  
 
It had been shown that the head domain of PKP1a is required for the nuclear 
localization of PKP1a in COS (Kowalcyk et al. 1999), HaCaT, and HeLa cells (Hatzfeld 
et al. 2000). Sobolik-Delmaire et al. (2010) had identified the segment 55-125 as an 
important region for the nuclear targeting in A431 cells. We have further enlarged the 
mapping of the regions important for the nuclear localization of PKP1a (Figure R34). 
The first 109 residues of the head domain of PKP1a were dispensable for the nuclear 
localization. Shorter deletion mutants starting on positions 116 to 151 showed a 
progressive increase in the cytoplasmic fraction of PKP1a. Fragments with further 
deletions or complete ablation of the head domain showed an equal distribution 
between nucleus and cytoplasm. Our results suggest that the segment 110-132, and 
probably the region 133-150, play an important role in the nuclear-to-cytoplasmic 
relocation of PKP1a.  
 
Since PKP1 lacks defined NLSs, it is possible that an unidentified nuclear protein 
assists PKP1a with the nuclear import. However, efforts to identify PKP1-binding 
partners have been mostly unproductive so far. Only recently, some putative nuclear 
PKP1-interacting partners have been suggested, but the biological significance of the 
reported interactions is still pending (Reddy 2013). Interestingly, the nuclear 
determinant that we have identified is downstream of the DP-binding site (residues 
~98-116). The recruitment of DP to the nucleus by PKP1a suggests that PKP1a 
probably interacts simultaneously with DP and a putative nuclear binding partner 
(Figure D1). 
 
It is also possible that the nuclear localization of PKP1a relies on some PTM, rather 
than on binding to a nuclear protein. It is well established that some modifications, such 
as phosphorylation, palmitoylation, ubiquitination, etc. regulate diverse protein features 
including protein localization, activity, and stability (Deribe et al. 2010; Hunter 2010). 
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Accordingly, the nuclear determinant that we have identified (residues ~116-132) 
matches one of the hot-spots of phosphorylation mentioned before (region ~118-121) 
(Figure D1). Notably, Akt2-dependent phosphorylation of PKP1a at S118 regulates the 
subcellular distribution of PKP1, although it apparently has a minor effect on its nuclear 
localization (Wolf et al. 2013). In addition, it has been recently reported that 
palmitoylation of a conserved cysteine residue present in the three PKPs ARM-
domains regulates PKP incorporation into assembled DMs, and prevents PKP-
dependent DM formation (Roberts et al. 2014). Yet, further investigation on the effects 
of PTMs in PKPs, is still needed.  
 
 
 
Figure D1. PKP1-head domain functional sites. A) Schematic representation of PKP1a. The head 
domain of PKP1a is represented by a line divided in 24 segments of 10 residues. The ARM-domain is 
represented by its atomic structure (PDB entry 1xm9). B) Detail of the PKP1-head domain. Numbers 
above the sequence identify the functional domains of PKP1-head: i) DP-binding site (DP-site), DP is 
represented by the DP-NT fragment (region 1-545), which interacts with PKP1a in the region ~98-116; ii) 
Nuclear determinant identified in this work (Nuclear determinant), corresponding to the region ~116-132. In 
the figure it is also represented the uncharacterized nuclear protein that might participate in the PKP1 
nuclear-targeting (?) by interacting with this region of the PKP1-head domain (residues ~116-132). Notice 
that both sites are not mutually exclusive, but also are located one next to the other; iii) Predicted 
phosphorylation sites are marked by red dots (http://www.phosphosite.org). Notice that one of the hot-spot 
of phosphorylation matches the DP-binding site (~98-110), whereas the next is inside the nuclear 
determinant (~118-121). 
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The analysis of N-terminal deletion mutants revealed an important role of the region 
116-132 in the nuclear localization of PKP1a. Yet, this segment is not sufficient by itself 
to mediate nuclear targeting, suggesting that this process may involve multiple sites at 
the head domain. In fact, the N-terminal segment 1-132 was enriched in the nucleus in 
the absence of other regions, despite it was dispensable for nuclear targeting in the 
initial N-terminal deletion analysis. The contribution of multiple sites to the nuclear 
localization of PKP1a was further supported by the efficient nuclear localization of 
PKP1a internal deletion mutants in which the regions 116-132 or 110-150 had been 
removed. Collectively, our results suggest that the head domain of PKP1a may contain 
at least three regions involved in its nuclear accumulation: the 116-132 motif, and two 
additional regions up- and downstream of this segment (sites P1, P2, and P3). 
 
Our results could be explained if PKP1a interacts with several nuclear partners via 
several putative sites (Figure D2 shows an explanation with three putative sites). In this 
model, the nuclear targeting of PKP1a would require the combined contribution of 
several regions; therefore, it would be lost only when more than one nuclear 
localization site is deleted. In the N-terminal deletion mutants, fragments trimmed down 
to ~110 would lose the P1 site, but they could still be targeted to the nucleus through 
the P2 and P3 sites (Figure D2-B). Shorter N-terminal deletion fragments, in which the 
region 116-132 was removed, would have lost the P1 and P2 sites. The remaining P3 
site would be insufficient to maintain PKP1a in the nucleus (Figure D2-C). Internal 
deletion mutants that lack the 110-150 region (site P2) would be recruited to the 
nucleus via the P1 and P3 sites (Figure D2-D). Finally, the N-terminal fragment 1-132, 
which lacks the putative P3 site, would be targeted to the nucleus by the P1 and P2 
sites (Figure D2-E). 
 
The existence of multiple regions that contribute to the nuclear targeting of proteins has 
been previously reported (Guo et al. 2013; Mavinakere et al. 2012; Shaulsky et al. 
1990). For instance, the C-terminal region of p53 contains a cluster of three NLSs that 
mediate nuclear import; where NLS-I and -II cooperate to target p53 to the nucleus 
(Shaulsky et al. 1990). In the case of PKP1, it also seems that the nuclear 
determinants do not participate equally in the nuclear targeting of PKP1. For instance, 
the fragment PKP1-1-132 (region 1-132) that in our hypothetical model has two 
putative binding-sites for nuclear proteins does not show a restricted nuclear 
localization. Conversely, the internal deletion mutants and the N-terminal deletion 
fragments trimmed up to residue 109, which also harbour two putative interaction-sites, 
show this confined localization.  
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Figure D2. Multiple regions of the PKP1-head contribute to the PKP1-nuclear localization. 
Hypothetical models to explain how multiple regions of the PKP1-head domain contribute to the PKP1-
nuclear localization. A) Schematic representation of WT PKP1a-head with three nuclear interacting 
partners (P1, P2, and P3). In this scenario, PKP1a would localise to the nucleus. B-C), N-terminal deletion 
mutants of the PKP1-head domain compromise the interaction of putative PKP1-nuclear binding partners. 
Depending on the depth of the deletion one or more sites would be removed. In this scenario, PKP1a 
would preserve the nuclear localization when at least two nuclear determinants were present (B). D) The 
internal deletion of the 116-132 or 110-150 segments only would remove one of the nuclear localization 
sites. Thus, the nuclear localization of PKP1a would not be affected. E) The N-terminal fragment 1-132, 
which lacks the putative P3 site, would be targeted to the nucleus by the P1 and P2 sites.  
 
Finally, NLSs are characterized by short sequences of positively charged amino acids 
(Kalderon et al. 1984). The very basic condition of the head domain of PKP1a, with an 
pI ~9.5, might favour that multiple sequences within this domain act as non-canonical 
NLSs that cooperate to retain PKP1a in the nucleus. 
 
During all these experiments we realised that independent of how much we trimmed 
PKP1a and, even working only with the PKP1-ARM domain, a remaining nuclear 
staining was repeatedly observed. Previous reports had suggested that PKP1 might 
have at least two NLS (Sobolik-Delmaire et al. 2010). However, we considered other 
possibilities, such as the nuclear recruitment of PKP1a-fragments by means of the 
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homo-association with endogenous PKP1 (Hofmann, Mücke, et al. 2000). Yet, this 
option was ruled out because the subcellular distribution of PKP1 mutants was similar 
in NHK (that expresses endogenous PKP1) and in PKP1-null keratinocytes established 
from a patient with skin fragility-ectodermal dysplasia syndrome whit total ablation of 
PKP1 (South et al. 2003) (Figure R37). These subcellular distributions were also 
similar to those previously observed in COS-7 cells. 
 
At this point we thought again in a possible effect of the CFP tag. We had previously 
observed that our CFP-tagged constructs of PKP2a, PKG, and DP showed specific 
subcellular distributions; including PKP2a, which did not exhibit any nuclear signal (see 
Figures R29, R30, and R32). So, it was very unlikely that the same CFP-tag was 
recruiting to the nucleus the CFP-tagged PKP1a deletion constructs that lack the first 
116 to132 residues (i.e. 133-726, 151-726, 181-726, and ARM-domain). Yet, we 
analysed the localization of constructs fused to an N-terminal HA tag (using two 
vectors: pCEFLHA and pcDNA3-HA) or FLAG tag (pCEFLAG vector) (Figure R38). Full 
length PKP1a showed a similar distribution in the CFP-, HA-, and FLAG-tagged 
constructs. The ARM domain showed an equal nuclear and cytoplasmic distribution 
when expressed with a CFP-tag or with a HA-tag using the pcDNA3-HA vector. 
Strikingly, the ARM domain was excluded from the nucleus when the PKP1-ARM was 
tagged with FLAG or with HA using the pCEFLAG or the pCEFLHA vectors, 
respectively. The contrasting results observed for the HA-tagged ARM domain with the 
pcDNA3-HA and pCEFLHA vectors suggested that it might be a dependence of the 
promoter used (EF1 promoter in pCEFL-vectors or CMV in pcDNA3-based vectors). 
This is in agreement with the nuclear localization of the CFP-tagged ARM construct, 
which was also made using the pcDNA3 vector. 
 
Despite these unexpected vector-dependent results, altogether they reveal that the 
nuclear localization of PKP1a is determined by the head domain, without participation 
of secondary NLSs located in the ARM-protein. This was confirmed by analysing the 
subcellular distribution of several HA-tagged PKP1a N-terminal deletion mutants (made 
in the pCEFLHA vector), which highlighted the role of the 116-151 region of the head 
domain of PKP1a for its nuclear targeting. Constructs starting at residue 151 or 181 did 
not show nuclear localization. Collectively, these results agreed with those observed 
with similar constructs tagged with CFP (compare Figures R34 and R39).  
 
Finally, we also analysed whether the subcellular distribution of PKP2a was also 
determined by sequences in its head domain (region 1-348). In COS-7 cells, PKP2a is 
predominantly located at the plasma membrane. This distribution was also observed in 
the N-terminal deletion mutants 65-838 (PKP2-65) and 151-838 (PKP2-151). However, 
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further N-terminal deletions, as in the fragment 220-838 (PKP2-220) and the isolated 
armadillo domain (PKP2-ARM, region 349-838), resulted in the loss of the specific 
localization at the plasma membrane. PKP2-220 and PKP2-ARM appeared distributed 
throughout the whole cell. Interestingly, the armadillo domain of PKP2a showed a 
prominent nuclear presence, similar to that observed for the CFP-tagged armadillo 
domain of PKP1a. 
 
Altogether, these results suggest that PKP1a and PKP2a harbour specific regions 
within their head domains that dictate the functional subcellular localization of these 
proteins. Interestingly, each protein is specifically targeted to different subcellular 
compartments but, in the absence of the functional-targeting sequences in the head 
domain, both are equally misallocated showing a diffuse distribution throughout the 
cell, including nuclear staining. This is particularly striking for PKP2 that is absent from 
the nucleus in the full length form. Therefore, the nuclear localization of CFP-tagged 
constructs of PKP1a and PKP2a that lack the relevant targeting sequences most likely 
does not correspond to a native function. 
 
Structure of the C-terminal half of the PD of DP 
 
While the N-terminal half of the PD of DP harbours the PKP1a-interaction site, the C-
terminal half (repeats SR7-SR9) contributes indirectly to the function of the PD. 
Therefore, we have analysed the structure of this region of DP. 
 
The constructs of DP used in the functional assays contain the C-terminal half 
extended to residue 1056, including the initial part (residues ~1026-1056) of the rod 
domain. The rod domain is thought to mediate homo-dimerization by means of coiled-
coil interactions (Green, Virata, et al. 1992; O´Keefe et al. 1989). By using Co-IP 
assays we have shown that the short segment 1026-1056 of the rod domain mediates 
self-association of the C-terminal part of the PD. 
 
To further study the structure of the C-terminal region of the PD of DP, we expressed in 
bacteria and purified the fragment 660-1056 that includes the SR7-SR9 and beginning 
of the rod domain. Attempts to crystallize this fragment were not sufficient successful 
and we only obtain microcrystals, not suitable for crystallographic analysis (data not 
shown). To overcome this limitation, we applied SAXS to analyse the structure at low-
resolution of this region of DP.  
 
Surprisingly, analysis of the SAXS profiles revealed that the apparent molecular weight 
of this fragment (42.3 kDa) correspond to the theoretical molecular mass of the 
monomer (46.8 kDa). Thus, in contrast to the association detected by Co-IP, the short 
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N-terminal segment of the rod domain was insufficient to mediate self-association in 
vitro using purified protein. The differences between the Co-IP results that revealed 
dimerization and the monomeric state observed in vitro suggest that the homo-
association might be stabilized by adaptor molecules present in the COS-1 cell lysates. 
It would also be possible that in mammalian cells the DP fragment undergoes PTMs 
that favour self-association. Finally, the association observed by Co-IP might represent 
only a minor fraction of the total protein levels in the lysates. 
 
The monomeric SR7-SR9 has an elongated shape with a maximum dimension of ~165 
Å, as revealed by the SAXS-derived P(r) distance distribution function and the ab initio 
reconstructions of the structure. This elongated shape is consistent with three 
concatenated tandem SRs. In fact, a homology 3D model of this region built using the 
structure of the SR7-SR9 region of plectin reproduced the scattering data. It had been 
suggested that the region 883-1022 of DP would not form a SR, but it would constitute 
a flexible region instead (Al-Jassar et al. 2011). Yet, the DP region 885-1025 shares a 
~38% sequence identity with the SR9 of plectin, supporting that DP has a well ordered 
and bona fide SR9. Moreover, our SAXS data indicates that the SR7-SR9 region is an 
apparently rigid structure. 
 
Since the DP-CT fragment (region 660-1056) did not dimerize in solution but it is well 
stablished that DP and other plakins form dimers via coiled-coil interactions of the rod 
domain, we stabilized the homo-dimerization by adding a leucine zipper of the yeast 
transcriptional activator GCN4 at the C-terminus. GCN4 forms a stable homo-dimeric 
parallel coiled coil that has been extensively characterized and is frequently used as a 
model homo-dimerization motif (O’Shea et al. 1991). The structure of the DP-CT-GCN4 
protein (DP region 660-1060) was analysed by SAXS. The molecular mass of this 
fragment in solution estimated from the SAXS data (~119 kDa) was approximately 
twice the molecular weight calculated from the sequence (51.2 kDa) indicating that the 
GCN4 effectively stabilizes the homo-dimer. Low resolution reconstructions of the DP-
CT-GCN4 structure using the scattering data and ab initio methods revealed an 
elongated and flat structure being narrow towards one of the longitudinal ends, with 
overall dimensions of approximately 240 Å x 105 Å x 45 Å . This shape suggested that 
the two protomers run parallel and possibly establish contacts along the SR7-SR9 
modules. Interestingly, the crystal structure of the SR7-SR9 of plectin contains two 
plectin molecules in the asymmetric unit of the crystal. A composite atomic model of 
the DP-CT-GCN4 based on the crystallographic dimer of plectin matched the ab initio 
low resolution structure of DP and approximately reproduced the scattering data, 
suggesting that the model reproduces the overall features of the DP dimeric structure.  
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This suggests that the observed parallel arrangement of the SR7-SR9 might also occur 
in plectin and other plakins. Nonetheless, the specific arrangement of the two DP 
molecules might be slightly different from that observed in the plectin crystal structure.  
 
Collectively, the PD of DP resembles a tripartite articulated structure consisting of three 
apparently rigid modules: the SR2-like domain, the SR3-SR6 region, and the SR7-SR9, 
that are connected by flexible linkers.  
 
Dimerization of DP via the rod domain would favour the interaction with other proteins 
by exposing bivalent biding sites. The parallel and proximal arrangement of the SR7-
SR9 module probably restricts the maximum distance between binding sites located in 
the N-terminal half of the PD. This is likely to impose a limit in the maximum separation 
of the ligands to achieve efficient binding, and suggests that efficient binding of DP to 
other proteins, such as PKPs, requires a minimum ligand density. 
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1. The N-terminal half of the plakin domain of desmoplakin interacts with the head 
domain of plakophilin 1a. This association is independent of the assembly of 
desmosomes. 
 
2. The SR2-like domain of desmoplakin is necessary and sufficient for the interaction 
with plakophilin 1a. The SR3 domain contributes secondarily to this interaction.  
 
3. The central region of the head domain of plakophilin 1a, residues 98-116, is critical 
for the interaction with desmoplakin. Within this region, the residues 104-116 form a 
crucial motif of interaction. 
 
4. The head domain of plakophilins 1a and 2a is the main determinant of their 
subcellular localization. 
 
5. Plakophilin 1a localizes predominantly to the nucleus in desmosome-bearing and 
non-bearing cells lines. The segment 116-132 acts as a nuclear localization signal. 
Yet, these residues are not sufficient to maintain plakophilin 1a in the nucleus. 
 
6. The nuclear localization of PKP1a requires the combined contribution of several 
regions of the head domain. In the presence of sequences either up- or down-
stream of the region 110-150, this segment is dispensable for nuclear targeting.  
 
7. The N-terminal region of desmoplakin, residues 64-164, has very high content of α-
helical structure that is likely to consist of three helices that form a non-canonical 
SR2-like domain. 
 
8. The SR2-like domain of desmoplakin is apparently located on one side of the SR3-
SR6 segment, and possibly makes lateral contacts with the SR3.  
 
9. The C-terminal half of the plakin domain, residues 660-1056, forms a monomeric 
rigid rod-like structure in solution that is compatible with a structure consisting of an 
array of three SR (SR7-SR9). 
 
10. Dimerization of the C-terminal half of the plakin domain of desmoplakin by a 
coiled-coil that mimics the rod domain results in a parallel arrangement with possible 
inter-protomer contacts along the SR7-SR9 domains. 
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